Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),0.8461782099414383,2.5544808322934354,0.0,0.0,0.0,19/29,9.42%,GRIA2;GABRB3;GABRA5;GABRB1;GRIA4;GABRA2;GRID1;GRID2;GABRG3;GABRA3;GRIK1;GABRA4;GABRB2;GRIN2D;GLRA3;GRIK2;GRIK5;GABRG2;GLRA2
prerank,glutamate receptor activity (GO:0008066),0.8784385765988478,2.4117420472994895,0.0,0.0,0.0,13/19,4.69%,GRIA2;GRM5;GRIA4;GRM7;GRM1;GRID1;GRID2;GRM8;GRIA1;GRIK1;GRIN2D;GRIK2;GRIK5
prerank,ligand-gated cation channel activity (GO:0099094),0.6420543355831746,2.3530284341933116,0.0,0.0,0.0,23/75,8.42%,GRIA2;GRIN1;GRIA4;KCNJ3;ASIC2;KCNJ6;KCNN2;GRIN2A;ASIC4;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;KCNJ11;KCNN1;ASIC1;KCNJ10;TRPM2;GRIA3;KCNN3;KCNK1
prerank,ligand-gated ion channel activity (GO:0015276),0.7673370428610696,2.344323302395327,0.0,0.0,0.0,14/30,7.38%,GRIA2;GRIN1;GABRB1;GRIA4;GRID1;GRID2;GRIN2A;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;GRIA3
prerank,ligand-gated channel activity (GO:0022834),0.7693361595575192,2.3367216046417174,0.0,0.0,0.0,14/29,7.38%,GRIA2;GRIN1;GABRB1;GRIA4;GRID1;GRID2;GRIN2A;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;GRIA3
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.7587962365585533,2.2875275643146837,0.0,0.0,0.0,11/28,8.57%,GABRA5;GABRA2;GRID1;GRID2;GABRG3;GABRA3;GRIK1;GABRA4;GRIK2;GRIK5;GABRG2
prerank,GABA-A receptor activity (GO:0004890),0.8413606814656748,2.2815898401690125,0.0,0.0,0.0,10/18,8.57%,GABRB3;GABRA5;GABRB1;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRD;GABRG2
prerank,ligand-gated anion channel activity (GO:0099095),0.8349848294314905,2.2744430376337976,0.0,0.0,0.0,12/17,9.42%,GABRB3;GABRA5;GABRB1;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;GLRA3;GABRG2;GLRA2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.8402759522940987,2.2531780249703264,0.0,0.0,0.0,12/17,10.09%,GRIA2;GRIN1;GRIA4;GRIN2A;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;GRIA3;GRIN3A
prerank,GABA receptor activity (GO:0016917),0.7900836621363554,2.2411975153062746,0.0,0.0,0.0,10/21,8.57%,GABRB3;GABRA5;GABRB1;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRD;GABRG2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.8139780310479005,2.2259725592353576,0.0,0.0,0.0,11/19,8.57%,GABRA5;GABRA2;GRID1;GRID2;GABRG3;GABRA3;GRIK1;GABRA4;GRIK2;GRIK5;GABRG2
prerank,voltage-gated cation channel activity (GO:0022843),0.5793070711427155,2.199151940553324,0.0,7.205550852985526e-05,0.001,33/97,11.72%,KCND2;HCN1;GRIN1;CACNA1A;KCNH7;CACNA1B;KCNQ3;KCNC2;GRIN2A;KCNH5;KCNH8;GRIN2B;CACNA2D1;GRIN2D;CACNG2;KCNJ11;CACNA1E;HCN2;KCND3;KCNC3;KCNH1;KCNQ5;CACNB2;LRRC55;KCNC1;KCNK1;CACNG3;OPRM1;GRIN3A;CACNG8;CACNB4;KCNQ2;KCNA2
prerank,cell adhesion mediator activity (GO:0098631),0.7401131434992502,2.167905793250675,0.0,6.651277710448176e-05,0.001,17/24,14.57%,DSCAM;BSG;LRRC4C;PLXNB3;ROBO4;CNTN6;DSCAML1;NPTN;VSTM2L;ESAM;NINJ1;NTNG1;ROBO3;CNTN4;CNTN2;JAM3;BCAM
prerank,potassium channel activity (GO:0005267),0.5755698043581409,2.1605187200469134,0.0,6.176186445416165e-05,0.001,27/89,8.42%,KCND2;HCN1;KCNH7;KCNQ3;KCNC2;KCNN2;KCNH5;GRIK1;KCNH8;KCNMB2;KCNMB3;GRIK2;GRIK5;KCNJ11;KCNN1;KCNK13;KCNK10;KCNMB4;HCN2;KCND3;KCNC3;KCNH1;KCNQ5;KCNK9;LRRC55;KCNC1;KCNK1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.8658179549935381,2.153850793214198,0.0,0.00011528881364776841,0.002,9/12,8.57%,GABRB3;GABRA5;GABRB1;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRG2
prerank,chloride channel activity (GO:0005254),0.604729901986768,2.134042457543283,0.0,0.00010808326279478287,0.002,18/59,10.99%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;GLRA3;TTYH2;ANO5;GABRD;GABRG2;ANO4;GLRA2;CLCN1
prerank,retinoid binding (GO:0005501),-0.7338649746049979,-2.094825039960476,0.0,0.00449372290000083,0.004,7/22,5.82%,NR2F2;ALDH1A2;PTGDS;RBP1;CYP26B1;RBP4;ABCA4
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.8325182199668076,2.079590459195513,0.0,0.000610352542841127,0.011,9/13,9.42%,GABRA5;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GLRA3;GABRG2;GLRA2
prerank,voltage-gated potassium channel activity (GO:0005249),0.5610064109299059,2.0672158564079206,0.0,0.0007205550852985525,0.014,22/80,8.42%,KCND2;HCN1;KCNH7;KCNJ3;KCNQ3;KCNC2;KCNJ6;KCNN2;KCNH5;KCNH8;KCNJ11;KCNN1;HCN2;KCNJ10;KCND3;KCNC3;KCNH1;KCNQ5;KCNN3;LRRC55;KCNC1;KCNK1
prerank,anion channel activity (GO:0005253),0.5828131641508723,2.061466574173495,0.0,0.0007281398756701162,0.015,18/61,10.28%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;LRRC8B;GABRB2;GLRA3;ANO5;GABRD;GABRG2;ANO4;GLRA2;VDAC2
prerank,amyloid-beta binding (GO:0001540),0.5610732051865309,2.045265200607512,0.0,0.0009078994074761762,0.019,29/79,13.89%,GRIA2;ITM2A;GRIN1;CACNA1A;GRIA4;CACNA1B;NLGN1;MAPK8IP2;GRIN2A;GRIA1;APBB1;GRIN2B;APBA2;PFDN5;APBB3;TGFB2;FZD6;CLU;PFDN6;ATP1A3;GRIA3;ITM2C;TLR2;APBB2;FZD4;ITGAM;SORL1;INSR;CD36
prerank,platelet-derived growth factor binding (GO:0048407),-0.8737641467989373,-2.0036435008916804,0.0,0.01348116870000249,0.022,7/11,3.45%,COL1A2;COL3A1;COL5A1;COL1A1;PDGFRA;PDGFRB;COL6A1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.7032517311141896,1.985175546294362,0.0021141649048625794,0.0027998711885886614,0.059,3/21,3.12%,GRM5;GRM1;GRIA1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.8295639655119385,1.949179360901332,0.0,0.004559148539707205,0.096,6/10,8.57%,GABRA5;GABRA2;GABRG3;GABRA3;GABRA4;GABRG2
prerank,histone acetyltransferase activity (GO:0004402),-0.6414919184388441,-1.933932013321447,0.0,0.03183053720833922,0.074,15/30,16.87%,KAT2B;EP300;KAT6B;BAZ1A;CREBBP;HAT1;ATF2;TADA3;KAT14;MCM3AP;EPC2;KAT8;BRCA2;ARRB1;EPC1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.7387552049317448,1.9145828773892062,0.0,0.00713349534445567,0.158,6/16,2.83%,PTPRG;PTPRB;PTPRN2;PTPRD;PTPRR;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.7387552049317448,1.9145828773892062,0.0,0.00713349534445567,0.158,6/16,2.83%,PTPRG;PTPRB;PTPRN2;PTPRD;PTPRR;PTPRT
prerank,Toll-like receptor binding (GO:0035325),0.7853545443582832,1.8889650096778394,0.0,0.010099300075544512,0.222,7/11,13.89%,TIRAP;S100A9;S100A8;TOLLIP;TLR2;DAB2IP;CD36
prerank,glycine binding (GO:0016594),0.7860690126763752,1.8885880050445418,0.0,0.009810634622911062,0.223,6/11,10.09%,GRIN1;GLRA1;GRIN2B;GLRA3;GLRA2;GRIN3A
prerank,protease binding (GO:0002020),-0.4895942459201698,-1.8525639757272847,0.0,0.08257215828751525,0.225,39/99,19.91%,COL1A2;COL3A1;TIMP3;STIM1;COL1A1;ITGAV;CFLAR;CCBE1;PRKN;GSK3B;ITGB1;LCOR;DPP4;ANXA2;TRIP4;BCL2;F3;ADAMTSL4;LDLR;SELENOS;CHMP3;LONP2;RHBDD2;FAP;RIOK3;FN1;SRI;BRCA2;BDKRB2;ECM1;SERPINE1;BFAR;DERL1;SYVN1;VCP;PARK7;ITGB3;TIMP2;CARD16
prerank,sodium channel activity (GO:0005272),0.5764199557019619,1.8410544685946415,0.0,0.01754951941082697,0.377,12/37,8.42%,HCN1;SCN1A;ASIC2;ASIC4;GRIK1;GRIK2;GRIK5;SCN4B;ASIC1;HCN2;SCN3A;KCNK1
prerank,calcium-activated potassium channel activity (GO:0015269),0.757676578292044,1.8311866046980856,0.004555808656036446,0.019022654251881786,0.412,6/11,7.72%,KCNN2;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNN3
prerank,amino acid binding (GO:0016597),0.5871916898092966,1.8286008634841282,0.002109704641350211,0.01884375781691111,0.419,9/31,10.09%,GRIN1;GRM7;AARS2;GLRA1;GRIN2B;GLRA3;NOS3;GLRA2;GRIN3A
prerank,glutamate receptor binding (GO:0035254),0.6793151156466078,1.81995665457852,0.002061855670103093,0.020348475608831126,0.451,9/17,10.21%,CAMK2A;IGSF11;SHISA6;SHANK3;HIP1;SHISA7;HOMER1;SHANK2;HOMER2
prerank,SUMO transferase activity (GO:0019789),-0.6834437080564042,-1.8040277911580296,0.0,0.13054265024502412,0.396,8/16,15.41%,PIAS1;HDAC4;RANBP2;NSMCE2;PIAS3;UBE2I;PIAS4;TOPORS
prerank,R-SMAD binding (GO:0070412),-0.6762054578585761,-1.7878558253343824,0.00375234521575985,0.1336882562750247,0.462,10/18,14.59%,SMAD3;LDLRAD4;SMAD6;DDX5;SMAD2;PMEPA1;JUN;SMAD4;PPM1A;SMURF1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6429463470772723,-1.771329857123132,0.0038910505836575876,0.13898442969288283,0.529,7/18,7.85%,PDLIM5;BAIAP2L1;RAB10;ANXA2;TMOD3;ANXA1;CNN3
prerank,semaphorin receptor binding (GO:0030215),0.616332865236688,1.7666421365219014,0.0,0.03600915929498443,0.674,8/23,4.44%,RIT2;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,inward rectifier potassium channel activity (GO:0005242),0.6064161968122977,1.7467272976759882,0.006896551724137931,0.04344947164350271,0.75,8/24,8.42%,KCNJ3;KCNJ6;KCNN2;KCNJ11;KCNN1;KCNJ10;KCNN3;KCNK1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.5566736644246506,-1.7302306151904225,0.003787878787878788,0.1970216633969114,0.697,17/33,25.45%,PCF11;SCAF8;DHX9;AR;CTR9;TBP;RPRD2;WDR43;GTF2B;HNRNPU;CDC73;DRAP1;WAC;CCAR2;AGO1;RTRAF;RECQL5
prerank,ion channel activity (GO:0005216),0.4677227585499606,1.7240812395353782,0.0,0.0538451163741282,0.827,18/80,7.38%,GRIA2;GRIN1;GABRB1;GRIA4;GRID1;GRID2;GRIN2A;ASIC4;GRIA1;GRIK1;GRIN2B;GRIN2D;UNC80;GRIK2;GRIK5;TMEM63B;TRPM2;GRIA3
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6748475247025929,-1.7166912237102987,0.005649717514124294,0.20359061249725982,0.747,6/15,21.04%,ALDH1A1;ALDH1A2;ALDH2;ALDH1L1;ALDH7A1;ALDH4A1
prerank,ankyrin binding (GO:0030506),0.6337075767611454,1.716098580176983,0.002136752136752137,0.05668649241636966,0.85,8/19,11.30%,SLC4A1;SPTBN4;SPTB;SLC8A1;KCNJ11;NRCAM;KCNQ2;SPTBN1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6933284806556004,-1.7096393381194974,0.007434944237918215,0.19783615067253651,0.774,6/13,21.04%,ALDH1A1;ALDH1A2;ALDH2;ALDH1L1;ALDH7A1;ALDH4A1
prerank,chemorepellent activity (GO:0045499),0.5943782865964051,1.7074977396569488,0.008714596949891068,0.05961255157115682,0.869,9/25,4.44%,NRG3;SEMA3C;SEMA6A;NRG1;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,protein tyrosine kinase activator activity (GO:0030296),0.634720953877865,1.7058109906297079,0.0043859649122807015,0.05915757250301116,0.872,5/19,5.39%,NRG3;GRM5;NRG1;GAS6;CD24
prerank,cAMP binding (GO:0030552),0.7113380927058968,1.7026233361859053,0.00425531914893617,0.05912446591801096,0.882,6/11,13.00%,HCN1;PDE4B;PDE10A;PDE2A;PDE4D;PDE4A
prerank,transforming growth factor beta binding (GO:0050431),-0.5902004100227215,-1.6974829454117302,0.00796812749003984,0.20507717234549241,0.814,12/23,16.37%,TGFBR3;TGFBR1;LTBP1;ITGAV;TGFBR2;THBS1;TWSG1;CD109;ACVR1;TGFB3;LRRC32;VASN
prerank,histone demethylase activity (GO:0032452),-0.5828372515895776,-1.6938961729030435,0.005825242718446602,0.1954769461500361,0.823,11/27,15.83%,KDM7A;KDM4B;PHF8;KDM5B;KDM6A;PHF2;FBXL19;KDM3B;KDM3A;JARID2;KDM2A
prerank,androgen receptor binding (GO:0050681),-0.5889340748210817,-1.693581833360554,0.001838235294117647,0.18147727096157198,0.825,16/25,25.24%,FOXP1;DDX5;EP300;TGFB1I1;NSD1;PRPF6;PRMT2;WIPI1;KDM3A;RNF14;PARK7;ARID5A;RNF6;TRIM68;KDM1A;ZBTB7A
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6984294303412957,1.6903937942022107,0.011086474501108648,0.06428109839900245,0.903,2/11,6.29%,HCN1;HCN2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.6856382709756916,-1.688278689717837,0.007751937984496124,0.1775020545500328,0.836,4/13,2.70%,BMP6;BMP5;BMP7;BMP4
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.3971251965070544,-1.6870572266618162,0.0,0.16888908565836452,0.839,58/188,17.17%,ZBTB20;PBX1;BNC2;TCF7L2;SMAD3;SOX5;CREB3L2;NFKB1;PRDM5;SMAD6;FOXC1;PER3;FOXO3;HDAC4;BCOR;NCOR1;TFEB;TBL1X;BRD7;TBL1XR1;YAP1;KMT2D;HMGB1;GABPB2;STAT3;FOXC2;RUNX1;DHX9;REST;AR;DHX36;FOXK1;TBP;NFYC;CHD3;GABPA;NR1H3;JUN;CALCOCO1;SMAD4;GLIS2;ZBED4;TBX18;MEF2C;ARID5B;IRF1;SOX13;GLI1;ATF6;SOX6;HINFP;RXRA;KLF15;FOXK2;VSX1;SFPQ;SIX1;NFYB
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.3894662981627134,-1.68059908763672,0.0,0.17005932599690643,0.862,75/232,21.12%,RNF220;PDZRN3;RNF152;PELI2;SMURF2;CBLB;RNF43;UBR2;TRIM44;PIAS1;KCMF1;PRKN;ARIH1;WWP2;TRIP12;RNF115;RNF217;HUWE1;UBR5;UHRF2;RBBP6;DTX4;RC3H1;MEX3C;SH3RF1;UFL1;NSMCE2;RNF19A;WWP1;ASB2;TRAF3IP2;RNF8;CDC42;RNF145;HLTF;RNFT1;XIAP;PIAS3;RNF216;HERC2;UBR1;GID4;RFWD3;TRIM5;UBR3;TRIM11;CUL3;PIAS4;TRIM25;DTX3L;NHLRC3;SH3RF2;SMURF1;UBR4;TRIM39;SH3RF3;TOPORS;MSL2;RNF181;HECTD1;BFAR;MYLIP;SYVN1;AREL1;TRAF6;RNF14;UBE2D3;LRSAM1;DTX2;COP1;RNF11;NFX1;ANAPC11;TRIM63;ARIH2
prerank,I-SMAD binding (GO:0070411),-0.6783644516925627,-1.6778044505700378,0.013157894736842105,0.16481389577355987,0.868,10/13,21.35%,SMAD3;TGFBR1;SMAD6;TGFB1I1;SMAD2;AXIN1;SMAD4;SMURF1;SMAD9;SMAD1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5459161555854526,1.676333551500191,0.006437768240343348,0.07156774816442238,0.931,8/32,11.72%,KCNQ3;KCNC2;KCNC3;KCNH1;KCNQ5;KCNC1;KCNQ2;KCNA2
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.6139750732709514,-1.670083188236139,0.016544117647058824,0.16957562665697576,0.891,6/18,5.30%,TGFBR3;SMAD3;TGFBR1;SMAD6;TGFBR2;SMAD2
prerank,poly-pyrimidine tract binding (GO:0008187),-0.5852668429249621,-1.6663706025211356,0.013806706114398421,0.16792332942108368,0.908,8/23,6.46%,RBMS1;RBMS3;ATXN1;HNRNPH1;DIS3L2;KHDRBS1;RBMS2;U2AF2
prerank,DNA-binding transcription factor binding (GO:0140297),-0.3955652964549569,-1.6574458893739863,0.0,0.17581690846253245,0.926,54/189,14.62%,FHL2;TCF7L2;SMAD3;PRRX1;PRDM5;RBPJ;PIAS1;EP300;HDAC4;RERE;NCOR1;RBBP8;WWP2;GSK3B;YAP1;MEF2A;HMGB1;SMAD2;CBX5;SKI;CREBBP;NBN;STAT3;BCL2;DHX9;CRTC3;AR;RUNX1T1;TBP;PIAS3;DACT1;ATF2;TEAD3;CHD4;MIER1;EIF4E;GABPA;JUN;HCFC1;CRTC1;ID2;TLE4;TLE1;MEF2C;HES1;SIK1;TCF3;PIAS4;RB1;BHLHE41;CGGBP1;TCERG1;STAT1;HDAC1
prerank,poly(U) RNA binding (GO:0008266),-0.6014001419391267,-1.656877778221861,0.015414258188824663,0.1683541186464597,0.926,7/20,5.06%,RBMS1;RBMS3;ATXN1;HNRNPH1;DIS3L2;KHDRBS1;RBMS2
prerank,BMP receptor binding (GO:0070700),-0.6856399460696442,-1.6566754359849605,0.015594541910331383,0.1607527237409388,0.926,4/12,2.70%,BMP6;BMP5;BMP7;BMP4
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.3474932479637428,-1.6485100440434135,0.0,0.1661212128576394,0.94,182/731,18.28%,ZBTB20;NFIA;PBX1;FOXP2;FOXP1;NR2F2;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;ZBTB7C;MAF;SOX5;TEAD1;FOXD1;PRRX1;NFKB1;PRDM5;HOXB6;ZNF148;HIVEP2;ZKSCAN2;RBPJ;THRB;GLI2;ZNF423;GLIS3;HOXC6;FOXP4;NR1D2;ZFHX3;ZEB1;RARB;FOXC1;KLF9;ZIC2;FOXO3;HDAC4;CREB5;ARNT;NR3C2;TFEB;MXI1;HOXB3;MEOX2;FOXN3;ELF1;NFIB;KCNIP3;NR6A1;TOP1;NFIX;RREB1;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;ZNF182;SMAD2;PRRX2;HOXA5;PBX3;TBX15;SKI;ZBTB16;ZIC5;STAT3;TEF;HOXA7;NSD1;JDP2;DNMT3A;ELF4;FOXC2;RUNX1;HOXC4;SKIL;HIVEP3;DHX9;ZEB2;HOXA3;REST;CEBPG;HOXB5;ZBTB37;GTF2IRD1;AR;DHX36;ZNF496;FOXK1;MAFG;SP2;NFYC;ZBTB1;CHD2;KDM6A;ATF2;TEAD3;HOXB4;UBP1;ZNF467;ZFAT;ZNF569;RFX2;GABPA;NR1H3;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;ZBTB24;NFATC4;TBX18;RORA;MEF2C;NRF1;TFCP2;HES1;TEAD2;ZNF692;IRF9;TCF3;TCF7L1;BHLHE41;ZBTB34;CCAR1;PATZ1;IRF1;SOX13;GLI1;ATF6;SOX6;SIX5;STAT1;CC2D1B;HINFP;ZNF367;HDAC1;MED8;ZSCAN18;ZKSCAN1;MKX;ZNF18;CARF;SNAPC3;HOXB9;RXRA;HOXC5;KLF15;RUNX2;MNT;FOXK2;SALL1;PRDM15;ATOH8;IKZF2;KLF6;ZNF112;FOXL1;HEYL;MYBL1;SIX1;STAT5A;TBX2;NR4A1;NFYB;NR4A2;CC2D1A;STAT5B;NFIC;ZFHX4;HNRNPU;POU6F2;TFCP2L1
prerank,ubiquitin protein ligase activity (GO:0061630),-0.3804801965470742,-1.6409638934846646,0.0,0.1710423278812816,0.946,72/228,21.12%,RNF220;PDZRN3;RNF152;PELI2;SMURF2;CBLB;RNF43;UBR2;TRIM44;KCMF1;PRKN;ARIH1;WWP2;TRIP12;RNF115;RNF217;HUWE1;UBR5;UHRF2;RBBP6;DTX4;RC3H1;MEX3C;SH3RF1;RNF19A;UBE4B;WWP1;ASB2;TRAF3IP2;RNF8;CDC42;RNF145;UBE2K;HLTF;RNFT1;XIAP;RNF216;HERC2;UBR1;GID4;RFWD3;TRIM5;UBR3;TRIM11;CUL3;TRIM25;DTX3L;NHLRC3;SH3RF2;SMURF1;UBR4;TRIM39;SH3RF3;TOPORS;MSL2;RNF181;HECTD1;BFAR;MYLIP;SYVN1;AREL1;TRAF6;RNF14;UBE2D3;LRSAM1;DTX2;COP1;RNF11;NFX1;ANAPC11;TRIM63;ARIH2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.7118147767004662,-1.6407043721248762,0.011494252873563218,0.16465000705603042,0.946,7/10,22.24%,SETD5;NSD3;NSD1;SETD3;SETD2;ASH1L;PRDM9
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.345898465545631,-1.6394423548681694,0.0,0.16000246056445264,0.948,183/730,18.28%,ZBTB20;NFIA;PBX1;FOXP2;FOXP1;NR2F2;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;ZBTB7C;MAF;SOX5;TEAD1;FOXD1;PRRX1;CREB3L2;NFKB1;PRDM5;HOXB6;ZNF148;HIVEP2;ZKSCAN2;RBPJ;THRB;GLI2;ZNF423;GLIS3;HOXC6;FOXP4;NR1D2;ZFHX3;ZEB1;RARB;FOXC1;KLF9;ZIC2;FOXO3;HDAC4;CREB5;ARNT;NR3C2;TFEB;MXI1;HOXB3;MEOX2;ELF1;NFIB;KCNIP3;NR6A1;TOP1;NFIX;RREB1;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;ZNF182;SMAD2;PRRX2;HOXA5;PBX3;TBX15;SKI;ZBTB16;ZIC5;STAT3;TEF;HOXA7;NSD1;JDP2;DNMT3A;ELF4;FOXC2;RUNX1;HOXC4;SKIL;HIVEP3;DHX9;ZEB2;HOXA3;REST;CEBPG;HOXB5;ZBTB37;GTF2IRD1;AR;DHX36;ZNF496;FOXK1;MAFG;SP2;NFYC;ZBTB1;CHD2;KDM6A;ATF2;TEAD3;HOXB4;UBP1;ZNF467;ZFAT;ZNF569;RFX2;GABPA;NR1H3;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;ZBTB24;NFATC4;TBX18;RORA;MEF2C;NRF1;TFCP2;HES1;TEAD2;ZNF692;IRF9;TCF3;TCF7L1;BHLHE41;ZBTB34;CCAR1;PATZ1;IRF1;SOX13;GLI1;ATF6;SOX6;SIX5;STAT1;CC2D1B;HINFP;ZNF367;HDAC1;MED8;ZSCAN18;ZKSCAN1;MKX;ZNF18;CARF;SNAPC3;HOXB9;RXRA;HOXC5;KLF15;RUNX2;MNT;FOXK2;SALL1;PRDM15;ATOH8;PRMT5;IKZF2;KLF6;ZNF112;FOXL1;HEYL;MYBL1;SIX1;STAT5A;TBX2;NR4A1;NFYB;NR4A2;CC2D1A;STAT5B;NFIC;ZFHX4;HNRNPU;POU6F2;TFCP2L1
prerank,glucose transmembrane transporter activity (GO:0005355),0.6153437892556752,1.6373883087748864,0.014492753623188406,0.09829091918557556,0.979,4/17,4.30%,SLC2A1;SLC2A3;SLC2A5;SLC5A11
prerank,G protein-coupled receptor activity (GO:0004930),0.38060995247607315,1.635545698006329,0.0,0.09741201772665406,0.979,57/239,19.10%,ADGRL4;PAX8;GRM5;ADGRL3;ADGRB3;MTNR1B;HCAR2;GRM1;ADGRB1;GRM8;ADRB1;S1PR5;HCRTR1;GPR101;GPR149;LGR5;MTNR1A;GPR35;P2RY1;ADGRA1;APLNR;ELOVL4;GPR26;GPR17;ADRA1D;ADRA1A;ADGRL2;GPR75;TRHR;GPR176;HCRTR2;OPRM1;MRGPRE;CELSR2;F2RL2;F2R;CNR1;GRPR;GPR85;RORB;GRM3;OPRK1;ADGRG1;OPRL1;NPFFR2;NPR1;CALCRL;ADCYAP1R1;ADGRE1;GPR45;CYSLTR1;C3AR1;NTSR2;GPR22;ADGRE5;S1PR1;ADORA2A
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.5138752542042584,-1.6283319224566946,0.01,0.16984608220188321,0.961,15/34,15.53%,GAB2;FCHSD2;MYO1B;ADAP2;GBF1;ARAP1;MAPKAP1;CYTH3;ZFYVE1;DAPP1;IQGAP2;KIF16B;OGT;PARD3;ZFYVE16
prerank,SH2 domain binding (GO:0042169),-0.5234405468164548,-1.621291362428682,0.003816793893129771,0.17529531562592524,0.97,8/31,7.61%,AFAP1;DAG1;SH3PXD2B;ABL1;PAG1;IRS1;KHDRBS1;INPPL1
prerank,thyroid hormone receptor binding (GO:0046966),-0.5475085681543189,-1.6115734735696148,0.009505703422053232,0.18505615770089626,0.982,18/28,27.06%,NCOR1;TRIP12;MED17;NSD1;MED12;NCOA6;MED1;PRMT2;GTF2B;TRIP6;MED16;ARID5A;HMGN3;MED13;GTF2H1;TAF7;GAS2L1;JMJD1C
prerank,cyclic nucleotide binding (GO:0030551),0.5581612305629865,1.6088847930423986,0.012987012987012988,0.1183769068704765,0.993,8/21,13.00%,HCN1;PDE4B;PDE10A;PDE2A;PDE11A;KCNH1;PDE4D;PDE4A
prerank,calcium ion binding (GO:0005509),0.3631165722865093,1.6046472481733078,0.0,0.11958533280754863,0.993,61/323,11.21%,SPOCK2;ADGRL3;SPOCK1;GRIN1;NRXN1;CDH12;CDH8;SYT1;PCLO;SYT6;S100A16;RASGRP3;KCNIP4;MMP12;SYT7;CDH7;CDH19;CDH20;S100A9;S100A8;S100G;DNER;SYT12;SYT11;CDH18;RYR2;MCTP1;CDH2;RYR3;MEX3B;SNCA;KCNIP1;SLC8A1;ENPP2;RCN2;CDH10;PITPNM1;SLC25A23;HSPA5;SLIT3;SLIT1;TRPM2;CPNE1;MELK;CIB2;TUBB4A;THBS3;SYT10;DYSF;S100A2;PCDHB6;TPT1;ARSA;DCHS1;PVALB;ASTN2;GALNT3;AIF1;CALM1;PCDHA4;SYT2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5960834364687924,-1.6022409326525582,0.01744186046511628,0.19517736462336938,0.988,5/18,3.24%,TGFBR3;TGFBR1;BMPR1A;LTBP1;TGFBR2
prerank,metalloendopeptidase activity (GO:0004222),-0.4345691639999565,-1.6001652585062718,0.0,0.19203417457342256,0.988,21/76,12.75%,TRABD2B;ADAMTS2;ADAMTS10;ADAMTS12;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;ADAMTS5;ECE1;ADAMTSL4;ADAMTS9;NRDC;MMP14;ADAM9;MBTPS2;ADAM19;ADAMTS15;MMP2;ADAM33;NLN
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.33303200011844303,-1.5945314283492402,0.0,0.19565248220081738,0.99,202/830,18.67%,ZBTB20;NFIA;PBX1;FOXP2;FOXP1;NR2F2;HLF;PKNOX2;ZIC4;AEBP1;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;ZBTB7C;MAF;SOX5;TEAD1;FOXD1;PRRX1;NFKB1;PRDM5;HOXB6;ZNF148;HIVEP2;ZKSCAN2;RBPJ;THRB;GLI2;ZNF423;GLIS3;HOXC6;FOXP4;NR1D2;ZFHX3;ZEB1;RARB;FOXC1;KLF9;ZIC2;FOXO3;HDAC4;CREB5;ARNT;CUX1;OSR1;NR3C2;TFEB;MXI1;HOXB3;MEOX2;ELF1;NFIB;KCNIP3;NR6A1;TOP1;NFIX;RREB1;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;ZNF182;SMAD2;PRRX2;HOXA5;PBX3;TBX15;SKI;ZBTB16;ZIC5;STAT3;TEF;HOXA7;NSD1;TFDP2;JDP2;HOXC8;DNMT3A;ELF4;FOXC2;RUNX1;HOXC4;SKIL;HIVEP3;DHX9;ZEB2;HOXA3;REST;VEZF1;CEBPG;HOXB5;ZBTB37;GTF2IRD1;ZBTB8A;AR;DHX36;ZNF496;FOXK1;CDC5L;MAFG;TBP;SP2;NFYC;ZBTB1;CHD2;KDM6A;ATF2;TEAD3;HOXB4;UBP1;ZNF467;ZFAT;ZNF569;RFX2;GABPA;NR1H3;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;ZBTB24;CREBRF;NFATC4;TBX18;RORA;MEF2C;NRF1;TFCP2;HES1;TEAD2;ZNF692;IRF9;TCF3;TCF7L1;RB1;BHLHE41;ZBTB34;CCAR1;PATZ1;IRF1;SOX13;GLI1;ATF6;SOX6;SIX5;TRPS1;ZFP3;STAT1;CC2D1B;HINFP;ZNF367;HDAC1;MED8;ZSCAN18;ZKSCAN1;MKX;PRDM2;ZNF18;CARF;SNAPC3;HOXB9;RXRA;HOXC5;KLF15;RUNX2;BBX;MNT;FOXK2;SALL1;PRDM15;ATOH8;IKZF2;KLF6;GTF2B;ZNF112;FOXL1;HEYL;MYBL1;SIX1;STAT5A;TBX2;NR4A1;ZFP37;NFYB;TWIST2;NR4A2;CC2D1A;STAT5B;NFIC;ZFHX4;HNRNPU;POU6F2;TFCP2L1;ZKSCAN7;ZNF436;NFATC3
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4696640235533456,1.5944382227348919,0.018072289156626505,0.1268897505210751,0.996,12/49,7.68%,SYT1;PCLO;SYT6;SYT7;SYT12;SYT11;MCTP1;CPNE9;CPNE8;CPNE1;SYT10;DYSF
prerank,calcium activated cation channel activity (GO:0005227),0.5954158507122063,1.5897403468145326,0.022727272727272728,0.1286431012286349,0.996,6/17,6.13%,KCNN2;KCNMB2;KCNMB3;KCNN1;TMEM63B;KCNMB4
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.6515076090759999,-1.5815897799434064,0.016216216216216217,0.21351992446064552,0.994,7/12,20.78%,GAB2;IRS1;SHC1;FRS2;SH2B1;BLNK;PIK3R1
prerank,ubiquitin-specific protease binding (GO:1990381),-0.5798642657950833,-1.5791303987366818,0.021660649819494584,0.21183277582283327,0.996,9/19,18.92%,PRKN;LCOR;SELENOS;CHMP3;RHBDD2;DERL1;SYVN1;VCP;PARK7
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.44997706675406557,-1.572167695125907,0.0057251908396946565,0.21781716856718308,0.996,18/60,15.19%,LRRK1;CTDSPL;PPM1D;LRRK2;PPM1E;CDC14A;PPP4C;CAMK2G;SSU72;PPP2CB;PPM1H;PPM1M;MTMR3;PPM1A;CTDSPL2;DUSP1;CDC14B;PPP1CB
prerank,frizzled binding (GO:0005109),-0.49787062514994707,-1.5618415262928762,0.020161290322580645,0.23351755875490426,0.999,15/34,25.49%,LRP6;WNT4;RNF43;WNT5B;WNT6;RYK;WNT9A;FZD7;WNT5A;FZD1;MYOC;DVL3;WNT16;DVL2;ZNRF3
prerank,carboxylic acid binding (GO:0031406),0.4888518213152503,1.559898568629439,0.021739130434782608,0.15695569466720644,0.996,10/38,10.09%,GRIN1;GRM7;MAG;GLRA1;GRIN2B;GLRA3;NOS3;RTN4R;GLRA2;GRIN3A
prerank,nuclear receptor binding (GO:0016922),-0.4053633361381467,-1.55833243050052,0.0018832391713747645,0.23370395379261075,0.999,63/111,30.14%,FOXP1;TCF7L2;SMAD3;DDX5;EP300;NCOR1;TRIP12;TGFB1I1;BAZ2A;PPARGC1B;LCOR;BCAS3;MED17;DCAF1;TRIP4;NSD1;MED12;PRPF6;PPARGC1A;NCOA6;NCOA1;MED1;JUP;PRMT2;TADA3;HIF1A;WIPI1;MMS19;STAT1;KDM3A;LATS1;RXRA;GTF2B;NR4A1;CNOT1;NR4A2;STAT5B;RNF14;PARK7;TRIP6;MED16;TACC2;PPID;ARID5A;HMGN3;MED13;SMARCD3;MED14;GTF2H1;RNF6;TRIM68;KDM1A;PHB2;ZBTB7A;TAF7;GAS2L1;JMJD1C;ESR1;NCOA7;NR1H4;CALR;SNW1;THRAP3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.5226044956189055,1.5546560156342017,0.022587268993839837,0.1594849030073145,0.997,8/30,11.74%,SLC39A10;SLC40A1;SLC39A2;SLC30A1;SLC30A3;SLC25A37;SLC39A8;SLC30A5
prerank,vinculin binding (GO:0017166),-0.6606600714362574,-1.5480358840819168,0.0392156862745098,0.24875121368820385,1.0,5/11,16.22%,DAG1;CTNNA1;TLN1;SYNM;SORBS3
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5383733266747943,1.5461670051706145,0.03497942386831276,0.1664662385810981,0.997,5/22,6.46%,SYT1;AP2M1;APBB1;APBB3;CLU
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.6170289227213164,-1.5446969892248423,0.03213610586011342,0.25015057476671293,1.0,6/14,19.72%,CYB5R4;NOX4;AIFM1;CYBA;MICAL1;NCF2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.3274947054760716,-1.537355327704685,0.0,0.2594563259387979,1.0,111/597,13.71%,ZBTB20;PBX1;BNC2;FOXP1;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;MAF;SOX5;TEAD1;CREB3L2;NFKB1;PRDM5;HOXB6;THRB;SMAD6;GLI2;NR1D2;RARB;FOXC1;PER3;FOXO3;HDAC4;CREB5;ABL1;BCOR;NCOR1;ARNT;CUX1;OSR1;NR3C2;TFEB;MBNL2;MEOX2;TBL1X;BRD7;ELF1;NFIB;TBL1XR1;NR6A1;NFIX;YAP1;GMEB1;RARG;KMT2D;HMGB1;NR3C1;KLF3;PRRX2;HOXA5;GABPB2;TBX15;ZIC5;STAT3;TEF;HOXA7;JDP2;HOXC8;ELF4;FOXC2;RUNX1;HOXC4;DHX9;REST;KDM5B;CEBPG;HOXB5;ZBTB37;AR;DHX36;FOXK1;MBD2;MAFG;TBP;SP2;NFYC;ATF2;HOXB4;UBP1;CHD3;RFX2;GABPA;NR1H3;JUN;CALCOCO1;SMAD4;GLIS2;MCM9;NFATC4;ZBED4;TBX18;MEF2C;ARID5B;TFCP2;HES1;TEAD2;IRF9;TCF7L1;BHLHE41;IRF1;YBX1;SOX13;GLI1;ATF6;SOX6
prerank,hexose transmembrane transporter activity (GO:0015149),0.6289093229684715,1.5367136140388142,0.042643923240938165,0.17499783136912028,0.997,3/12,2.66%,SLC2A1;SLC2A3;SLC2A5
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6374922261389788,-1.5348308798835686,0.02862595419847328,0.25808765850675497,1.0,5/12,3.24%,TGFBR3;TGFBR1;BMPR1A;LTBP1;TGFBR2
prerank,neuropeptide binding (GO:0042923),0.562850344631729,1.5336441433174892,0.02386117136659436,0.17521593898187843,0.997,5/18,15.06%,GPR149;OPRM1;SORL1;OPRK1;OPRL1
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.34090181318061585,-1.5326966386136587,0.0,0.2559549668458806,1.0,105/346,21.17%,RNF220;PDZRN3;RNF152;PELI2;SMURF2;CBLB;UBE2N;RNF43;UBE2E2;UBR2;TRIM44;KCMF1;BCOR;PRKN;BIRC6;FBXW8;ARIH1;KLHL13;BTRC;WWP2;TRIP12;RNF115;RNF146;RNF217;HUWE1;UBR5;UHRF2;RBBP6;RNF213;DTX4;RC3H1;MEX3C;SH3RF1;RNF214;RNF19A;WWP1;UBE2H;ASB2;TRAF3IP2;RNF8;CDC42;RNF145;FBXO10;UBE2K;HLTF;MAEA;RNFT1;XIAP;DDB2;FBXO3;ANAPC4;TNFAIP1;RNF216;HERC2;RNF103-CHMP3;TRAF2;UBR1;UBE2R2;GID4;RFWD3;TRIM5;UBR3;TRIM11;CUL3;TRIM25;DTX3L;NHLRC3;SH3RF2;UBE2B;SMURF1;UBR4;TRIM39;SH3RF3;CUL2;TOPORS;ERCC8;UBE2E1;MSL2;TRAF3;RNF181;HECTD1;RNF20;BFAR;FBXO22;UBE2S;MYLIP;UBA7;SYVN1;FBXW11;AREL1;TRAF6;RNF14;UBE2D3;LRSAM1;DTX2;COP1;RNF11;NFX1;PML;ANAPC11;CUL1;TRIM63;TTC3;ARIH2;SHARPIN
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.5030556581993993,-1.5319096095706295,0.015779092702169626,0.25125658796109296,1.0,19/33,34.25%,PCF11;SCAF8;DHX9;CTR9;RPRD2;SPTY2D1;WDR43;GTF2B;HNRNPU;CDC73;WAC;CCAR2;AGO1;RTRAF;RECQL5;RRN3;ZNF326;ELOF1;URI1
prerank,AMP binding (GO:0016208),-0.6574276537117922,-1.5295779363698379,0.03893805309734513,0.24998886882902344,1.0,6/11,21.91%,PRKAG2;MPPED2;PFKP;PRKAG3;PFKM;PFKL
prerank,histone methyltransferase activity (GO:0042054),-0.4885408177032572,-1.5259934444124497,0.013409961685823755,0.2516235172728243,1.0,17/32,24.46%,SETD7;KMT5B;KMT2C;NSD3;SMYD3;SETD2;PRMT2;N6AMT1;SETDB1;EHMT1;PRMT5;PRMT8;KMT5A;NTMT1;EZH2;PRDM9;KMT2E
prerank,RNA polymerase II complex binding (GO:0000993),-0.49364340818720237,-1.5167473838307772,0.021400778210116732,0.26532503035657073,1.0,14/32,25.45%,PCF11;SCAF8;DHX9;CTR9;RPRD2;WDR43;GTF2B;HNRNPU;CDC73;WAC;CCAR2;AGO1;RTRAF;RECQL5
prerank,cell-cell adhesion mediator activity (GO:0098632),0.4594418278001625,1.5151703621887251,0.029940119760479042,0.19599098320120628,0.999,14/42,12.10%,DSCAM;BSG;LRRC4C;PLXNB3;ROBO4;CNTN6;DSCAML1;NPTN;VSTM2L;ESAM;NTNG1;ROBO3;CNTN4;CNTN2
prerank,peptidoglycan binding (GO:0042834),0.6564141479111396,1.5132479790375224,0.05021834061135371,0.1949156933046838,0.999,3/10,10.01%,PGLYRP1;TLR2;NOD1
prerank,voltage-gated sodium channel activity (GO:0005248),0.5447716295532018,1.5125889271033262,0.03777777777777778,0.1921679626354336,0.999,9/22,15.79%,HCN1;SCN1A;SCN4B;HCN2;SCN3A;SCN2A;CACNA1I;SCN8A;SCN2B
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5829726160801096,1.5115868549875102,0.030042918454935622,0.18977819713240987,0.999,7/15,7.08%,HS6ST3;HS3ST6;HS3ST5;HS3ST2;HS6ST2;NDST4;HS3ST4
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.5211132099754804,-1.5115444062326937,0.03614457831325301,0.27067509638090104,1.0,8/25,10.48%,GAB2;PLEKHA2;FCHSD2;ADAP2;MAPKAP1;ZFYVE1;DAPP1;KIF16B
prerank,ligand-gated calcium channel activity (GO:0099604),0.5600897054680262,1.511385535653136,0.025806451612903226,0.18662638729263528,0.999,7/19,6.46%,GRIN1;GRIN2A;RYR2;RYR3;GRIN2B;GRIN2D;TRPM2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.6222624974194353,-1.5043094808757254,0.0531496062992126,0.2801555370469268,1.0,7/12,26.20%,CYFIP2;LARP1;GEMIN5;EIF4E;EIF4E3;NCBP3;NCBP2
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5924456523961862,-1.5001969673616318,0.056179775280898875,0.28427382774035864,1.0,8/13,19.35%,PDGFRA;PDGFRB;PDGFC;VEGFA;ERN1;VEGFD;ITGA5;ITGB3
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.6199065971289365,-1.4994753491375474,0.056179775280898875,0.2799364680555517,1.0,6/12,16.29%,SULF1;GNS;SULF2;ARSK;ARSI;GALNS
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.44267273528221146,-1.4935671424934165,0.023483365949119372,0.28733392895887655,1.0,21/44,24.46%,SETD7;KMT5B;SETD5;KMT2C;KMT2D;NSD3;NSD1;SMYD3;SETD3;SETD2;N6AMT1;SETDB1;EHMT1;KMT5C;ASH1L;KMT5A;KMT2A;EZH2;PRDM9;CXXC1;KMT2E
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.4764299029656513,-1.4915615942478528,0.025193798449612403,0.28632360381591826,1.0,17/34,25.83%,STK3;FAM20A;CCNT2;CAB39L;CCNT1;IGF2;MAP2K1;CCNK;RICTOR;DDX3X;MTCP1;TAOK1;CAB39;ALS2;DBF4;IRGM;INCENP
prerank,FAD binding (GO:0071949),-0.5107946324545336,-1.4885104485314462,0.03571428571428571,0.2875134783755248,1.0,11/24,18.26%,MICAL3;DDO;MICAL2;MTHFR;AIFM1;SQOR;PRODH;KDM1B;NQO2;MICAL1;SQLE
prerank,potassium channel regulator activity (GO:0015459),0.44211900576120927,1.4875760994841343,0.030800821355236138,0.21420558639314613,1.0,12/49,8.45%,DPP10;KCNIP4;KCNIP1;WNK2;KCNMB2;KCNMB3;DPP6;KCNMB4;KCNAB1;AKT1;LRRC55;SGK3
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.617888704003394,1.4846255271708424,0.06134969325153374,0.21442202380410608,1.0,3/11,12.77%,KCNJ3;KCND3;KCNJ8
prerank,methylation-dependent protein binding (GO:0140034),-0.4205875923855866,-1.4844223522853746,0.016605166051660517,0.29105177486579453,1.0,30/57,30.85%,KDM7A;CBX5;PYGO1;PHF8;CHD8;PHF2;ZCWPW2;MPHOSPH8;TDRD3;KAT8;ING5;PHF1;L3MBTL2;MORC3;MSL3;RRP8;BPTF;MSH6;ZMYND8;MORC4;ING1;NCAPD3;SPIN1;CXXC1;KMT2E;ATRX;ZMYND11;GLYR1;WDR5;CDYL
prerank,potassium:proton antiporter activity (GO:0015386),-0.6576910757664475,-1.4834817282625197,0.04380952380952381,0.287496135534144,1.0,3/10,6.17%,SLC9A1;SLC9A8;SLC9A2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.4794848003295072,-1.4798514859627616,0.028409090909090908,0.2899855558906786,1.0,16/32,29.48%,FTO;KDM7A;KDM4B;PHF8;TMLHE;EGLN3;BBOX1;ALKBH1;KDM2A;TYW5;JMJD4;TET2;EGLN2;PHYHD1;HSPBAP1;TET3
prerank,carboxy-lyase activity (GO:0016831),0.5144003441982431,1.4775348081439152,0.03497942386831276,0.22090728111628866,1.0,6/23,10.44%,FAHD1;DDC;PISD;MVD;UXS1;GAD1
prerank,single-stranded DNA binding (GO:0003697),-0.3880029061823362,-1.475399550707536,0.008097165991902834,0.29479216410224746,1.0,48/93,32.85%,RBMS1;RAD23B;RBBP8;TOP1;HMGB1;SMC6;WDR48;RAD51B;TDP2;MLH1;DHX9;FUBP1;DHX36;PCBP2;SSBP2;MCM9;RTF1;RAD51D;NABP2;APTX;MCM6;BRCA2;CTC1;MSH3;DMC1;SPRTN;WBP11;HNRNPU;POLR2H;PARK7;STN1;SSBP1;ERCC1;CRY2;LONP1;MCM4;POLR2D;MCMDC2;IGHMBP2;SAMHD1;TWNK;NEIL3;RNF138;RPA2;PCBP1;RAD51;CDC45;POLA1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.6187992798449113,-1.4746253125005244,0.04933586337760911,0.2910847747466055,1.0,6/12,24.26%,SLC9A1;SLC9A8;SLC9A2;LETM1;SLC9B2;SLC9A9
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.4279807291701564,-1.4728739481388635,0.02286902286902287,0.2897689622551383,1.0,27/53,27.39%,MICAL3;AOX1;DDO;MICAL2;POR;NOX4;MTHFR;AIFM1;SQOR;PRODH;KDM1B;PPOX;DPYD;ACOX1;NQO2;MICAL1;SQLE;SDHA;NOS1;ACOX3;ILVBL;CRY2;KDM1A;GSR;MTO1;ACADVL;GFER
prerank,acetyltransferase activity (GO:0016407),-0.48599273560684636,-1.4727197820825408,0.04159132007233273,0.285276508768386,1.0,11/31,16.27%,KAT2B;EP300;KAT6B;CREBBP;PAFAH2;PAFAH1B2;SAT1;KAT8;NAA15;ESCO1;GTF2B
prerank,glycerophospholipid flippase activity (GO:0140333),0.6250985471465117,1.4722039688459911,0.0787746170678337,0.22456404553280784,1.0,7/11,11.06%,ATP8A1;ATP11A;ATP10A;ATP10B;ATP11C;ATP8A2;ABCB4
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6041299160647927,-1.4712588723313902,0.054003724394785846,0.2834728806426753,1.0,6/12,14.76%,KDM7A;KDM4B;PHF8;PHF2;KDM3B;KDM3A
prerank,intracellular chloride channel activity (GO:0061778),0.5549670661489399,1.4710721248869447,0.045662100456621,0.2187321741883665,1.0,4/16,8.66%,ANO3;TTYH2;ANO5;ANO4
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.5549670661489399,1.4710721248869447,0.045662100456621,0.2187321741883665,1.0,4/16,8.66%,ANO3;TTYH2;ANO5;ANO4
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.46510897531778206,1.470228106602683,0.034482758620689655,0.21310588208439285,1.0,17/34,21.30%,NDUFC1;NDUFA4;NDUFA1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;NDUFB2;NDUFB9;NDUFA7;NDUFA12;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.46510897531778206,1.470228106602683,0.034482758620689655,0.21310588208439285,1.0,17/34,21.30%,NDUFC1;NDUFA4;NDUFA1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;NDUFB2;NDUFB9;NDUFA7;NDUFA12;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.6076390292262952,-1.4665465612361164,0.06126126126126126,0.2890659734827147,1.0,4/11,20.58%,UBR5;UBE4B;UBE2K;ANAPC11
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.35340207460924605,-1.4656657147758911,0.007936507936507936,0.2862251836028306,1.0,46/173,18.67%,ZBTB20;FOXP2;FOXP1;AEBP1;NFKB1;PRDM5;ZNF148;FOXP4;ZFHX3;ZEB1;FOXO3;MXI1;KCNIP3;ZKSCAN3;NR3C1;SKI;ZBTB16;JDP2;SKIL;ZEB2;REST;ZBTB37;GTF2IRD1;FOXK1;SP2;ZBTB1;JUN;NFATC4;TBX18;HES1;ZNF692;TCF3;BHLHE41;ZBTB34;PATZ1;SOX13;TRPS1;PRDM2;MNT;FOXK2;HEYL;TBX2;ZFP37;CC2D1A;ZNF436;NFATC3
prerank,tau-protein kinase activity (GO:0050321),-0.5396250277454842,-1.4654906955670313,0.046966731898238745,0.2821215408156771,1.0,10/20,19.79%,ROCK2;ROCK1;GSK3B;MARK3;MARK4;BRSK1;MARK1;SIK3;PRKAA1;TAOK1
prerank,retinoic acid binding (GO:0001972),-0.5980242832407889,-1.4625812826065367,0.06284658040665435,0.28362304918851394,1.0,2/12,3.51%,NR2F2;CYP26B1
prerank,ionotropic glutamate receptor binding (GO:0035255),0.64195052947427,1.4602521543636209,0.07660455486542443,0.22362427072240576,1.0,5/10,9.15%,IGSF11;SHISA6;SHANK3;SHISA7;SHANK2
prerank,sialyltransferase activity (GO:0008373),0.525346139448551,1.4586855326430979,0.0651685393258427,0.222299003638599,1.0,7/20,12.68%,ST6GALNAC3;ST8SIA4;ST3GAL6;ST8SIA1;ST8SIA6;ST8SIA3;ST6GAL2
prerank,rRNA binding (GO:0019843),0.4434269070286084,1.454143241610161,0.046153846153846156,0.2253503276767346,1.0,18/42,18.59%,RPL23;RPF2;RPLP0;MRPS18A;RPL12;MRPS7;RPL5;ERI1;FASTKD5;RPS14;RPS3;UTP23;RPS5;MDM2;PPAN;RPS9;CIRBP;MRPL18
prerank,hexosaminidase activity (GO:0015929),-0.6054600151621734,-1.4540837102278843,0.06115107913669065,0.29680699320952453,1.0,6/12,19.92%,CEMIP;OGA;HEXD;CEMIP2;HEXA;NAGA
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.43300806753375437,-1.4500166117134787,0.046065259117082535,0.3006937789765481,1.0,14/48,18.37%,TRPM3;PIEZO2;NALCN;ATP6V1B2;SLC41A1;TRPM6;SLC12A7;CALHM2;SLC12A2;PKD2;TRPM4;CALHM5;TRPV2;TRPM7
prerank,chemokine binding (GO:0019956),-0.4775125686372896,-1.44974144374889,0.07183364839319471,0.29680048492101074,1.0,9/30,21.55%,ITGAV;PDPN;CCR9;HMGB1;ITGB1;ITGA4;CX3CR1;ITGB3;FGF2
prerank,RNA polymerase binding (GO:0070063),-0.5378032547937451,-1.4457023958025559,0.06566604127579738,0.3009980262765049,1.0,9/18,15.51%,CCNT2;PABPN1;CCNT1;SCAF8;DHX9;PHRF1;STOM;TCERG1;ANP32B
prerank,neuropeptide receptor activity (GO:0008188),0.48521200341128623,1.4448187978763434,0.041928721174004195,0.23637648254916335,1.0,7/29,11.38%,SORCS3;TACR1;SORCS1;TACR3;HCRTR2;OPRM1;GRPR
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.3304119242550904,-1.4426461234660795,0.0,0.3026201392943416,1.0,65/254,18.67%,NFIA;HLF;NFAT5;TCF4;SMAD3;PRRX1;NFKB1;RBPJ;MDM4;FOXC1;FOXO3;HOXB3;MEOX2;ELF1;NFIB;RREB1;GMEB1;MEF2A;NR3C1;SMAD2;HOXA5;PLSCR1;ZBTB16;STAT3;HOXA7;TFDP2;ELF4;FOXC2;RUNX1;HOXC4;VEZF1;CEBPG;AR;CDC5L;NFYC;ATF2;UBP1;GABPA;JUN;HIF1A;SMAD4;GLIS2;CREBRF;MEF2C;NRF1;TFCP2;TCF3;IRF1;ATF6;HINFP;PRDM2;KLF15;FOXK2;PRDM15;KLF6;ZNF112;MYBL1;SIX1;NR4A1;SMARCD2;NFYB;NR4A2;NFIC;TFCP2L1;NFATC3
prerank,GTPase binding (GO:0051020),-0.3346258570336241,-1.437474123176443,0.0020242914979757085,0.30919661686238104,1.0,71/195,23.01%,AKAP13;RNF152;AFDN;PLCE1;ABCA1;ERC1;LRRK2;FLNA;DOCK7;MAPKAP1;SGSM2;RADIL;DNM1L;PDE6D;RANBP2;STRN3;PAK2;TMEM127;RAB3GAP1;BRAF;BRK1;USP6NL;UNC13B;IQGAP2;TNFAIP1;LZTR1;CDC42EP5;RUSC2;USP33;TBC1D20;GGA3;EXOC2;NCKAP1;ARFIP2;YBX3;FGD1;BECN1;YBX1;ARHGDIB;FGD4;ANKRD27;RANBP9;WASF1;RCC1;WHAMM;STOML2;RASA1;GNB1;PICALM;CCDC186;CDC42EP4;AMBRA1;ANKFY1;RABGGTB;RHOH;CHM;TRIOBP;RTKN;RABGAP1;TBC1D7;TRIP11;CHML;DVL3;BNIP3;GGA2;ALS2;ATG14;RAPGEF4;TNPO3;XPO5;RGP1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.47023638221786007,1.4317182245352689,0.06526315789473684,0.25191029637969925,1.0,7/32,9.57%,SLC7A5;SLC6A6;SLC1A1;MFSD12;SLC7A8;SLC43A2;SLC36A1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.6234411339667026,-1.4252192645039032,0.062381852551984876,0.3316617151472835,1.0,4/10,15.83%,KDM7A;KDM4B;PHF8;KDM2A
prerank,regulatory RNA binding (GO:0061980),-0.45048134376989146,-1.4247258283193416,0.04085603112840467,0.32833417147780036,1.0,8/38,8.05%,DICER1;PUM2;ZC3H7A;RC3H1;DHX9;PUM1;TUT4;RBM10
prerank,small GTPase binding (GO:0031267),-0.33596037146940055,-1.4223927118052735,0.007858546168958742,0.3284213091071553,1.0,65/170,24.34%,AKAP13;RNF152;AFDN;PLCE1;ABCA1;ERC1;LRRK2;FLNA;DOCK7;MAPKAP1;SGSM2;DNM1L;PDE6D;RANBP2;STRN3;PAK2;TMEM127;RAB3GAP1;BRAF;BRK1;USP6NL;UNC13B;IQGAP2;TNFAIP1;LZTR1;CDC42EP5;RUSC2;USP33;TBC1D20;GGA3;EXOC2;NCKAP1;ARFIP2;YBX3;FGD1;ARHGDIB;FGD4;ANKRD27;RANBP9;WASF1;RCC1;WHAMM;PICALM;CCDC186;CDC42EP4;ANKFY1;RABGGTB;RHOH;CHM;TRIOBP;RTKN;RABGAP1;TBC1D7;TRIP11;CHML;DVL3;GGA2;ALS2;RAPGEF4;TNPO3;XPO5;RGP1;GCC1;RAB8A;KIF3A
prerank,alanine transmembrane transporter activity (GO:0022858),0.5958396428432312,1.4217228625583933,0.09401709401709402,0.26361037868417997,1.0,4/12,16.03%,SLC6A6;SLC7A8;SLC36A1;SLC3A2
prerank,transcription cis-regulatory region binding (GO:0000976),-0.31107814771204395,-1.42074869082318,0.0,0.32786202278406057,1.0,93/406,17.29%,ZBTB20;PBX1;BNC2;FOXP1;AEBP1;TCF7L2;GLI3;SMAD3;SOX5;TEAD1;CREB3L2;NFKB1;PRDM5;SMAD6;FOXC1;PER3;FOXO3;HDAC4;BCOR;NCOR1;ARNT;CUX1;OSR1;TFEB;MXI1;TBL1X;BRD7;FOXN3;TBL1XR1;RREB1;YAP1;MEF2A;KMT2D;HMGB1;NR3C1;SMAD2;GABPB2;STAT3;TFDP2;HOXC8;FOXC2;RUNX1;REST;VEZF1;ZBTB8A;AR;DHX36;TAF4;FOXK1;CDC5L;TBP;NFYC;ATF2;CHD3;GABPA;NR1H3;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;CREBRF;ZBED4;XRN2;TBX18;RORA;MEF2C;ARID5B;TFCP2;TCF3;RB1;IRF1;SOX13;GLI1;ATF6;SOX6;TRPS1;ZFP3;HINFP;HDAC1;PRDM2;SNAPC3;RXRA;KLF15;BBX;MNT;FOXK2;VSX1;SFPQ;SIX1;ZFP37;NFYB;TWIST2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5766790712976815,-1.4202513837903874,0.08630393996247655,0.3244940957263758,1.0,6/13,24.26%,SLC9A1;SLC9A8;SLC9A2;LETM1;SLC9B2;SLC9A9
prerank,cytochrome-c oxidase activity (GO:0004129),0.5416027887520307,1.4181121896428557,0.06981981981981981,0.26581071223782093,1.0,8/15,21.28%,COX7A1;NDUFA4;COX4I1;COX6A1;COX6B1;COX10;COX8A;COX5B
prerank,metal ion binding (GO:0046872),0.3104505604460713,1.417439673570441,0.0018656716417910447,0.26324820378276353,1.0,88/477,12.30%,SPOCK2;ADGRL3;SPOCK1;GRIN1;NRXN1;CDH12;CDH8;SYT1;MT2A;PCLO;SYT6;S100A16;RASGRP3;KCNIP4;MMP12;SYT7;CDH7;CDH19;CDH20;S100A9;S100A8;S100G;DNER;SYT12;SYT11;CDH18;RYR2;MCTP1;CDH2;PDE2A;PGP;RYR3;MEX3B;SNCA;KCNIP1;NUDT3;SLC8A1;ENPP2;RCN2;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B;CDH10;PITPNM1;SLC25A23;HSPA5;CSGALNACT1;SLIT3;SLIT1;NUDT12;TRPM2;CPNE1;MELK;CIB2;TUBB4A;HPRT1;THBS3;SYT10;DYSF;S100A2;IDH3G;PCDHB6;TPT1;ARSA;TPPP;ACVR1C;DCHS1;PIF1;PVALB;ASTN2;GALNT3;IMPA1;AIF1;APEX1;CALM1;PCDHA4;BRSK2;SYT2;SNN;HACL1;RET;SPARCL1;SNCB
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6181061354746,-1.4154622206865457,0.08076923076923077,0.33106190364908716,1.0,3/10,10.99%,SLC6A13;SLC6A12;SLC6A1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.3379909293410511,-1.4102767468981798,0.007920792079207921,0.33792220089685737,1.0,49/181,14.62%,TCF7L2;SMAD3;PRRX1;RBPJ;MDFIC;PIAS1;EP300;HDAC4;RERE;NCOR1;ARNT;RBBP8;WWP2;GSK3B;ANXA4;MEF2A;BAZ2A;BCAS3;CREBBP;STAT3;TRIP4;DHX9;AR;TAF4;PPARGC1A;TBP;PIAS3;NCOA1;DACT1;MED1;JUP;ATF2;TEAD3;CHD4;MIER1;JUN;TADA3;HIF1A;PARP9;ID2;HES1;TCF3;PIAS4;RB1;BHLHE41;DTX3L;TCERG1;STAT1;HDAC1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.5195295756665841,1.4091614890920152,0.0942622950819672,0.27242986849996104,1.0,6/20,11.74%,SLC39A10;SLC39A2;SLC30A1;SLC30A3;SLC39A8;SLC30A5
prerank,histone acetyltransferase binding (GO:0035035),-0.5025074402480709,-1.4076173701509997,0.07076350093109869,0.3390769899608221,1.0,14/21,28.88%,GLI3;KANSL1L;MEF2A;BCAS3;TRIP4;HIF1A;STAT1;CITED2;PCNA;EID1;TRIM68;ZBTB7A;TAF7;EGR1
prerank,DNA binding (GO:0003677),-0.295961159977935,-1.4059920787745155,0.0,0.338222862645375,1.0,269/694,30.94%,PBX1;RBMS1;FOXP2;DENND4A;NR2F2;EGFR;HLF;ZIC4;TCF4;TCF7L2;SMAD3;TEAD1;FOXD1;PRDM5;ZNF148;HIVEP2;INO80;RBPJ;THRB;GLI2;ZNF423;RARB;FOXC1;ZIC2;FOXO3;EP300;HDAC4;ABL1;ARNT;CUX1;RAD23B;MEOX2;RBBP8;NFIB;NUPR1;NR6A1;TOP1;CCNT1;BCLAF3;KHDRBS1;EZH1;RARG;MEF2A;KMT2D;HUWE1;HMGB1;ZKSCAN3;SMC6;SMAD2;RBM6;HOXA5;CREBBP;ZBTB16;NBN;STAT3;WDR48;HOXA7;RAD51B;TDP2;MLH1;DNMT3A;BCL2;FOXC2;CHD8;DHX9;ZEB2;KDM5B;HDGFL2;CEBPG;FUBP1;DHX36;ZNF496;SAFB2;PCBP2;AIFM1;WRN;TAF4;PPARGC1A;CDC5L;NFYC;DDB2;CHD2;CHD4;CHD3;RFX2;NR1H3;SSBP2;JUN;DDX60;HIF1A;CALCOCO1;SMAD4;MCM9;BCLAF1;XRN1;RTF1;XRCC4;ZMYM4;RORA;RAD51D;ARID5B;PDS5B;ERCC3;SPTY2D1;TFCP2;HES1;WDR76;NABP2;TCF3;TCF7L1;CCDC25;PATZ1;APTX;CGGBP1;IRF1;TSHZ3;YBX1;SOX13;ZMYM3;GLI1;ATF6;PARP4;SOX6;PHF1;STAT1;PRKDC;RBM5;HINFP;CRLF3;MCM6;BRCA2;CTC1;ILF2;DDX3X;PRDM2;MSH3;CARF;SNAPC3;TOPORS;RXRA;FOXK2;DMC1;SFPQ;MRE11;FOXL1;SPRTN;CAMTA2;SIX1;TBX2;NR4A1;NFYB;ZDHHC1;POGK;NR4A2;WBP11;HNRNPU;TAF6L;MSL3;SDE2;DCLRE1A;POLR2H;PARK7;BPTF;GTF3C4;ELK4;MSH6;RNF11;H1-0;TERT;PCNA;SMC1A;TAF12;NFYA;ZBTB49;ZIC3;STN1;SURF6;USF1;XRCC6;CXXC5;ARID5A;SSBP1;DRAP1;MYRF;PRDM9;SPHK1;IRF2;CLSPN;MAFK;MAFB;DEDD;DNASE2;RAD51C;HDAC2;ERCC1;HSF1;NR2F1;TFAP4;MBD3;ZNF35;ARID3B;GTF3C1;SIRT3;TSHZ2;FOXE1;SNAPC1;CRY2;ZBTB7A;CREBZF;QRICH1;SPO11;KIN;ATAD5;PPARA;OGG1;ZNF219;HOXB2;NR2C1;ENDOV;ORC1;GTF3C6;TIPIN;MBD6;MAFF;SOX12;LONP1;GTF2H4;ZNF292;DNASE1L1;SAP30L;MCM4;APP;SOX10;SAFB;POLR2D;MPG;SLTM;CDK9;MCMDC2;TIMELESS;CGAS;ZBTB4;IGHMBP2;E2F1;SUPV3L1;ZMYND11;EGR1;ZFPL1;FOXO4;POLRMT;NR1H4;GLYR1;NFE2L2;SAMHD1;HIC1;CALR;THRAP3;ZNF76;BATF;PSIP1;MLX;MLXIPL;GTF2A1;CR2;FANCG;TWNK;FOXD2;NR5A2;SOX8
prerank,methylated histone binding (GO:0035064),-0.395286965146761,-1.4059790609602185,0.03802281368821293,0.33406114126364195,1.0,31/62,30.85%,KDM7A;CBX5;PYGO1;PHF8;CHD8;PHF2;ZCWPW2;MPHOSPH8;TDRD3;KAT8;ING5;PHF1;L3MBTL2;MORC3;MSL3;RRP8;BPTF;MSH6;ZMYND8;MORC4;ING1;NCAPD3;SPIN1;CXXC1;KMT2E;TAF7;ATRX;ZMYND11;GLYR1;WDR5;CDYL
prerank,sodium:proton antiporter activity (GO:0015385),-0.5995754004159887,-1.405414674155056,0.06554307116104868,0.33115175675585384,1.0,5/11,24.26%,SLC9A1;SLC9A8;SLC9A2;SLC9B2;SLC9A9
prerank,sequence-specific DNA binding (GO:0043565),-0.30004084188313473,-1.4021800380916738,0.0,0.3336047840853026,1.0,96/590,12.23%,ZBTB20;PBX1;FOXP2;FOXP1;NR2F2;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;MAF;TEAD1;FOXD1;PRDM5;HOXB6;ZNF148;SMG6;RBPJ;THRB;GLI2;ZNF423;NR1D2;RARB;FOXC1;FOXO3;SMG1;HDAC4;CREB5;ABL1;ARNT;CUX1;OSR1;NR3C2;TFEB;MBNL2;MEOX2;ELF1;NFIB;NR6A1;NFIX;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;PRRX2;HOXA5;TBX15;ZIC5;TEF;HOXA7;JDP2;HOXC8;BCL2;ELF4;FOXC2;HOXC4;ZEB2;KDM5B;CEBPG;HOXB5;ZBTB37;HNRNPD;SAFB2;FOXK1;MBD2;PPARGC1A;MAFG;SP2;SMG7;ATF2;HOXB4;UBP1;UPF1;RFX2;GABPA;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;NFATC4;TBX18;RORA;MEF2C;FBXL19;TFCP2;TELO2;HES1;TEAD2;IRF9
prerank,metallopeptidase activity (GO:0008237),-0.35597321117374586,-1.398622242354267,0.020370370370370372,0.33662799224113366,1.0,26/113,12.75%,TRABD2B;ADAMTS2;ADAMTS10;ADAMTS12;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;PAPPA;ADAMTS5;BRCC3;MYSM1;ECE1;ANPEP;ADAMTSL4;ADAMTS9;NRDC;MMP14;ADAM9;LAP3;MBTPS2;ADAM19;ADAMTS15;MMP2;ADAM33;NLN
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.3943746655910635,1.3953648649814996,0.042682926829268296,0.291416165976991,1.0,25/57,21.30%,NDUFC1;COX7A1;NDUFA4;COX4I1;NDUFA1;COX6A1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;COX6B1;NDUFB2;UQCRH;NDUFB9;NDUFA7;COX10;NDUFA12;COX8A;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;COX5B;NDUFB7
prerank,muscle alpha-actinin binding (GO:0051371),-0.542113949266749,-1.394978231362427,0.10220440881763528,0.33993692055300395,1.0,6/15,12.33%,PDLIM5;PDLIM7;PALLD;SYNPO2;PDLIM2;PKD2
prerank,active ion transmembrane transporter activity (GO:0022853),0.4346045320923547,1.3908802856981382,0.0891304347826087,0.29507314976828675,1.0,9/37,9.69%,SLCO1C1;SLC4A1;SLCO4C1;COX7A1;NDUFA4;COX4I1;COX6A1;SLCO5A1;SLCO2B1
prerank,pentosyltransferase activity (GO:0016763),-0.4358759962420257,-1.3815621822923208,0.06727272727272728,0.36574201672739315,1.0,12/36,13.62%,LARGE1;TNKS2;UPP2;ZC3HAV1;PARP10;PARP14;PARP9;PPAT;PARP1;QTRT2;SIRT5;PARP4
prerank,monocarboxylic acid binding (GO:0033293),-0.5138098988670681,-1.379750612465481,0.0940959409594096,0.3653990715555273,1.0,4/18,15.53%,NR2F2;CYP26B1;NAPEPLD;RXRA
prerank,voltage-gated ion channel activity (GO:0005244),0.5373080255039514,1.372075272809228,0.09394572025052192,0.32399615299432355,1.0,5/14,14.61%,KCND2;HCN1;CACNA1E;VDAC2;VDAC3
prerank,four-way junction DNA binding (GO:0000400),-0.5169599927485027,-1.371578889854392,0.1100196463654224,0.3793238310446723,1.0,8/17,23.20%,ABL1;HMGB1;RAD51B;WRN;RAD51D;FANCM;MSH6;RAD51C
prerank,manganese ion binding (GO:0030145),-0.4032988331149838,-1.363013891184558,0.060546875,0.3943999213778818,1.0,20/48,23.90%,LARGE1;MPPED2;B4GALT1;ABL1;XPNPEP1;TDP2;WRN;ME1;ABL2;FAM20C;PPM1M;PCK2;XYLT2;SOD2;NEK4;GALNT1;B4GALT7;MPPE1;XXYLT1;PRIMPOL
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.38709656385955615,1.3622174829522162,0.07407407407407407,0.33793654260983536,1.0,15/60,8.39%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK;ACVRL1;EPHA10
prerank,double-stranded DNA binding (GO:0003690),-0.2950338830525204,-1.3605930922604397,0.0,0.3956348536542398,1.0,101/531,17.04%,ZBTB20;PBX1;RBMS1;FOXP1;EGFR;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;GLI3;MAF;TEAD1;HOXB6;THRB;GLI2;NR1D2;RARB;FOXO3;CREB5;ABL1;ARNT;CUX1;OSR1;NR3C2;TFEB;MBNL2;MEOX2;ELF1;RBBP8;NFIB;NR6A1;TOP1;NFIX;GMEB1;RARG;HMGB1;NR3C1;KLF3;SMAD2;PRRX2;HOXA5;TBX15;ZIC5;WDR48;TEF;HOXA7;RAD51B;JDP2;HOXC8;ELF4;FOXC2;HOXC4;DHX9;KDM5B;HDGFL2;CEBPG;HOXB5;ZBTB37;FOXK1;MAFG;SP2;ATF2;HOXB4;UBP1;RFX2;GABPA;JUN;DDX60;GLIS2;NFATC4;TBX18;MEF2C;TFCP2;HES1;TEAD2;IRF9;TCF7L1;BHLHE41;APTX;CGGBP1;YBX1;ATF6;STAT1;PRKDC;MSH3;HOXB9;RXRA;KLF15;RUNX2;BBX;DMC1;VSX1;KLF6;MRE11;SPRTN;CAMTA2;SIX1;TBX2;NR4A1
prerank,phospholipase activator activity (GO:0016004),-0.6063105497996616,-1.3565513905630173,0.11380597014925373,0.4011882227508983,1.0,3/10,11.22%,ARHGAP6;PDPK1;STX4
prerank,poly-purine tract binding (GO:0070717),-0.4651194996211338,-1.3521144746040061,0.1095890410958904,0.4067551896712708,1.0,6/27,5.06%,RBMS1;RBMS3;RBPMS;ATXN1;KHDRBS1;RBMS2
prerank,peptidase inhibitor activity (GO:0030414),-0.4361272343974411,-1.3494604873556206,0.09018036072144289,0.40871134569523676,1.0,9/33,11.79%,CAST;PROS1;GPC3;TFPI;ITIH2;RECK;RENBP;SERPIND1;PSMF1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.40267562313700445,1.3472470268222592,0.08080808080808081,0.36227263802831067,1.0,11/51,9.69%,SLCO1C1;SLC7A5;SLC4A1;SLCO4C1;MFSD2A;SLC35A1;SLCO5A1;SLC7A8;SLC25A14;SLC35C1;SLCO2B1
prerank,ATPase binding (GO:0051117),-0.37084738225594305,-1.346975833093716,0.04007633587786259,0.4099924576716183,1.0,27/71,22.45%,EGFR;ANK2;ABCA1;TMTC4;SNTA1;PTPN3;ATP6V0A4;CHMP4A;AR;NCSTN;SELENOS;RALA;PKD2;SNX10;METTL21A;NOP58;SNU13;CLPP;DERL1;TCIRG1;SYVN1;ATP5IF1;ATP1B3;PEX26;S100A1;PIH1D1;WFS1
prerank,transcription coactivator binding (GO:0001223),-0.486772454727492,-1.3452742237488302,0.11573236889692586,0.4096974470277073,1.0,8/20,12.14%,SMAD3;THRB;CCNT2;VGLL4;AR;SMAD4;RORA;TEAD2
prerank,protein serine/threonine kinase activity (GO:0004674),-0.3014479280285139,-1.344423600730038,0.004210526315789474,0.40748938828366904,1.0,110/335,22.13%,ROCK2;GRK5;EGFR;TGFBR1;BMPR1A;CDK8;TLK1;CLK1;MAPK4;MYLK;ARAF;STK3;FAM20A;ROCK1;SMG1;CAMK1D;LRRK2;PRKAA2;TGFBR2;CSNK1A1;TOP1;GSK3B;STK17B;TBK1;IRAK3;NRK;MARK3;CDK16;BCR;CDK7;SLK;PAK2;ALPK1;MAP4K4;TAOK3;EIF2AK3;CAMK2D;IRAK2;MTOR;BRAF;MAP3K5;PDPK1;CAMK2G;MARK4;MAP2K1;CDK13;GRK3;WNK4;CCNK;CLK2;MAP3K20;WNK1;CSNK1E;HIPK1;BRSK1;PRKCD;DMPK;FAM20C;PRKAB2;CLK3;CDK11B;ULK2;RIOK3;MKNK2;SIK1;EIF2AK4;RPS6KC1;STK33;CPNE3;MAPK6;EIF2AK2;PRKDC;BMP2K;ACVR1;ERN1;LATS1;PRKCZ;MAP3K14;CSNK2A1;PIK3R4;GRK6;MARK1;DAPK1;SIK3;TRIO;IKBKE;DAPK2;PRKACA;PRKD1;PRKAA1;NEK4;CSNK1D;STK16;MAP3K1;CDK10;CDK2;NEK6;FASTK;IRAK1;TAOK1;NRBP2;BCKDK;CDK6;MAST2;AKT2;MKNK1;ATR;MAP3K12;PRKCA;SIK2
prerank,GTPase activator activity (GO:0005096),-0.30188074254292535,-1.343296282063463,0.011695906432748537,0.4057322181258481,1.0,84/313,16.77%,AKAP13;RANBP3L;ALDH1A1;ARHGAP29;DENND4A;DOCK5;ARHGAP10;ARHGAP42;DOCK11;ERRFI1;PLCE1;ASAP3;SIPA1L1;DENND2A;FARP1;ARHGAP28;ASAP1;STXBP5;ARHGAP20;LRRK2;ARHGEF10L;ARHGEF17;ARAP1;TBC1D16;SMAP1;SBF2;IQSEC2;ARHGAP24;BCR;SGSM2;DNM1L;RANBP2;SEC23A;NRP1;ARFGEF1;RAB3GAP1;CYTH3;GMIP;RAPGEF3;VAV2;ARHGAP17;USP6NL;RAB3IL1;IQGAP2;ARFGAP1;ARFGAP3;TBC1D2B;HERC2;TBC1D20;TBC1D8B;RAB3IP;RCC1L;JUN;RP2;ARHGEF18;FNIP1;DENND4C;ARHGAP32;MON1A;SERGEF;SEC23B;FGD1;DNMBP;TBCK;DENND5A;GRTP1;TBC1D22B;FGD4;ANKRD27;RCC1;TBC1D9;ACAP2;RAPGEF2;FARP2;RASA1;SH3BP5L;NGEF;ARRB1;ARHGAP18;DOCK1;ARHGEF11;ARHGEF6;RIC8B;TBCD
prerank,lipoprotein particle receptor binding (GO:0070325),0.4472334542207992,1.3339869020396935,0.11233480176211454,0.3838008948185613,1.0,6/27,9.08%,SYT1;AP2M1;APBB1;APBB3;CLU;RELN
prerank,water transmembrane transporter activity (GO:0005372),0.5520788927314989,1.3334365417002323,0.13347457627118645,0.3799167731513629,1.0,3/11,12.21%,AQP9;AQP11;AQP4
prerank,anion transmembrane transporter activity (GO:0008509),0.5535171998362887,1.3309945181992866,0.12987012987012986,0.37997751868133867,1.0,4/12,10.65%,SLC4A1;ABCG2;SLCO2B1;SLC39A8
prerank,lipoprotein particle binding (GO:0071813),0.5013702608277789,1.3288255942608032,0.12896405919661733,0.3791827731094798,1.0,7/20,14.42%,PLTP;SCARF1;HSPD1;SORL1;SCARB1;CD36;STAB2
prerank,transcription coregulator binding (GO:0001221),-0.39917709944255314,-1.3284447617267017,0.081374321880651,0.43748455875696857,1.0,20/50,21.57%,SMAD3;THRB;PER3;CCNT2;VGLL4;LCOR;ZBTB16;AR;UBE2I;SMAD4;RORA;TEAD2;EHMT1;USP11;PHF1;CNOT2;NEK6;TERT;ZBTB49;EZH2
prerank,SH3 domain binding (GO:0017124),-0.37278550316389863,-1.3283633251050078,0.06627680311890838,0.43320169623114063,1.0,19/62,17.93%,DPYSL3;AFAP1;CBLB;ABL1;PRKN;WASF2;KHDRBS1;SYNJ2;PLSCR1;VASP;PTPN22;PTPN12;ADAM9;ABI1;WIPF1;CYBA;SOCS7;AFAP1L2;MICAL1
prerank,miRNA binding (GO:0035198),-0.4369874063595665,-1.3192159440567652,0.10325047801147227,0.45139446530508337,1.0,12/30,29.35%,PUM2;ZC3H7A;RC3H1;PUM1;TUT4;RBM10;YBX1;RBM4;ZNF346;AGO1;ZC3H7B;ZC3H10
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5409581864092822,-1.318911693124303,0.14595660749506903,0.447670459297855,1.0,4/12,9.27%,CDK8;CDK7;CDK13;CCNK
prerank,low-density lipoprotein particle binding (GO:0030169),0.5187617047503817,1.3184594370184455,0.1206896551724138,0.39575345716595084,1.0,6/16,14.42%,PLTP;SCARF1;SORL1;SCARB1;CD36;STAB2
prerank,acid-thiol ligase activity (GO:0016878),-0.5263798294788669,-1.3151662670026676,0.15658362989323843,0.4532051712971425,1.0,2/13,3.04%,ACSL1;ACSS3
prerank,DNA secondary structure binding (GO:0000217),-0.4239592365151384,-1.31287932390869,0.08924949290060852,0.45433501796003534,1.0,12/31,23.20%,ABL1;RBBP8;HMGB1;RAD51B;WRN;MEF2C;RAD51D;FANCM;MSH6;KMT2A;CLSPN;RAD51C
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.492681909087963,1.3122875418659434,0.13118279569892474,0.4029448213628344,1.0,6/18,21.42%,SRD5A2;HSD17B7;HSD11B1;HSD17B2;HSD17B10;HSD3B7
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5453350572819643,-1.3080134955361487,0.14583333333333334,0.4619568745637872,1.0,7/12,20.78%,IGF1;IRS1;SHC1;IGF2;GNAS;ARRB1;PIK3R1
prerank,tropomyosin binding (GO:0005523),-0.5031191941151929,-1.3079506161908085,0.13825757575757575,0.4577498734065131,1.0,3/16,10.45%,CALD1;TMOD3;S100A6
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.5625159600084851,-1.3079164734467847,0.14869888475836432,0.4535162655989045,1.0,7/11,39.75%,SLC22A5;SLC22A4;SLC25A47;SLC25A29;SLC25A20;SLC22A3;SLC25A45
prerank,5'-3' exonuclease activity (GO:0008409),-0.5135114705636372,-1.306876549464784,0.14774774774774774,0.4518816352643358,1.0,6/14,23.03%,CPSF3;XRN1;XRN2;MRE11;DCLRE1A;EXOG
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.4902887077722432,-1.3052273974792312,0.12859884836852206,0.45175437922253714,1.0,5/18,12.66%,ALDH1A1;ALDH1A2;ALDH2;AKR1B1;ALDH6A1
prerank,RNA cap binding (GO:0000339),-0.4949752511358944,-1.2986156798057804,0.16116504854368932,0.4639047424977921,1.0,8/16,31.14%,CYFIP2;LARP1;GEMIN5;EIF4E;EIF4E3;NCBP3;NCBP2;LSM1
prerank,transcription corepressor binding (GO:0001222),-0.44908644849857304,-1.2974233072444514,0.12007168458781362,0.4627513286341764,1.0,13/27,28.17%,PER3;LCOR;ZBTB16;RORA;EHMT1;USP11;PHF1;CNOT2;NEK6;EZH2;ZBTB7A;HDAC3;ESR1
prerank,CoA-ligase activity (GO:0016405),-0.5167926603644288,-1.2971552310599053,0.14285714285714285,0.4593313515622471,1.0,2/14,3.04%,ACSL1;ACSS3
prerank,alpha-actinin binding (GO:0051393),-0.45350472491566707,-1.296826012196046,0.12083333333333333,0.4559724455094592,1.0,9/24,12.33%,CACNA1C;DAG1;PDLIM5;PDLIM7;CACNA1D;PALLD;SYNPO2;PDLIM2;PKD2
prerank,pre-mRNA binding (GO:0036002),-0.4377505491310807,-1.296663667302612,0.14484126984126985,0.45241450063592425,1.0,8/28,9.95%,CELF2;DDX5;CELF1;U2AF2;SRSF6;RNPC3;SLU7;SLBP
prerank,phospholipase binding (GO:0043274),-0.5320419749935914,-1.296115927538284,0.14652014652014653,0.4498157494967936,1.0,3/13,7.95%,ARHGAP6;PRKN;PDPK1
prerank,phosphotyrosine residue binding (GO:0001784),-0.4054243657333594,-1.295149476700884,0.10077519379844961,0.44809255586986535,1.0,16/37,25.51%,ABL1;IRS1;SHB;SHC1;PTPN3;VAV2;ABL2;YES1;NCK2;RASA1;PTPN11;PIK3R1;SHF;CRKL;SYK;SHC3
prerank,receptor ligand activity (GO:0048018),0.3024024567329442,1.2947045183103087,0.022,0.43626522321604655,1.0,37/245,10.55%,NRG3;KITLG;IL17F;SEMA3C;SEMA6A;MIF;AMH;IL7;NRG1;SEMA4A;SEMA4F;GAS6;SEMA6D;FGF10;SEMA4D;TAFA2;SEMA7A;BMP8A;IL12A;SCGB3A1;TGFB2;TAFA1;AMELX;WNT7B;FGF5;ENDOU;TNFSF13B;EPO;TIMP1;GPNMB;NMB;SST;POMC;THPO;BMP3;PDGFB;SCG2
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.5739036341133633,-1.290137815195691,0.15482695810564662,0.456413101526593,1.0,6/10,18.14%,EP300;HAT1;ATF2;KAT8;BRCA2;MSL3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.49878985705083867,1.2894088783145423,0.15450643776824036,0.44257680135648175,1.0,5/14,23.53%,CAPN11;CAPN6;CAPN5;CAPN2;CAPN15
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3637994005907743,1.2886148160673911,0.08041237113402062,0.439149837427956,1.0,13/60,5.87%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.40703170944793915,-1.2854138066327752,0.09381237524950099,0.4640248992851285,1.0,16/34,24.46%,SETD7;KMT5B;NSD3;SMYD3;SETD3;SETD2;N6AMT1;SETDB1;EHMT1;METTL21A;EEF2KMT;KMT5A;EZH2;PRDM9;CAMKMT;KMT2E
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5053434690797745,1.2843557305584887,0.18259023354564755,0.4438023003989181,1.0,3/14,0.51%,SPOCK2;SPOCK1;SPOCK3
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.5635522967303525,-1.2839091696617893,0.17757009345794392,0.46399593062381456,1.0,3/10,9.24%,DSE;GLCE;RENBP
prerank,poly(A) binding (GO:0008143),-0.47385027689835746,-1.2809779930461445,0.15369649805447472,0.4673660627887418,1.0,5/21,5.06%,RBMS1;RBMS3;RBPMS;KHDRBS1;RBMS2
prerank,kinase binding (GO:0019900),-0.27858860468477675,-1.279566570626315,0.011976047904191617,0.467281648141128,1.0,139/435,22.55%,PRKAG2;EGFR;SASH1;TCF7L2;SMAD3;PTN;ERRFI1;ANK2;GSN;PKD1;LIMS1;MAPK4;KIF13B;NBEAL1;NISCH;PDGFRB;KAT2B;IL31RA;FOXO3;PPP1R12A;GHR;TAX1BP1;PRKN;WWC2;TNS2;DLG4;IBTK;GSK3B;RPTOR;CNTLN;FLNA;IRAK3;MAPKAP1;IL15RA;DLG1;NR3C1;RND3;EIF4ENIF1;RBBP6;AXIN1;PAK2;SKI;SLC12A7;UBQLN1;STAT3;UFL1;TRIP4;CENPJ;SHC1;TPCN2;ADCY6;CDC42;VDAC1;SP100;PTPRK;PTPN22;ATF2;CCNK;WNK1;PLCG1;TOM1L2;RB1CC1;PTPN2;SLC12A2;TRAF2;RHOA;PRKCD;HIF1A;DNAJC3;PRKAB2;EXOC2;MAVS;KIZ;WWC1;PARP1;TRIM5;TELO2;RHOBTB2;SUFU;SIK1;RB1;RICTOR;MAML1;BECN1;MAPRE1;MOB1B;CDK5RAP1;ERCC6L2;CCND3;LATS1;CDC25B;PPP1CB;MAP2K7;TNIP2;RAB11FIP2;ADRA2A;TTC28;CACUL1;PRKACA;LRRC14;PTPN1;RHOBTB1;FBXW5;BLNK;TRAF6;RHOH;MAP3K1;MYOM1;PARK7;RHOC;MTCP1;PTPN11;NEK6;IRAK1;CARD16;MAP2K6;MVP;TRIP6;SPRED2;CAB39;PRKAG3;PFKM;DGKD;PIH1D1;USF1;CDK5RAP3;LRBA;GATA6;SMAD1;PRKAB1;MSN;TBL2;NBEAL2;PFKL;MAP3K12;CIR1;PRKRIP1;TICAM1;CHP1
prerank,mRNA binding (GO:0003729),-0.2971904237429337,-1.2781734772068885,0.021367521367521368,0.46681796216764815,1.0,59/249,14.84%,RBMS1;SAMD4A;CELF2;SRRM2;RBFOX2;RBMS3;RBPMS;DDX5;CELF1;EIF4G3;LUC7L2;HNRNPR;PUM2;YTHDF3;SYNCRIP;PCF11;KHDRBS1;DDX6;RBMS2;EIF4ENIF1;RC3H1;ZC3H12C;SCAF8;NYNRIN;HNRNPM;DHX9;PTBP3;SF3B1;DENR;SRSF6;LARP1;SRBD1;PUM1;HDLBP;FUBP1;DCP1A;DHX36;PCBP2;CSDC2;GEMIN5;HNRNPK;SLBP;LSM14A;SF3B6;DAZAP1;YTHDC1;DCP1B;KHNYN;TPR;SNRNP70;YBX3;SERBP1;NSRP1;ACO1;RBM5;SRSF1;ZC3H12B;EDC3;DDX3X
prerank,vitamin D receptor binding (GO:0042809),-0.5124503147011301,-1.2780304181479916,0.16792452830188678,0.4633875487168888,1.0,10/14,30.14%,MED17;MED12;MED1;RXRA;MED16;MED13;MED14;TAF7;SNW1;THRAP3
prerank,3'-5' DNA helicase activity (GO:0043138),-0.4760778475925733,-1.2688871475118408,0.19298245614035087,0.4821253191045605,1.0,6/16,14.57%,DHX9;WRN;ASCC3;ERCC3;FANCM;MCM6
prerank,Tat protein binding (GO:0030957),0.5467480505172465,1.2683018088937748,0.1912087912087912,0.4747704704528285,1.0,3/10,4.32%,ACTB;GABARAPL1;SMARCB1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.31994434269959465,1.2662133145849224,0.06300813008130081,0.47474055159254513,1.0,25/134,10.65%,SLCO1C1;SLC7A5;SLC6A6;SLC4A1;SLCO4C1;SLC7A1;ABCG2;MFSD2A;SLC35A1;SLC17A6;SLC1A1;SLC52A2;SLC25A42;SLC25A23;MFSD12;SLC1A2;SLCO5A1;SLC6A8;SLC7A8;SLC52A3;SLC66A1;SLC36A1;SLCO2B1;ABCC4;SLC39A8
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5367029197604617,-1.2661486593350026,0.16356877323420074,0.4856119908065413,1.0,4/11,8.85%,AKAP13;KSR1;SH3RF1;MAP2K1
prerank,alkali metal ion binding (GO:0031420),-0.5201201728700431,-1.2660367834327364,0.1864406779661017,0.481978743362489,1.0,2/13,2.77%,ATP1A2;HDAC4
prerank,lipase activator activity (GO:0060229),-0.5682170522182612,-1.265863833020313,0.1791044776119403,0.4784655793308424,1.0,2/10,7.95%,ARHGAP6;PDPK1
prerank,nuclear localization sequence binding (GO:0008139),0.4659072121388753,1.2646656013319737,0.16938775510204082,0.4732317578206774,1.0,3/18,2.67%,IPO5;IPO4;CABP1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.5097898601519765,-1.2635176527611676,0.19117647058823528,0.4804479761176084,1.0,10/13,42.91%,TRMT11;METTL1;THUMPD3;TRMT1L;FTSJ1;TRMT1;TRMT10C;TRMT5;WDR4;TRMT10B
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4775144506352197,1.2629382464521683,0.16452991452991453,0.4719841681587033,1.0,5/15,14.17%,SLA2;PIK3R5;SOCS1;PIK3R3;CCKBR
prerank,mRNA 3'-UTR binding (GO:0003730),-0.3393783549819937,-1.2601969193842086,0.07615230460921844,0.4850850995315349,1.0,34/79,29.24%,RBMS1;CELF2;RBMS3;DDX5;CELF1;PUM2;RBMS2;RC3H1;LARP1;PUM1;DHX36;CSDC2;GEMIN5;DAZAP1;YBX3;SERBP1;EXOSC9;CCT5;CPEB1;RNF20;HNRNPU;RBM4;ANGEL2;NUDT21;PABPC4;AUH;RSL1D1;FXR1;CPSF1;PCBP4;PARN;ZFP36L2;PABPC4L;CRYZ
prerank,ATP binding (GO:0005524),-0.28713206602214864,-1.259217760036519,0.03815261044176707,0.4840854285260584,1.0,84/266,24.01%,ATP1A2;PRKAG2;TGFBR1;BMPR1A;TLK1;ABCA1;MYO1B;KSR1;STK3;ABL1;ENPP1;TOP1;ABCD3;STK17B;N4BP2;IRAK3;MAP4K4;CHD8;DHX9;SMC4;MAP3K5;SYN3;DHX36;ABCD2;MARK4;ABCF1;WNK4;MAP3K20;WNK1;BRSK1;DMPK;HSPA14;CARS2;CDK11B;AK6;HSPA9;PEX6;ABCD4;MKNK2;PNPLA8;SIK1;MYO1F;PGK1;TBCK;MCM6;ACVR1;ERN1;LATS1;P2RX4;MARK1;PDXK;MTREX;DAPK1;PTPA;TARS1;SIK3;TAP2;OAS2;DAPK2;PXK;PFKP;HNRNPU;MLKL;EIF4G1;MSH6;NEK6;TAOK1;NME1;BCKDK;CDK6;PFKM;MAST2;AKT2;MKNK1;PFKL;SIK2;SPHK1;GSS;GALK1;CDC42BPG;TRNT1;RRM1;MVK;CLPX
prerank,kinesin binding (GO:0019894),0.42396050005282354,1.2565355880318179,0.16964285714285715,0.4813088670420544,1.0,11/27,20.37%,ACTB;MAPK8IP2;SNCA;SPTBN5;MAPK8IP1;RAB29;ATCAY;TTBK2;CLSTN1;KIF1B;CROCC
prerank,mannose binding (GO:0005537),0.5054323044040341,1.2533200806303806,0.1831578947368421,0.4838783078616498,1.0,1/12,0.95%,MBL2
prerank,ubiquitin binding (GO:0043130),-0.3470100411641735,-1.2517178809066087,0.08982035928143713,0.49864768995355363,1.0,18/73,17.01%,SMAD3;UBE2N;PRKN;RAD23B;UBXN2B;WDR48;DDI2;NBR1;RNFT1;MARK4;USP33;GGA3;FBXW7;ILRUN;USP13;FAF2;SPRTN;AUP1
prerank,phospholipid transfer activity (GO:0120014),0.4492191784568928,1.2514420693757622,0.18666666666666668,0.48319197543379994,1.0,9/21,18.19%,PLTP;CERT1;PITPNM1;PRELID3A;PLEKHA3;PRELID2;CPTP;MTTP;PITPNB
prerank,FMN binding (GO:0010181),0.5249791465184829,1.247940182972456,0.208,0.4856875005688593,1.0,3/11,7.94%,NDOR1;NOS3;DUS2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.5166016908978805,-1.2458802385846963,0.1958568738229755,0.5095401523405522,1.0,9/12,41.01%,NQO2;CBR4;NDUFS7;DHRS4;CRYZ;CBR1;NQO1;DCXR;AIFM2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.5383910345429777,-1.241535542156595,0.21636363636363637,0.5162164181375953,1.0,3/10,19.72%,NOX4;CYBA;NCF2
prerank,CXCR chemokine receptor binding (GO:0045236),0.5235411724386461,1.239713603864788,0.22903885480572597,0.49955183369892026,1.0,1/11,2.70%,CXCL12
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4902508202461056,1.2325180427724998,0.2021978021978022,0.5120160438490338,1.0,2/13,2.91%,PRKAR2B;RYR2
prerank,tRNA methyltransferase activity (GO:0008175),-0.46389955197137445,-1.2292945850315125,0.21062618595825428,0.5431745321138222,1.0,10/16,33.27%,TRMT9B;METTL2B;METTL2A;THUMPD3;FTSJ1;LCMT2;TRMT44;TYW3;ALKBH8;TRMT12
prerank,pyridoxal phosphate binding (GO:0030170),-0.4462631726898428,-1.228311857965397,0.18809980806142035,0.5417535076028985,1.0,14/20,41.56%,ABAT;PYGB;PYGM;PDXK;PLPBP;OAT;PSAT1;CBS;ACCS;CTH;PYGL;SHMT2;GLDC;SHMT1
prerank,NAD binding (GO:0051287),-0.42417328712884184,-1.2275743972251205,0.1873767258382643,0.5397377288354701,1.0,9/26,15.18%,ALDH1A1;CRYL1;ALDH2;GLUD1;ZC3HAV1;ME1;PARP9;SIRT5;BDH2
prerank,calcium channel activity (GO:0005262),0.332279771061103,1.2271395758414612,0.13704496788008566,0.5195496269119012,1.0,20/84,14.43%,SLC24A4;SLC24A2;GRIN1;TRPC5;CACNA1A;CACNA1B;RYR2;CACNA2D1;CACNG2;CACNA1E;TRPM2;CACNB2;CACNG3;OPRM1;CACNG8;CACNB4;TRPC1;TMCO1;PSEN1;CACNA1I
prerank,phosphatase inhibitor activity (GO:0019212),-0.44644285131120887,-1.2266660249045083,0.18640776699029127,0.5382967881958716,1.0,8/20,27.30%,PTN;STYX;CABIN1;ANP32E;BOD1L1;PPP1R2;BOD1;SAG
prerank,cadherin binding (GO:0045296),-0.27593958034936295,-1.2263651983423673,0.050100200400801605,0.5350810340709018,1.0,94/315,18.02%,PHLDB2;CALD1;PARVA;EGFR;AHNAK;AFDN;VCL;PI4KA;PDLIM5;CAST;MPP7;ASAP1;MPRIP;MYO1B;CTNNA1;ERC1;LIMA1;BAIAP2L1;CDH11;TLN1;NIBAN2;PACSIN2;FLNA;WASF2;DDX6;DLG1;ITGB1;SLK;SNX9;RAB10;ANXA2;PAK2;CDH1;ARVCF;TMOD3;ANXA1;TES;ZC3HAV1;LARP1;HDLBP;CHMP4B;CNN3;ZC3H15;ATXN2L;VASP;GCN1;KTN1;JUP;HNRNPK;CHMP5;GOLGA3;PLCB3;BAG3;PDXDC1;HCFC1;NOTCH3;GIPC1;PLIN3;ABI1;TXNDC9;ARGLU1;CAPZA1;ARFIP2;CEMIP2;CCT8;ATIC;GLOD4;TRIM25;STX5;MAPRE1;SERBP1;PCMT1;CAPZB;LASP1;CTTN;STAT1;NUDC;NUMB;ACVR1;NCK1;DDX3X;YWHAE;P2RX4;EMD;PAICS;ARHGAP18;VASN;MRE11;FXYD5;PICALM;PFKP;CC2D1A;S100A11;PTPN1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5166998093619042,-1.2254144246993308,0.2271880819366853,0.5335319047468378,1.0,8/11,36.82%,CFLAR;CASP12;CASP2;CASP6;PYCARD;CASP1;CASP4;CASP7
prerank,phosphatidylinositol binding (GO:0035091),-0.3248540549868659,-1.2252357245533885,0.11954459203036052,0.5302027265520763,1.0,30/91,21.37%,ITPR1;PARD3B;APPL2;ITPR2;SNX24;NUMA1;EEA1;PIGK;BCAS3;SNX9;ZFYVE1;FCHO2;PITPNA;PITPNC1;TULP3;PITPNM2;PLEKHF2;APPL1;SNX10;PARD3;ZFYVE16;SNX8;RUBCN;PICALM;ANKFY1;GPAA1;PLEKHF1;C2CD2L;MPPE1;PLEKHN1
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.3823506865779111,-1.2225130567255196,0.1643835616438356,0.5333888592197413,1.0,16/38,23.51%,GAB2;SORBS1;LRRK2;IRS1;AXIN1;SHC1;FRS2;MMS19;NCK1;NCK2;SH2B1;BLNK;PTPN11;PIK3R1;DLG5;SPAG9
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.39287018524388917,-1.2219064372209698,0.1448692152917505,0.5312791542057719,1.0,11/34,19.20%,UBE2N;UBE2E2;BIRC6;UBE2H;UBE2K;UBE2I;UBE2R2;UBE2B;UBE2E1;UBE2S;UBE2D3
prerank,glucuronosyltransferase activity (GO:0015020),0.44574662127197756,1.219403494322914,0.2097457627118644,0.5326692550568256,1.0,3/19,5.63%,B3GAT1;B3GAT2;CSGALNACT1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5356286832289298,1.2184002051287095,0.24210526315789474,0.5294955811011296,1.0,4/10,9.69%,SLCO1C1;SLCO4C1;SLCO5A1;SLCO2B1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.3161562010574831,-1.216047921583186,0.12127236580516898,0.5419445640368958,1.0,30/100,17.97%,GAB2;FCHSD2;MYO1B;ADAP2;SNX24;SH3PXD2B;GBF1;ARAP1;OSBPL8;MAPKAP1;OSBPL5;CYTH3;ZFYVE1;DAPP1;PLA2G4A;IQGAP2;KIF16B;WIPI1;SNX21;ARFIP2;GSDMD;OGT;ATG2A;PARD3;PLEKHA8;ZFYVE16;WDR45B;RUBCN;ATG2B;ANKFY1
prerank,solute:sodium symporter activity (GO:0015370),-0.4087265793124839,-1.2124465691124409,0.1918819188191882,0.5468593659897864,1.0,4/27,10.92%,SLC5A3;SLC20A2;SLC4A10;SLC5A6
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.36607485255006145,-1.212041195329014,0.18234165067178504,0.5441929638310034,1.0,18/42,25.51%,ABL1;IRS1;SHB;SHC1;PTPN3;VAV2;ABL2;YES1;FBXW7;YWHAE;NCK2;RASA1;PTPN11;PIK3R1;SHF;CRKL;SYK;SHC3
prerank,protein heterodimerization activity (GO:0046982),-0.2922450256612189,-1.2115271391003744,0.08793456032719836,0.5418190169704449,1.0,51/178,21.37%,ATP1A2;BMP6;TCF4;TPM1;ZHX2;ARNT;ADRA1B;IRAK3;EXT1;SAE1;MEF2A;ITGB1;BCL2;MIGA2;IRAK2;ZBTB1;HIF1A;PAFAH1B2;MEF2C;PSMF1;AGTR1;QTRT2;TCF3;BHLHE41;SRI;ATF6;KATNA1;HEXA;GCA;MICU1;RCC1;YWHAE;CYBA;BDKRB2;PRMT5;ADRA2A;BUD23;NR4A1;TOP2B;TLR4;NR4A2;RALGAPB;IRAK1;TPM2;P4HB;SMC1A;PPP2CA;DGKD;USF1;RALGAPA2;NAE1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.3721734314704057,-1.2105866930508011,0.18269230769230768,0.5404471260350313,1.0,10/42,15.71%,CCNL2;KAT2B;CCNT2;CCNL1;CCNH;CCNT1;CCNK;CCNYL1;CCND3;CNPPD1
prerank,myosin binding (GO:0017022),-0.3518971295909096,-1.2090611833888318,0.18095238095238095,0.5406147350733992,1.0,12/55,12.21%,CALD1;KIRREL1;TRAK1;GSN;STXBP5;RAB10;ARFGEF1;SPATA6;RHOA;GIPC1;RAB11A;RALA
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.4608404773103537,-1.2081879213907816,0.21102661596958175,0.5394896519406402,1.0,7/15,29.75%,KMT2C;KMT2D;SETD3;KMT2A;PRDM9;CXXC1;WDR5
prerank,GABA receptor binding (GO:0050811),0.5009179055163823,1.2079795776734095,0.22637362637362637,0.5502700831205912,1.0,4/11,9.22%,GABARAPL1;GABARAP;SHISA7;LHFPL4
prerank,estrogen receptor binding (GO:0030331),-0.3944588026255995,-1.2078823033763009,0.17286245353159851,0.5366605953915421,1.0,15/32,21.77%,PPARGC1B;LCOR;DCAF1;TRIP4;NSD1;NCOA6;NCOA1;MED1;PRMT2;WIPI1;MMS19;LATS1;CNOT1;PPID;ARID5A
prerank,Wnt-activated receptor activity (GO:0042813),-0.4696131700742623,-1.207069022018033,0.2174757281553398,0.5350376275504322,1.0,4/15,6.01%,ROR1;PKD1;RYK;FZD2
prerank,calcium:sodium antiporter activity (GO:0005432),0.5113666660745964,1.206047921534478,0.2564102564102564,0.5498004843200968,1.0,3/10,4.70%,SLC24A4;SLC24A2;SLC8A1
prerank,magnesium ion binding (GO:0000287),-0.29914133798230325,-1.205418545635146,0.09615384615384616,0.5358020564393374,1.0,41/135,23.75%,EYA2;OPA1;CLYBL;DIS3L2;STK3;ABL1;LRRK2;IRAK3;PLSCR1;NUDT5;TDP2;MAP3K5;DHX36;WRN;MAP3K20;BRSK1;ABL2;RP2;PPA1;SIK1;ERN1;LATS1;MARK1;PDXK;MAP2K7;FOXK2;EPHX2;SIK3;XYLT2;PSPH;MSH6;NEK6;NME1;PGM1;MAST2;SIK2;SPHK1;GSS;CDC42BPG;XXYLT1;MVK
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.4208994166732717,-1.2026781138774598,0.222007722007722,0.5391432741175338,1.0,11/25,24.50%,TNKS2;ZC3HAV1;PARP10;PARP14;PARP9;PARP1;SIRT5;PARP4;PARP6;SIRT4;SIRT3
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.40467007220592793,-1.2020145453139206,0.2026266416510319,0.5371907963465045,1.0,7/27,11.44%,ITPR1;ITPR2;SLC41A1;CNNM2;SLC12A2;ZDHHC13;ATP2B1
prerank,tubulin binding (GO:0015631),0.2727749523479521,1.2015440247714562,0.058704453441295545,0.5560726467981684,1.0,66/296,15.28%,DNM3;NAV3;EML5;SYBU;GIT1;PACRG;S100A9;S100A8;TTLL7;UNC5C;AGBL4;MAP1B;MAP2;STMN1;FGF13;REEP1;GABARAPL1;KIF1A;SNCA;HOOK1;KIF21B;MTUS1;DST;MAP6D1;PAK1;GABARAP;SPAG5;CEP44;TRIM36;NEFM;SNPH;MTCL1;MAPRE3;TERF1;KIFC2;CLIP2;STMN4;RMDN1;CAMSAP1;STMN2;NUSAP1;TPPP;TUBGCP3;ARHGEF2;KIF26B;REEP2;MID2;APC;DIP2B;CCDC88A;KIF19;EML6;DCTN1;SGIP1;RPS3;DIXDC1;EFHC2;MACO1;NDRG1;STMN3;GOLGA2;DCX;ARHGEF7;CAPN6;REEP3;TPPP3
prerank,sterol binding (GO:0032934),-0.34648817744798566,-1.2013377898219968,0.16380952380952382,0.535314740462599,1.0,16/56,12.62%,ABCA1;ANXA6;OSBPL8;SOAT1;GRAMD1C;INSIG2;OSBPL5;OSBPL11;SIDT1;VDAC1;NR1H3;NPC2;RORA;ERLIN1;OSBPL9;APOD
prerank,RNA binding (GO:0003723),-0.2433911761559045,-1.1977867408268692,0.008714596949891068,0.5407688154339709,1.0,522/1321,31.47%,BICC1;RBMS1;SAMD4A;ROCK2;FNDC3B;CELF2;SRRM2;AHNAK;RRBP1;LRP1;RBFOX2;RBMS3;SON;NSA2;ERI3;HOXB6;SMG6;TNS1;DCN;RBPMS;ANKRD17;DDX5;CELF1;FARS2;ANKHD1;CAST;EIF4G3;HNRNPH1;UBE2N;DIAPH1;RBM39;VIM;NUFIP2;CTNNA1;DICER1;SMG1;SNTB2;LUC7L2;TNRC6B;MBNL2;PABPN1;NUDT4;HNRNPR;TOP1;ZCCHC24;KMT2C;PRRC2C;PUM2;YTHDF3;FLNA;ZC3H7A;RSRC2;SYNCRIP;PCF11;TNRC6A;WDR33;MAP4;DDX17;KHDRBS1;ACIN1;CASC3;EIF4A2;DDX6;HUWE1;TRMT9B;BAZ2A;HMGB1;RBMS2;PPARGC1B;SCAF4;SRSF10;MOV10;EIF4ENIF1;RBM6;RBBP6;DDX46;FUS;GOLGB1;SEC23IP;CCT6A;ANXA2;NUDT5;RC3H1;ZC3H12C;STAT3;SCAF8;MEX3C;CS;NYNRIN;HNRNPM;TBCA;U2AF2;YLPM1;GFM1;STXBP1;IFIT2;PDCD11;PUS10;ANXA7;ADK;DHX9;TES;PTBP3;AKAP8L;SF3B1;DENR;CPSF3;SRSF6;ZC3HAV1;LARP1;SRBD1;PUM1;HDLBP;HNRNPUL1;HNRNPD;NUP42;ZC3H15;SIDT1;TUT4;RBM10;FUBP1;DCP1A;DHX36;PRPF6;SAFB2;PCBP2;KNOP1;DDX42;ATXN2L;PPARGC1A;SPATS2L;CAVIN1;CDC5L;HLTF;GCN1;CSDC2;KTN1;SMG7;NSUN6;CDK13;ABCF1;CHD2;UBE2I;LAS1L;GEMIN5;HNRNPK;MAP3K20;UBAP2L;SPATS2;CSNK1E;ARCN1;PNISR;ALG13;EIF4E;CHD3;PRPF3;FAM120A;UPF1;SLBP;DHX40;CSDE1;RCC1L;JUN;LSM14A;DDX60;SF3A1;RPGR;SF3B6;RPL11;RBM45;DAZAP1;PRRC2B;CLK3;CDK11B;AKAP1;YTHDC1;ASCC3;BCLAF1;SCAF11;FCF1;XRN1;DUSP11;RTF1;ZC3H4;ZBED4;XRN2;LGALS1;PARP1;DCP1B;ACAA2;DYNC1LI1;KHNYN;SF3A3;ALKBH1;ARF1;HSPA9;WDR43;TPR;ZYX;DIMT1;ZCRB1;ALDH6A1;SNRNP70;TRIM25;YBX3;EIF2AK4;CCAR1;APTX;STRAP;SRFBP1;DDX23;TDRD3;HTATSF1;GTPBP10;YBX1;KIF1C;MAPRE1;CWC22;CPNE3;SERBP1;DDX19B;TCERG1;APOBEC1;NSRP1;URB1;RBM42;EIF2AK2;TXN;ACO1;SEC63;RARS2;BMS1;PRKDC;NAA15;RBM5;SRSF1;ZC3H12B;EDC3;OTUD4;EXOSC9;ILF2;DDX3X;YWHAE;RRP36;NOP58;FAM32A;SREK1;MAK16;BRIX1;EFTUD2;RPP14;HELZ;NOM1;DNTTIP2;SNU13;R3HDM2;DDX27;MTREX;EXOSC10;PRR3;DYNC1H1;TYW5;NOP53;SFPQ;BUD23;HELB;MRPL39;NXF1;GANAB;NSUN2;OAS2;TENT5A;CNOT1;PRPF40B;DDX50;HSPE1;SLC25A11;EWSR1;SHFL;CDC42EP4;DDX31;ARHGEF1;WBP11;CSTF3;KRR1;RPN1;HNRNPU;PTPN1;EIF1AX;CHCHD1;VCP;MRPL3;RRP8;TRMT1L;GPATCH4;SNRPF;ALDH18A1;COL14A1;EIF3A;UTP3;ZRANB2;PARK7;MSI2;HNRNPA3;UTP6;ESF1;EIF4G1;MRPL1;SIDT2;RBM4;ELP5;SRSF7;KARS1;SRSF11;NFX1;PKM;TRIP6;H1-0;IFIT3;TERT;EIF3L;NUP98;RRP7A;P4HB;SMC1A;RBPMS2;SRRM1;UPF3B;NME1;CCDC9B;ASS1;RBM33;PSMC1;SRSF2;SURF6;XRCC6;ERAL1;MSN;TBL2;DHX57;EBNA1BP2;ZNF346;MRPL32;FBRSL1;CRKL;SSBP1;PYM1;LRRC47;LUC7L3;PRKRIP1;DALRD3;NAP1L4;CSTF1;MRPL10;ZC3H13;GTF2F1;XPO5;CCAR2;UTP18;LBR;CPSF4;NUDT21;RPUSD4;DDX41;AGO1;HDAC2;IMP3;MRPL43;TRNT1;WDR6;APEH;AATF;USO1;RTRAF;BOP1;BCCIP;EXOSC3;EIF3H;GAR1;CNOT4;DHX15;NONO;PPHLN1;ALDOA;PABPC4;NOA1;PARP12;PPP1R10;GNL3L;IREB2;TRMT1;FAM50A;NAP1L1;ARL6IP4;PRPF38A;UNK;NCBP3;DUS3L;CLUH;KDM1A;NKRF;PSTK;KIN;RBM28;RPL7L1;RSL1D1;FXR1;MTO1;TDRD7;EDF1;TRMT2A;HARS2;NCBP2;TWF2;PRRC2A;ENDOV;ELAC2;PCBP3;TSR1;PRPF8;CRNKL1;FYTTD1;NAT10;DHX58;LSM6;LUC7L;NOL12;PES1;NIP7;DHX37;RBM22;SRP72;CCT3;GNL3;PNLDC1;RBM19;MRPL22;PCBP4;EIF3C;ZC3H7B;CACTIN;LONP1;GTF2E2;POLR1G;RRS1;SUGP1;RPL22;SAFB;POLR2D;HNRNPL;GRN;ISY1;SLTM;PARN;NELFE;PIN4;CCDC124;RBM34;FASTKD1;ZFP36L2;MRPL12;POP4;IGHMBP2;ZNF106;PABPC4L;SUPV3L1;RBM18;NUDT1;KPNA2;CCDC47;TBL3;PNO1;SNRNP200;UTP4;RBM47;THOC2;POLRMT;ZC3H10;ZC3H18;RBM27;HNRNPUL2;SAMHD1;PEF1;ENO1;MPHOSPH10;MRPS24;MTPAP;CALR;SNW1;THRAP3;GDI2;NUDT7;SF3A2;TBRG4;PSIP1;USP36;CCDC86;FLYWCH2;DDX25;YWHAZ;ADARB1;UBE2L3;PINX1;UBA1;RPP38;MRPS26;TLR3;TRMT10C;IFIH1;SNRPA1;C1QBP;DHX33;SUGP2;LSM1;ZNF326;GTPBP1;GIGYF2;SRP19;SF3B4;MRM1;ERH;RDX
prerank,protein tyrosine kinase activity (GO:0004713),0.30733005027082944,1.1950258562773195,0.14166666666666666,0.5668385146786697,1.0,16/108,5.87%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;WEE2;FLT3;AATK;SRMS;ALK
prerank,cation transmembrane transporter activity (GO:0008324),0.3543819583683957,1.1940673142664315,0.1968503937007874,0.5638775875512353,1.0,8/48,9.57%,SLC7A5;SLC6A6;SLC7A1;SLC1A1;MFSD12;SLC7A8;SLC66A1;SLC36A1
prerank,fibroblast growth factor binding (GO:0017134),-0.4199672739235191,-1.1933068987803985,0.2294455066921606,0.5484934470443321,1.0,13/21,28.69%,ITGAV;THBS1;GLG1;FGFR2;KL;FIBP;CEP57;ITGB3;FGFR4;GPC1;FGFRL1;S100A13;FGFBP3
prerank,GTPase regulator activity (GO:0030695),-0.2808761100599904,-1.1922574993951165,0.0855397148676171,0.5474685435607699,1.0,64/212,19.74%,RANBP3L;ALDH1A1;ARHGAP29;ARHGAP10;ARHGAP42;ERRFI1;ASAP3;SIPA1L1;ARHGAP28;ASAP1;STXBP5;ARHGAP20;LRRK2;ARHGEF10L;ARAP1;TBC1D16;SMAP1;ARHGAP24;BCR;SGSM2;DNM1L;PDE6D;RANBP2;SEC23A;NRP1;ARFGEF1;RAB3GAP1;GMIP;ARHGAP17;USP6NL;IQGAP2;ARFGAP1;ARFGAP3;TBC1D2B;TBC1D20;TBC1D8B;WASL;JUN;RP2;ARHGAP32;SEC23B;TBCK;GRTP1;TBC1D22B;TBC1D9;ACAP2;RAPGEF2;RASA1;ARRB1;ARHGAP18;DOCK1;ARHGEF6;RIC8B;TBCD;NPRL3;ARHGAP15;RHOH;TBC1D17;RANBP3;SIPA1L3;RALGAPB;RTKN;RABGAP1;TBC1D7
prerank,insulin-like growth factor I binding (GO:0031994),-0.4737084849177122,-1.1907394904102866,0.2351851851851852,0.5478289055005758,1.0,6/13,8.22%,IGFBP2;IGFBP5;ITGAV;IGFBP3;IGFBP6;IGFBP4
prerank,microtubule binding (GO:0008017),0.2772081542326872,1.1898742738773693,0.08155339805825243,0.5690481820803059,1.0,57/222,17.80%,DNM3;NAV3;EML5;SYBU;S100A9;S100A8;MAP1B;MAP2;FGF13;REEP1;KIF1A;HOOK1;KNSTRN;KIF21B;MTUS1;DST;MAP6D1;SPAG5;CEP44;NEFM;SNPH;MTCL1;MAPRE3;TERF1;KIFC2;CLIP2;RMDN1;CAMSAP1;NUSAP1;TPPP;TUBGCP3;ARHGEF2;KIF26B;REEP2;MID2;APC;CCDC88A;KIF19;EML6;DCTN1;SGIP1;RPS3;MACO1;NDRG1;GOLGA2;DCX;CAPN6;REEP3;MACF1;CAMSAP3;STARD9;CLASP2;KIF21A;FHDC1;CCDC61;CRIPT;DNM1
prerank,endopeptidase regulator activity (GO:0061135),-0.3662462322898936,-1.1893971198066837,0.2157258064516129,0.5480080945346925,1.0,8/40,11.79%,CAST;PROS1;TFPI;ITIH2;RECK;RENBP;SERPIND1;PSMF1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5107043181964971,1.188954195017162,0.28289473684210525,0.5660411383718401,1.0,1/10,0.14%,ADARB2
prerank,lysine-acetylated histone binding (GO:0070577),-0.4264011959624951,-1.1882099339264316,0.21851851851851853,0.5443684756532061,1.0,7/20,21.36%,MLLT3;BRD7;BAZ2A;BRD3;PHIP;ZMYND8;KMT2A
prerank,acetylation-dependent protein binding (GO:0140033),-0.4264011959624951,-1.1882099339264316,0.21851851851851853,0.5443684756532061,1.0,7/20,21.36%,MLLT3;BRD7;BAZ2A;BRD3;PHIP;ZMYND8;KMT2A
prerank,actin binding (GO:0003779),-0.2861492643890439,-1.1879897775904442,0.12133891213389121,0.5415906960559642,1.0,32/170,11.64%,CALD1;SYNE2;PARVA;PAWR;MICAL3;PHACTR1;SORBS1;DAG1;VCL;GSN;TPM1;PDLIM5;LIMA1;PHACTR2;ABL1;PRKN;LRRK2;SHROOM2;MICAL2;NCALD;ITGB1;PDLIM7;PLEKHH2;CORO7;SMTN;MAEA;IQGAP2;SYNPO2;ABL2;GIPC1;PDLIM2;CAPZA1
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.37865544267437057,-1.1842480305565632,0.19047619047619047,0.5477517388875245,1.0,18/34,28.14%,ERI3;DIS3L2;PAN3;CNOT8;XRN2;ERI2;EXOSC9;CNOT2;PAN2;EXOSC10;CNOT1;USB1;ANGEL2;EXOSC3;PNLDC1;PDE12;DIS3;PARN
prerank,cAMP response element binding (GO:0035497),-0.5142474601517839,-1.183989459340724,0.23655913978494625,0.545014605746747,1.0,4/10,10.31%,CREB3L2;CREB5;ATF2;JUN
prerank,death domain binding (GO:0070513),-0.5152671709106383,-1.1835076432705054,0.26373626373626374,0.5429030043596458,1.0,6/11,28.18%,BCL2;DAP;DAPL1;IRGM;CRADD;TRADD
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.39559396027893073,-1.1823141434610962,0.21787709497206703,0.5426035048651605,1.0,8/26,27.30%,PTN;PPP1R1A;CABIN1;BOD1L1;PPP1R2;PPP1R14A;BOD1;SAG
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.2898855831039441,-1.182293197622625,0.13957934990439771,0.5394081991222553,1.0,39/147,16.72%,AKAP13;DENND4A;DOCK5;DOCK11;PLCE1;DENND2A;FARP1;ARHGEF17;SBF2;IQSEC2;BCR;ARFGEF1;RAB3GAP1;CYTH3;RAPGEF3;VAV2;RAB3IL1;HERC2;RAB3IP;RCC1L;ARHGEF18;FNIP1;DENND4C;MON1A;SERGEF;FGD1;DNMBP;DENND5A;FGD4;ANKRD27;RCC1;RAPGEF2;FARP2;SH3BP5L;NGEF;DOCK1;ARHGEF11;ARHGEF6;RIC8B
prerank,diacylglycerol kinase activity (GO:0004143),0.49029762471575333,1.1817462762563802,0.2531914893617021,0.5792702454067352,1.0,3/11,7.01%,DGKI;DGKH;DGKB
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5093203569583709,-1.181321997204732,0.27052238805970147,0.5386649713746531,1.0,7/10,36.82%,CFLAR;CASP12;CASP2;CASP6;CASP1;CASP4;CASP7
prerank,fibroblast growth factor receptor binding (GO:0005104),0.415048200426882,1.1808146014427048,0.21975806451612903,0.5763277217296562,1.0,4/21,6.89%,FGF10;FRS3;NPTN;FGF5
prerank,actin monomer binding (GO:0003785),0.4091818114880225,1.1783389184399136,0.25308641975308643,0.5774240231548481,1.0,4/22,4.58%,MRTFA;TMSB4X;TMSB10;NOS3
prerank,calcium-release channel activity (GO:0015278),-0.4514952724702438,-1.1771912561027933,0.256120527306968,0.545688193991373,1.0,6/17,12.33%,ITPR1;ITPR2;TPCN1;TPCN2;RASA3;PKD2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.38506410472263697,-1.1766794592363714,0.2124248496993988,0.5434430921787768,1.0,10/31,19.20%,UBE2N;UBE2E2;BIRC6;UBE2H;UBE2K;UBE2R2;UBE2B;UBE2E1;UBE2S;UBE2D3
prerank,amino acid:sodium symporter activity (GO:0005283),-0.5035971556947862,-1.174845524668514,0.2741020793950851,0.5449821574908902,1.0,4/11,10.99%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,damaged DNA binding (GO:0003684),-0.3503370245174788,-1.1725343068873129,0.21818181818181817,0.5473263050165256,1.0,21/44,33.11%,EP300;RBBP8;HMGB1;SMC6;CREBBP;NBN;DDB2;ERCC3;APTX;SDE2;DCLRE1A;PCNA;ERCC1;CRY2;OGG1;MPG;FANCG;NEIL3;RPA2;PNKP;DDB1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.40355131335753586,-1.171952561628119,0.24339622641509434,0.5456171846545805,1.0,5/25,4.47%,MICAL3;CYP26B1;CYP27A1;MICAL2;POR
prerank,phospholipase inhibitor activity (GO:0004859),-0.5201490635261978,-1.17195135211567,0.27852998065764023,0.5424814537082899,1.0,4/10,7.02%,ANXA4;ANXA5;ANXA2;ANXA1
prerank,phosphatase binding (GO:0019902),-0.29942514307821927,-1.1698386382585022,0.1442687747035573,0.5445621802303864,1.0,38/105,24.89%,EGFR;SMAD3;JAK1;DLG4;SHOC2;TBK1;CTSC;DLG1;SMAD2;STAT3;EIF2AK3;AP3B1;ANAPC5;MAP3K5;ANAPC7;JUP;ANAPC4;WNK1;TRAF2;MTMR3;TRPC4AP;SH3RF2;MAP2K7;CDC27;TRAF3;IKBKE;VCP;MVP;PIK3R1;STX17;KIFAP3;MAST2;PPP1R3C;PPP1R3F;GTF2F1;SIRPA;KIF3A;CRY2
prerank,telomeric DNA binding (GO:0042162),-0.37820810113359576,-1.1677962701711369,0.244140625,0.5466001127455555,1.0,13/32,21.28%,SMG6;SMG1;HNRNPD;WRN;SMG7;UPF1;TELO2;CTC1;UPF3A;TERF2;TERT;STN1;XRCC6
prerank,actinin binding (GO:0042805),-0.41853424043314663,-1.166109410565807,0.2650375939849624,0.5476439166395078,1.0,8/21,14.51%,CACNA1C;DAG1;NFKB1;PDLIM5;CACNA1D;SYNPO2;PKD2;CSRP2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4550193414923092,1.1658471807292083,0.28958333333333336,0.6042068609307777,1.0,3/14,12.77%,KCNJ3;KCND3;KCNJ8
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.37693285740739374,-1.1654236253824957,0.24431818181818182,0.5462902799613368,1.0,8/35,12.42%,CLK1;ABL1;FRK;LYN;FER;ABL2;YES1;TEC
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3460489151567737,-1.1619007410517992,0.20747663551401868,0.5515982098258002,1.0,10/47,12.31%,SLC7A11;SLC7A2;SLC6A13;SLC47A1;PDPN;SLC1A5;SLC38A11;SLC6A1;SLC38A6;SLC22A4
prerank,signal sequence binding (GO:0005048),0.364201258976767,1.161861601735475,0.24435318275154005,0.6093811558700426,1.0,8/35,13.26%,IPO5;IPO4;CABP1;AP2M1;PEX5L;AP2B1;TIMM22;NFKBIA
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.25272409981294075,-1.1602447476725495,0.06981519507186858,0.552447059018852,1.0,147/431,28.21%,ATP1A2;PRKAG2;RHOQ;TGFBR1;BMPR1A;TLK1;ABCA1;MYO1B;KSR1;STK3;ANXA6;ABL1;ENPP1;LRRK2;RHOJ;ATL3;TOP1;ABCD3;STK17B;N4BP2;IRAK3;ARL3;RND3;RAP1B;RAB10;MAP4K4;MRAS;RAB22A;CHD8;GLUD1;DHX9;SMC4;MAP3K5;CDC42;SYN3;DHX36;ABCD2;MARK4;ABCF1;WNK4;MAP3K20;WNK1;ATL2;BRSK1;RHOA;DMPK;RHOT1;HSPA14;CARS2;CDK11B;ARFIP2;DYNC1LI1;AK6;ARF1;RALA;HSPA9;PEX6;ABCD4;RHOBTB2;MKNK2;PNPLA8;SIK1;MYO1F;GTPBP10;PGK1;TBCK;RASL12;RAB21;GBP3;BMS1;MCM6;ACVR1;ERN1;LATS1;P2RX4;MARK1;PDXK;MTREX;DAPK1;PTPA;TARS1;SIK3;TAP2;OAS2;DAPK2;GBP7;GBP2;PXK;PFKP;HNRNPU;RHOBTB1;TUBB2A;RHOH;RHOC;MLKL;GBP6;EIF4G1;MSH6;NEK6;MTG2;TAOK1;NME1;BCKDK;CDK6;PFKM;MAST2;AKT2;MKNK1;PFKL;RIT1;SIK2;SPHK1;RABL3;TUBB6;GSS;GALK1;ARL5A;CDC42BPG;TRNT1;RRM1;MVK;RHOT2;CLPX;RAB8A;RAB9A;NOA1;RAB7A;RPS6KA4;TAP1;RAB5A;TWF1;ABCF3;RRAGA;TWF2;TSR1;PRKCI;GNL3;DIRAS2;ABCB8;PIM1;LONP1;PRPS1;PRPS1L1;ARL4C;TUBA1C;MINK1;RAB39A
prerank,growth factor activity (GO:0008083),0.3184808452820368,1.1601445425774681,0.20440881763527055,0.6082352136659611,1.0,10/74,10.22%,NRG3;IL7;NRG1;FGF10;IL12A;AMELX;FGF5;ENDOU;THPO;PDGFB
prerank,ion gated channel activity (GO:0022839),0.3946199482712789,1.1595037757011386,0.25813449023861174,0.604553301355857,1.0,5/24,8.66%,ANO3;TMEM63B;TTYH2;ANO5;ANO4
prerank,NADPH binding (GO:0070402),0.4638284761156022,1.1578723478763169,0.278118609406953,0.6033564873899233,1.0,3/13,7.96%,NDOR1;DUS2;KCNAB1
prerank,voltage-gated calcium channel activity (GO:0005245),0.36601192073580097,1.1577161915110328,0.2773109243697479,0.5986023794481264,1.0,10/37,10.79%,CACNA1A;CACNA1B;CACNA2D1;CACNG2;CACNA1E;CACNB2;CACNG3;OPRM1;CACNG8;CACNB4
prerank,nuclear import signal receptor activity (GO:0061608),0.4468319994721044,1.1569229837280592,0.2653061224489796,0.5954519418735894,1.0,2/15,1.48%,IPO5;IPO4
prerank,general transcription initiation factor binding (GO:0140296),-0.40354906905138765,-1.1556121280047107,0.25047801147227533,0.5604864161821477,1.0,13/25,30.56%,AR;TBP;TAF13;GTF2B;TAF12;PSMC1;DRAP1;YEATS2;THRA;ESR1;BRF2;RUVBL2;GTF2A1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.3229630271535718,-1.147961522608517,0.2300380228136882,0.5758755277921394,1.0,20/69,22.24%,KAT2B;CERS5;EP300;KAT6B;SOAT1;CREBBP;PLA2G4A;ZDHHC13;MOGAT3;MBOAT7;KAT8;NAA15;ESCO1;ASPG;GTF2B;ZDHHC1;ZDHHC16;HHAT;LPCAT3;SPHK1
prerank,death receptor activity (GO:0005035),0.4855411916607467,1.1470826589595629,0.29878048780487804,0.6154590729082446,1.0,5/11,23.27%,TNFRSF19;TNFRSF25;TNFRSF1A;TNFRSF10B;EDA2R
prerank,insulin-like growth factor binding (GO:0005520),-0.4396451331429772,-1.1469177870967282,0.2768361581920904,0.5753745612057074,1.0,6/15,8.22%,IGFBP2;IGFBP5;ITGAV;IGFBP3;IGFBP6;IGFBP4
prerank,sodium channel regulator activity (GO:0017080),0.35187858741080935,1.1450071241733433,0.23625254582484725,0.615460612336571,1.0,9/37,17.62%,FGF12;FGF14;FGF13;SCN4B;SGK3;ATP2B4;SCN2B;GPLD1;PKP2
prerank,ephrin receptor activity (GO:0005003),0.42182956483779765,1.1439370280652021,0.2740899357601713,0.6080103359756236,1.0,5/17,8.39%,EPHA6;EPHB1;EPHA5;EFNB3;EPHA10
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.42182956483779765,1.1439370280652021,0.2740899357601713,0.6080103359756236,1.0,5/17,8.39%,EPHA6;EPHB1;EPHA5;EFNB3;EPHA10
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.39750771259928963,1.1431508404614694,0.23829787234042554,0.6051032608282084,1.0,6/24,15.44%,ZDHHC22;ZDHHC17;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14
prerank,protein kinase binding (GO:0019901),-0.2481019610451589,-1.1430565568281297,0.079002079002079,0.5821019667977977,1.0,153/480,24.18%,PRKAG2;GRK5;SASH1;TCF7L2;SMAD3;PTN;ERRFI1;ANK2;PKD1;LIMS1;MAPK4;PDLIM5;KIF13B;NBEAL1;ITGAV;NISCH;PDGFRB;PARD6G;KAT2B;IL31RA;FOXO3;PPP1R12A;GHR;ABL1;PRKN;PPM1D;IBTK;GSK3B;RPTOR;CNTLN;IRAK3;IRS1;KHDRBS1;MAPKAP1;IL15RA;DLG1;NR3C1;ITGB1;RND3;RBBP6;AXIN1;PAK2;SKI;SLC12A7;STAT3;UFL1;TRIP4;DUSP16;CENPJ;SHC1;NOX4;TPCN2;ADCY6;CDC42;EPHA4;NBR1;VDAC1;PTPRK;DACT1;ATF2;CCNK;WNK1;PLCG1;TOM1L2;RB1CC1;PTPN2;SLC12A2;TRAF2;RHOA;PRKCD;HIF1A;ADAM9;DNAJC3;PRKAB2;EXOC2;MAVS;KIZ;PARP1;ROR2;TRIM5;TELO2;RHOBTB2;TPR;SUFU;SIK1;TCF3;APPL1;RICTOR;MAML1;BECN1;MAPRE1;TRIB2;CDK5RAP1;ERCC6L2;DUSP1;ACVR1;CCND3;LATS1;CDC25B;PPP1CB;MAP2K7;DUSP10;TNIP2;RAB11FIP2;ADRA2A;CAVIN3;TOP2B;CACUL1;PRKACA;PTPN1;RHOBTB1;FBXW5;BLNK;TRAF6;RHOH;DACT3;MAP3K1;RHOC;MTCP1;PTPN11;NEK6;IRAK1;MAP2K6;MVP;SPRED2;PRKAG3;PIH1D1;USF1;CDK5RAP3;LRBA;GATA6;SMAD1;PRKAB1;MSN;TBL2;NBEAL2;MAP3K12;CIR1;DUSP7;PRKRIP1;TICAM1;NSF;PKIA;HSF1;MAPK7;SPAG9;CSPG4;BORA;AP2A1;SIRPA;BAG5;DACT2;PTPN23
prerank,nuclear export signal receptor activity (GO:0005049),-0.4817649261425895,-1.1425353930329067,0.3163841807909605,0.5801153359960531,1.0,4/11,10.44%,XPO4;EIF4ENIF1;NUP42;NUP214
prerank,adenyl ribonucleotide binding (GO:0032559),-0.25990410548876536,-1.1422820716954922,0.11387163561076605,0.5776789507053487,1.0,91/291,24.01%,ATP1A2;PRKAG2;TGFBR1;BMPR1A;MPPED2;TLK1;ABCA1;MYO1B;KSR1;STK3;ABL1;ENPP1;TOP1;ABCD3;STK17B;N4BP2;IRAK3;MAP4K4;CHD8;GLUD1;DHX9;SMC4;MAP3K5;SYN3;DHX36;ABCD2;MARK4;ABCF1;WNK4;MAP3K20;WNK1;BRSK1;ME1;DMPK;HSPA14;CARS2;CDK11B;AK6;HSPA9;PEX6;ABCD4;MKNK2;PNPLA8;SIK1;MYO1F;PGK1;TBCK;MCM6;ACVR1;ERN1;LATS1;RAPGEF2;P2RX4;MARK1;PDXK;MTREX;DAPK1;PTPA;TARS1;SIK3;TAP2;OAS2;DAPK2;PXK;HMGCR;PFKP;HNRNPU;MLKL;EIF4G1;MSH6;NEK6;TAOK1;NME1;BCKDK;PRKAG3;CDK6;PFKM;MAST2;AKT2;MKNK1;PFKL;SIK2;SPHK1;RAPGEF4;GSS;GALK1;CDC42BPG;TRNT1;RRM1;MVK;CLPX
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.36731583940771423,1.1415641881709606,0.24843423799582465,0.6041204133200168,1.0,7/31,11.72%,HCN1;SLC12A6;KCNK10;KCNK9;KCNK1;SLC12A3;KCNA2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.4713982326521765,-1.1391820006442417,0.32061068702290074,0.5821353680309899,1.0,7/12,28.14%,PAN3;CNOT8;CNOT2;PAN2;CNOT1;PNLDC1;PARN
prerank,phosphate ion binding (GO:0042301),0.483314801803851,1.1342042138654826,0.3076923076923077,0.6179015537271806,1.0,1/10,3.36%,PDE2A
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.33610008255959756,-1.1318473014677048,0.26,0.5970556247748444,1.0,12/49,16.02%,ATP1A2;MPPED2;DUSP16;PRUNE1;PTPN22;DUSP11;PXYLP1;PPP1CB;SACM1L;EPHX2;ACP2;DUSP10
prerank,cGMP binding (GO:0030553),0.46376065112288584,1.131041236200685,0.30735930735930733,0.6209824427272479,1.0,3/11,6.20%,PDE10A;PDE2A;PDE11A
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.41923088169061484,1.1295124008275736,0.3055555555555556,0.6200067699671774,1.0,3/18,7.86%,GAS6;SNCA;RPS6KA1
prerank,leak channel activity (GO:0022840),-0.41912099335919556,-1.1276717748139082,0.30844793713163066,0.6040431412975983,1.0,3/18,6.27%,KCNK2;NALCN;KCNK5
prerank,adenylyltransferase activity (GO:0070566),-0.4064734449770203,-1.1273987054779457,0.29980657640232106,0.6015794148577427,1.0,9/21,19.98%,TENT2;NMNAT2;ABL1;NMNAT3;PAPOLG;NMNAT1;OAS2;FLAD1;KARS1
prerank,syntaxin binding (GO:0019905),0.3225378497084021,1.1273802406043916,0.25793650793650796,0.6206192012635234,1.0,11/61,7.62%,CACNA1A;SYT1;SYT6;SYT12;SNAP25;UNC13A;STXBP5L;SNPH;NAPG;SYNPR;SYT10
prerank,nucleosomal DNA binding (GO:0031492),0.39303978617385815,1.1273524938438952,0.2854122621564482,0.6158651866085975,1.0,5/21,8.78%,ACTB;HMGA2;SMARCB1;HNRNPC;H3-3A
prerank,PDZ domain binding (GO:0030165),-0.321513596390425,-1.1260383565469048,0.27111984282907664,0.6017530218984096,1.0,12/61,7.19%,TGFBR3;ARHGAP29;CRIM1;PLEKHA2;SDC2;ERC1;PRKN;DLG4;SYNJ2;CXADR;FZD2;SLC22A5
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.30609397333829685,-1.1258890025241766,0.2328767123287671,0.5989992196860482,1.0,22/72,19.88%,GSN;SVIL;MYO1B;ADAP2;GSDME;SLC9A1;MAPKAP1;ANXA2;KCNJ2;FCHO2;ACTN2;PLCD1;TULP3;SNX21;GSDMD;FZD7;PARD3;MARK1;PICALM;FRMPD4;AVIL;VILL
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.3339045934304599,-1.1214170603847857,0.25948103792415167,0.6069378148448012,1.0,23/49,31.45%,ZFAND6;RNF169;RAD23B;UBQLN1;BRCC3;PARP10;ZBTB1;ABRAXAS2;TNIP2;SPRTN;ZRANB3;IKBKE;VCP;WDR81;SHARPIN;BAG6;UBQLN4;PRPF8;ABRAXAS1;TNFAIP3;ZFAND2B;FAAP20;UFD1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2589671266038027,-1.1201496394621522,0.1686746987951807,0.6068436905409625,1.0,71/269,18.51%,FHIT;EGFR;SMAD3;VCL;SMAD6;UBE2N;PRKN;JAK1;ARIH1;GSK3B;SNCAIP;CASC3;HM13;USP7;SMC6;SMAD2;DNM1L;SNX9;AXIN1;SKI;TRIP4;BCL2;MID1;RNF8;PCBP2;UBE2K;JKAMP;PPARGC1A;UQCRC1;HLTF;PTPN22;TXNIP;HERC2;TRAF2;JUN;SPOPL;HIF1A;RPL11;PARP9;CCDC50;RALA;HSPA9;CUL3;PIAS4;RB1;FBXW7;PATZ1;BECN1;SLF1;LTBR;DTX3L;TRIB2;STAT1;USP2;UBE2B;USP13;YWHAE;CUL2;FAF2;NDUFS2;ARRB1;TRAF3;IKBKE;AUP1;RNF20;DERL1;PRKACA;AMBRA1;TRAF6;VCP;TANK
prerank,adrenergic receptor binding (GO:0031690),0.42629043012880985,1.1184077763313138,0.30364372469635625,0.6343096687168178,1.0,5/16,12.59%,ADRB1;MAGI2;GRK2;UCHL1;PDE4D
prerank,channel activity (GO:0015267),0.33943492292044636,1.118145198310035,0.2815126050420168,0.6300888400661768,1.0,3/41,2.98%,AQP9;AQP11;ASIC4
prerank,solute:anion antiporter activity (GO:0140323),-0.44608817680074986,-1.1178494601071105,0.32558139534883723,0.6096599291331896,1.0,4/14,12.46%,SLC7A11;SLC26A7;SLC26A2;SLC4A3
prerank,ubiquitin protein ligase binding (GO:0031625),-0.25838816377312396,-1.1144451351152944,0.1765873015873016,0.6147630735198839,1.0,67/254,18.51%,FHIT;EGFR;SMAD3;VCL;SMAD6;UBE2N;PRKN;JAK1;ARIH1;GSK3B;SNCAIP;CASC3;HM13;USP7;SMC6;SMAD2;DNM1L;SNX9;AXIN1;SKI;BCL2;MID1;RNF8;PCBP2;UBE2K;JKAMP;PPARGC1A;UQCRC1;HLTF;PTPN22;TXNIP;HERC2;TRAF2;JUN;SPOPL;HIF1A;RPL11;CCDC50;RALA;HSPA9;CUL3;PIAS4;RB1;FBXW7;PATZ1;BECN1;SLF1;LTBR;TRIB2;USP2;UBE2B;USP13;YWHAE;CUL2;FAF2;NDUFS2;ARRB1;TRAF3;IKBKE;AUP1;RNF20;DERL1;PRKACA;AMBRA1;TRAF6;VCP;TANK
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.28842669166328283,-1.1139681137165554,0.22727272727272727,0.612834311834631,1.0,28/91,20.55%,GSN;SVIL;MYO1B;ADAP2;SH3PXD2B;GBF1;GSDME;SLC9A1;MAPKAP1;ANXA2;KCNJ2;FCHO2;ACTN2;PLCD1;TULP3;KIF16B;WIPI1;SNX21;GSDMD;FZD7;PARD3;MARK1;WDR45B;PICALM;FRMPD4;AVIL;VILL;WIPI2
prerank,LRR domain binding (GO:0030275),-0.44425670959006347,-1.1129936300249843,0.3076923076923077,0.612190310629406,1.0,5/14,11.45%,PAWR;ROBO1;ERC1;ZXDC;LRRFIP2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.4393420845682647,-1.1102064422745357,0.3313953488372093,0.6159618239901892,1.0,2/14,0.95%,SLC7A11;SLC1A3
prerank,Hsp70 protein binding (GO:0030544),0.36283906558049017,1.1097456445501834,0.29809725158562367,0.6471068702984867,1.0,9/31,13.23%,PACRG;SNCA;SACS;FICD;CYP2E1;MVD;IQCG;RNF207;RPS3
prerank,endopeptidase activity (GO:0004175),-0.25457659091391616,-1.109265209794372,0.1947261663286004,0.6150783219376136,1.0,46/257,15.12%,TRABD2B;ADAMTS2;ADAMTS10;ADAMTS12;THSD4;ADAMTSL3;ADAMTS6;USP24;ADAMTSL5;PCSK5;HTRA3;PLAT;USP7;CTSC;CTSH;ADAMTS5;DPP4;F3;DDI2;ECE1;ADAMTSL4;ADAMTS9;NRDC;USP33;MMP14;ADAM9;SENP1;USP47;MBTPS2;ADAM19;FAP;ADAMTS15;MMP2;ADAM33;NLN;CASP2;USP12;USP11;USP46;RHBDF1;USP35;PSMB2;USP2;ADAMTS17;USP13;MBTPS1
prerank,MAP kinase kinase activity (GO:0004708),-0.42594329614821097,-1.1074392378006013,0.3248175182481752,0.6168081816858104,1.0,9/15,36.50%,LRRK2;MAP2K4;MAP2K1;MAP2K7;MAP2K6;MAPK14;MAP2K3;MAPKAPK3;MAP2K2
prerank,metalloexopeptidase activity (GO:0008235),-0.3247775381519897,-1.1057293838407343,0.2815533980582524,0.6181538525857577,1.0,12/51,17.09%,CPQ;AEBP1;XPNPEP1;ANPEP;MMP14;LAP3;AGBL3;NPEPPS;CPM;CPXM2;LNPEP;CPXM1
prerank,cation channel activity (GO:0005261),0.29320478743655454,1.102764849365517,0.2572614107883817,0.6604542406838778,1.0,14/94,8.42%,HCN1;SLC24A4;SLC24A2;GRIN1;TRPC5;RYR2;UNC80;TMEM63B;KCNK10;CACNA1E;TRPM2;KCNK9;CACNB2;KCNK1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4785090250550126,-1.0991209788951792,0.36363636363636365,0.632231393524501,1.0,2/11,1.07%,ITPR1;ITPR2
prerank,phosphatidate phosphatase activity (GO:0008195),0.4347898596662713,1.0985069512815995,0.33405639913232105,0.6669046123760374,1.0,4/13,8.86%,PLPPR1;PLPPR5;PLPPR4;PLPP4
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.4697670530770056,-1.097824529515491,0.36973180076628354,0.6323428088144549,1.0,3/11,9.37%,EGFR;MAP3K5;MAP3K20
prerank,hormone receptor binding (GO:0051427),-0.43238724879846685,-1.0955694877652171,0.35018050541516244,0.6350288075686539,1.0,4/14,22.06%,JAK1;NCOA6;TYK2;PTHLH
prerank,N-methyltransferase activity (GO:0008170),-0.38661803159074454,-1.094398722461254,0.30994152046783624,0.6346020209448987,1.0,11/20,32.05%,ZCCHC4;SETD3;TRMT11;N6AMT1;DIMT1;METTL15;TRMT1L;TRMT1;HNMT;NNMT;FDXACB1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.45938778111263756,1.0939098185399017,0.33260869565217394,0.6738910776103373,1.0,4/12,13.00%,PDE4B;PDE2A;PDE4D;PDE4A
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.365765166314042,-1.093897948170224,0.325626204238921,0.6329202470991507,1.0,8/26,14.16%,SLC6A13;SLC16A12;SLC6A12;SLC16A6;SLC16A9;SLC5A6;SLC6A1;SLC27A1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.4710252633086754,1.092133313641639,0.34024896265560167,0.6738887355075726,1.0,4/10,10.79%,CACNA1A;CACNA1B;CACNB2;CACNB4
prerank,serotonin receptor activity (GO:0099589),0.38990395020088575,1.0894540496796223,0.34725274725274724,0.6663066859201624,1.0,2/22,3.45%,CHRM3;HTR2C
prerank,G protein-coupled amine receptor activity (GO:0008227),0.38990395020088575,1.0894540496796223,0.34725274725274724,0.6663066859201624,1.0,2/22,3.45%,CHRM3;HTR2C
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.38990395020088575,1.0894540496796223,0.34725274725274724,0.6663066859201624,1.0,2/22,3.45%,CHRM3;HTR2C
prerank,histone deacetylase binding (GO:0042826),-0.2863479689096104,-1.0839467666958191,0.26260504201680673,0.6547548705234382,1.0,25/88,18.34%,GLI3;KAT2B;HDAC4;BCOR;NCOR1;PRKN;MEF2A;LCOR;AKAP8L;DHX36;SP2;DACT1;CHD4;MIER1;NIPBL;MEF2C;HES1;BHLHE41;HDAC1;YWHAE;SFPQ;CAMTA2;TOP2B;ZMYND15;TRAF6
prerank,endoribonuclease activity (GO:0004521),-0.3533936307249794,-1.0821595044000867,0.3352059925093633,0.6564436862641165,1.0,8/32,14.71%,SMG6;DICER1;ZC3H12C;NYNRIN;CPSF3;KHNYN;ZC3H12B;ERN1
prerank,retinoic acid receptor binding (GO:0042974),-0.41105284442764695,-1.0788298090868305,0.36893203883495146,0.6618772361390508,1.0,8/17,21.77%,RARG;NSD1;NCOA6;MED1;PRMT2;CNOT1;NR4A2;ARID5A
prerank,bHLH transcription factor binding (GO:0043425),-0.39229535965444373,-1.0770548190883176,0.3382899628252788,0.6630264517669472,1.0,5/19,12.84%,FHL2;SMAD3;CREBBP;TCF3;BHLHE41
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.36329840935870394,1.0769594177777368,0.33542976939203356,0.6953346205431963,1.0,3/24,4.11%,CAMK2A;CAMKV;CAMK4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.48212841981917065,-1.0758213644720975,0.3950381679389313,0.6632162686635659,1.0,1/10,0.40%,DPYSL3
prerank,chemokine receptor activity (GO:0004950),0.36310415300150156,1.0748706449486427,0.3283898305084746,0.696148855195083,1.0,4/24,9.26%,GPR35;ACKR4;GPR17;GPR75
prerank,sulfotransferase activity (GO:0008146),-0.3427797412010838,-1.069965680319001,0.3453815261044177,0.6758253330887398,1.0,9/33,19.05%,UST;TPST1;HS3ST3A1;HS2ST1;CHST15;SULT1A1;CHST11;HS6ST1;CHST12
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.3424792201741343,-1.069412471333958,0.3493282149712092,0.674011187913559,1.0,19/33,33.47%,PRKN;ARIH1;RNF217;RNF19A;TCERG1;AUP1;TRAF6;RNF14;DCUN1D3;PARK7;ARIH2;RNF144A;SIAH2;PPARA;DCUN1D5;UBA2;RNF180;ANKIB1;DCUN1D4
prerank,nuclear receptor coactivator activity (GO:0030374),-0.3119792702984317,-1.0685349227618455,0.32427184466019415,0.6730656357547756,1.0,13/52,12.87%,ZMIZ1;PPARGC1B;SS18;MED17;MED12;ENY2;PPARGC1A;NCOA6;NCOA1;MED1;CALCOCO1;DCAF6;CCAR1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.34334328785368307,-1.0674995898372492,0.348,0.672737363684615,1.0,16/33,28.14%,ERI3;DIS3L2;CNOT8;XRN1;XRN2;ERI2;EXOSC9;PAN2;EXOSC10;USB1;ANGEL2;EXOSC3;PNLDC1;PDE12;DIS3;PARN
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.3053459198115748,-1.0672175821922063,0.33665338645418325,0.6704603504200547,1.0,11/55,12.31%,SLC7A2;SLC6A13;SLC16A12;SLC13A3;PDPN;SLC6A12;SLC16A6;SLC38A11;SLC16A9;SLC38A6;SLC22A4
prerank,C2H2 zinc finger domain binding (GO:0070742),0.44780756727815196,1.066333114295974,0.3900414937759336,0.7142877891523812,1.0,2/11,3.68%,LEF1;HMGA2
prerank,CoA hydrolase activity (GO:0016289),-0.40884179873437765,-1.0656956234527677,0.37254901960784315,0.6713580785785644,1.0,6/16,23.24%,HIBCH;ACAA2;ACOT11;ACOT9;ACOT8;ACOT6
prerank,single-stranded RNA binding (GO:0003727),0.32048491150557684,1.065361420369237,0.3426724137931034,0.7119672865213745,1.0,6/43,9.62%,ADARB2;ZFR2;SNRPC;RBM11;STRBP;DDX11
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.38103530197328594,-1.0646721621024413,0.3762183235867446,0.6708522970863112,1.0,9/21,17.45%,WASF2;ARFGEF1;AKAP8L;PRRC1;ACBD3;AKAP1;WASF1;AKAP9;PRKACA
prerank,translation elongation factor activity (GO:0003746),0.41171367823562316,1.0638373072344598,0.3775933609958506,0.711154612801119,1.0,6/14,17.75%,EEF1B2;TUFM;EIF5A2;EEF1A2;EEF1A1;EEF2
prerank,protein homodimerization activity (GO:0042803),-0.22611366687894285,-1.063052919599175,0.2037037037037037,0.6718728515896696,1.0,196/590,27.73%,CPQ;FOXP2;NR2F2;SMAD3;APPL2;BMPR1A;PDGFRA;TPM1;LRP6;AOX1;NADK2;RBPMS;MAPK4;ZHX2;GHR;CRYL1;ARNT;ENPP1;LRRK2;NPR3;TPST1;XPNPEP1;NR6A1;EEA1;FBLN5;KIT;ABCD3;FLNA;IRAK3;EXT1;HM13;SLK;DNM1L;SNX9;EIF2AK1;AXIN1;SNX6;DPP4;NUDT5;ZBTB16;VPS4B;STAT3;GLCE;FGFR2;MKLN1;MMUT;BCL2;MIGA2;CAMK2D;IRAK2;CDADC1;TRIM8;CRPPA;MID1;RNF8;MAP3K5;ECE1;CHMP4B;CHMP4A;S100A10;UBA5;CAMK2G;WRN;ABCD2;ZBTB1;JUP;PRMT2;PDGFC;TARS2;S100A6;SMAD4;PAFAH1B2;TBX18;TRIM5;PSMF1;NRF1;FAP;ACSL6;PAXX;HES1;ATIC;QTRT2;PKD2;TPR;TCF3;IL6R;BHLHE41;APPL1;EFEMP2;UPB1;SOX6;TXN;GBP3;APOE;TPD52L1;STAT1;VEGFA;ZNF318;GCA;ACVR1;ERN1;DPYD;MSH3;IL17D;PGRMC1;GLIPR2;PDXK;EPHX2;RAB11FIP2;NECTIN3;PTPA;TYW5;SFPQ;ADRA2A;CUBN;SMCHD1;CCDC66;GBP2;ACOX1;NQO2;S100A11;ANO1;ATP5IF1;PRMT8;CEP57;MYOM1;PARK7;PSPH;MGLL;MSH6;TERF2;IRAK1;GNPTG;PEX7;NAGA;KARS1;TPM2;CARNMT1;SNF8;SPPL3;TERT;PML;SLC39A13;RBPMS2;S100A1;DGKD;USF1;KMT2A;BNIP3;MAP3K12;ALS2;SSBP1;GALM;ST6GAL1;PRDM9;RABL3;F11R;GSS;PTH1R;GSTM2;NUDT21;HIP1R;SLC8B1;CYP2R1;TFAP4;PON3;MAP3K13;MZF1;SLIT2;TRIM68;TAP1;PHB2;GGCT;CBS;FBXO4;LDB1;BCL2L2;TRPC6;PHETA1;ST3GAL2;FXR1;RPE;LPL;RRAGA;NFS1;WARS1;SPPL2A;ZBTB7B;S100A13;SMIM1;ADRB2;RABEP1;PRPS1;PRPS1L1;CIP2A;PEX11B
prerank,protein phosphatase binding (GO:0019903),-0.2698522666695985,-1.062833342891568,0.321285140562249,0.669407126794807,1.0,39/117,24.94%,EGFR;JAK1;DLG4;SHOC2;SLC9A1;TBK1;STRN3;STAT3;EIF2AK3;AP3B1;ANAPC5;MAP3K5;ANAPC7;SMG7;JUP;ANAPC4;ANKLE2;TRAF2;MTMR3;PPP1R3B;SH3RF2;MAP2K7;CDC27;BOD1L1;PTPA;TRAF3;IKBKE;VCP;MVP;PIK3R1;STX17;KIFAP3;PPP1R3C;SPHK1;PPP1R3F;GTF2F1;SIRPA;KIF3A;MASTL
prerank,mannosyltransferase activity (GO:0000030),0.3825782441089309,1.0595781851097512,0.3538135593220339,0.7180631656285617,1.0,6/21,12.40%,TMTC2;ALG3;PIGM;ALG1;DPY19L1;ALG8
prerank,thioesterase binding (GO:0031996),-0.4509198884628166,-1.0586226163421066,0.4,0.6773933036837962,1.0,7/11,22.23%,CDC42;TRAF2;ADRA2A;TRAF3;TRAF6;HAUS7;TRAF5
prerank,myosin V binding (GO:0031489),0.40698782807100126,1.0580435365357017,0.3974358974358974,0.7173806674469062,1.0,3/15,7.15%,RAB3C;RAB6B;RAB39B
prerank,ribonuclease P RNA binding (GO:0033204),0.456908102110653,1.0574172493346263,0.3894736842105263,0.714320803218079,1.0,3/10,12.31%,RPP40;RPP30;POP5
prerank,calcium channel inhibitor activity (GO:0019855),-0.4523044132803894,-1.0551455889628205,0.41132075471698115,0.6831466369189602,1.0,1/11,0.25%,ITPR1
prerank,endopeptidase inhibitor activity (GO:0004866),-0.2852502401717343,-1.0548500380179695,0.3392857142857143,0.6808842797176481,1.0,15/82,11.79%,TIMP3;COL4A3;CAST;ROCK1;BIRC6;SERPING1;PROS1;TFPI;ANXA2;ITIH2;RECK;RENBP;NGF;SERPIND1;PSMF1
prerank,E-box binding (GO:0070888),-0.3267945093080287,-1.0527726596567548,0.3595959595959596,0.6833204971995707,1.0,10/34,24.87%,TCF4;ZEB1;HES1;TCF3;BHLHE41;ATOH8;PRMT5;TFAP4;SNAI1;TWIST1
prerank,protein tyrosine kinase binding (GO:1990782),0.28860807374832265,1.051880218619806,0.33669354838709675,0.7249137083043176,1.0,7/71,5.48%,NRG3;GRM5;GRB14;NRG1;DOCK4;GAS6;PITPNM1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.32551780616339837,-1.0489938347711165,0.39223300970873787,0.6900002152438222,1.0,15/38,24.66%,SH3PXD2B;ZFYVE1;PLA2G4A;KIF16B;WIPI1;SNX21;ATG2A;PARD3;WDR45B;ATG2B;PLEKHF1;WIPI2;PLEKHA4;JPH2;SNX12
prerank,calcium channel regulator activity (GO:0005246),0.3280827695791943,1.0482636896491446,0.39330543933054396,0.7296321319271378,1.0,8/37,13.76%,NRXN1;PRKG1;NRXN2;SLC30A1;SGK3;CACNG8;CALM1;CALM2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.351381525077512,-1.0473303928029891,0.39204545454545453,0.691355308937903,1.0,16/27,33.47%,PRKN;ARIH1;RNF217;RNF19A;AUP1;TRAF6;RNF14;DCUN1D3;ARIH2;RNF144A;SIAH2;PPARA;DCUN1D5;RNF180;ANKIB1;DCUN1D4
prerank,dipeptidyl-peptidase activity (GO:0008239),0.43906454572279385,1.0455284329827548,0.40503432494279173,0.7319891822360016,1.0,2/10,6.05%,DPP10;DPP6
prerank,semaphorin receptor activity (GO:0017154),-0.44447088419570147,-1.0435338767829752,0.4296028880866426,0.698231904898594,1.0,5/11,15.98%,PLXNA2;NRP1;PLXNB2;PLXND1;PLXNB1
prerank,cytokine activity (GO:0005125),0.26142240815805406,1.0433352404867657,0.33794466403162055,0.7333175569693605,1.0,16/131,10.55%,KITLG;IL17F;MIF;IL7;NRG1;CXCL12;BMP8A;IL12A;SCGB3A1;TGFB2;WNT7B;EPO;TIMP1;CCL2;BMP3;SCG2
prerank,N-acetyltransferase activity (GO:0008080),-0.3811006762381106,-1.0427361764079615,0.3768939393939394,0.6971255584453252,1.0,4/19,14.46%,KAT2B;EP300;SAT1;ESCO1
prerank,Notch binding (GO:0005112),-0.37236781733940605,-1.0420350751731662,0.40977443609022557,0.6960190634331721,1.0,4/22,12.56%,SNED1;JAG1;CCN3;CUL3
prerank,nuclease activity (GO:0004518),-0.3078787486292579,-1.0409025069516817,0.38461538461538464,0.6959385857870333,1.0,19/52,29.58%,DIS3L2;ENPP1;N4BP2;PLSCR1;WRN;RNASE12;REXO5;XRN2;REXO1;MRE11;RNASE4;NME1;EXOG;OGG1;PDE12;DNASE1L1;DIS3;PARN;SAMHD1
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.28318085085136396,-1.0399306967190358,0.3869653767820774,0.6954472001394604,1.0,23/78,24.04%,USP24;CFLAR;USP7;CTSC;CTSH;PIGK;CASP12;USP33;USP47;CASP2;USP12;USP11;USP46;USP35;USP2;USP13;USP34;CTSF;GPAA1;CTSL;USP18;USP9X;USP28
prerank,potassium ion antiporter activity (GO:0022821),-0.40885018052523625,-1.039857240813416,0.3940520446096654,0.692664955033497,1.0,4/15,6.17%,SLC24A3;SLC9A1;SLC9A8;SLC9A2
prerank,endonuclease activity (GO:0004519),-0.30808101061023385,-1.0360859241026303,0.39285714285714285,0.6995228647667959,1.0,11/49,16.77%,SMG6;DICER1;N4BP2;ZC3H12C;NYNRIN;CPSF3;KHNYN;ZC3H12B;ERN1;MRE11;ZRANB3
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.34275206698348165,1.0333689074768686,0.40756302521008403,0.7570867509343909,1.0,4/30,7.86%,SPOCK1;GAS6;SNCA;RPS6KA1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.3794813558687361,-1.0327996209934702,0.39807692307692305,0.7051750758044919,1.0,11/20,23.92%,USP7;SENP3;SENP1;USP47;SENP5;COPS2;USP50;DESI2;SENP2;USP9X;EIF3H
prerank,transition metal ion binding (GO:0046914),-0.22659516948912384,-1.0327508052041365,0.3407707910750507,0.7022822518159137,1.0,99/397,20.01%,AGMO;SMAD3;LARGE1;MPPED2;AOX1;LIMS1;SEC24D;GLI2;B4GALT1;MOXD1;CBLB;ZEB1;MDM4;PAPPA;HDAC4;ABL1;PRKN;ENPP1;ARIH1;KDM7A;XPNPEP1;ZCCHC4;EEA1;PLSCR1;SKI;RC3H1;TDP2;SEC23A;NSD1;PHF8;ASAH2;CDADC1;TRIM8;ZFYVE1;TES;KDM5B;ACO2;RNF8;ECE1;ANPEP;UBA5;WRN;ACER3;SLU7;PHF2;CHD4;CHD3;USP33;MNAT1;ENPP3;ME1;ABL2;FAM20C;NAPEPLD;BBOX1;SOD3;PPM1M;MSRB3;FBXL19;NPEPPS;PIAS4;ADAM33;KDM1B;CZIB;PCK2;SIRT5;UPB1;GLO1;ESCO1;KDM3A;PRDM2;P2RX4;RXRA;LNPEP;PDXK;KDM2A;LOXL3;TYW5;GTF2B;TARS1;ZFP37;NQO2;BAZ1B;RASSF1;PTPN1;RABGGTB;XYLT2;SOD2;NEK4;GALNT1;PARK7;APIP;B4GALT7;ZMYND8;NFU1;TIMP2;ETHE1;QPCTL;RNF11
prerank,lipid phosphatase activity (GO:0042577),0.42315521801356715,1.0327255800656585,0.42035398230088494,0.7540059070347414,1.0,7/14,19.58%,PLPPR1;PLPPR5;SGPP2;PLPPR4;PLPP6;SGPP1;PLPP7
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2764724687844405,1.0275860899446558,0.40408163265306124,0.7639635842019108,1.0,11/85,10.38%,AARS2;ABHD2;ENPP2;LYPLA1;LIPE;CA2;PLAAT1;PTRH2;PLA2G12A;ABHD8;ESD
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.36470050941933235,-1.0275722610634161,0.4096153846153846,0.7096589162100051,1.0,8/21,20.86%,CDK8;CDK7;CDK13;CCNK;CDK11B;CDK10;CDK2;CDK6
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.36470050941933235,-1.0275722610634161,0.4096153846153846,0.7096589162100051,1.0,8/21,20.86%,CDK8;CDK7;CDK13;CCNK;CDK11B;CDK10;CDK2;CDK6
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.42313464006830176,-1.0247291068551574,0.44727272727272727,0.7140506885913452,1.0,7/12,30.56%,TBP;STAT1;HDAC1;GTF2B;TBPL1;RUVBL2;GTF2A1
prerank,protein kinase inhibitor activity (GO:0004860),0.31068739149754937,1.0244006097489242,0.40122199592668023,0.7678178841791872,1.0,13/42,16.15%,YWHAB;CAMK2N1;INKA1;SNCA;DUS2;SPRY4;SOCS1;MAPK8IP1;CEP43;CIT;CIB1;CDKN1A;CDKN1B
prerank,gap junction channel activity (GO:0005243),-0.35921606662448347,-1.0221306563260761,0.4110898661567878,0.7181250051882575,1.0,3/22,8.71%,GJB6;GJA1;GJB2
prerank,TBP-class protein binding (GO:0017025),-0.36699786946680496,-1.021850950929808,0.4216417910447761,0.7159516795045928,1.0,11/21,30.56%,TAF13;GTF2B;TAF12;PSMC1;DRAP1;YEATS2;THRA;ESR1;BRF2;RUVBL2;GTF2A1
prerank,wide pore channel activity (GO:0022829),-0.35447532656842295,-1.0213017718728123,0.4187380497131931,0.7142651850382518,1.0,3/23,8.71%,GJB6;GJA1;GJB2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3701734413924637,1.0207879090297622,0.4346895074946467,0.7734298823320088,1.0,5/18,14.17%,SLA2;PIK3R5;SOCS1;PIK3R3;CCKBR
prerank,"DNA binding, bending (GO:0008301)",0.4010356301108355,1.0203055397365115,0.416015625,0.7698355104015481,1.0,3/14,7.00%,LEF1;HMGA2;TERF1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4037144911116761,1.0176930716409611,0.4276729559748428,0.772256977954,1.0,6/13,25.53%,RANBP1;CCDC88A;GDI1;ARHGDIG;SH3BP4;EIF5
prerank,ribonuclease P activity (GO:0004526),0.42837860783182274,1.0143024637338893,0.46624472573839665,0.7767656787121971,1.0,3/11,12.31%,RPP40;RPP30;POP5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.4320778405524169,1.0136597559740748,0.42369020501138954,0.7735553106670031,1.0,11/11,56.82%,DDAH1;ALLC;PADI6;PADI3;AGMAT;PADI4;PADI1;ARG1;ARG2;PADI2;DDAH2
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.2847433826357394,-1.0125459924759936,0.4247967479674797,0.733050105991905,1.0,20/71,14.97%,EYA2;PTPN13;EYA1;EYA4;PTPN14;CDC14A;TNS2;PTPN9;PTPRS;PTPN21;PTPN3;PTPRK;PTPN22;PTPN12;PTPN2;DUSP11;MTMR3;DUSP1;CDC14B;CDC25B
prerank,store-operated calcium channel activity (GO:0015279),0.43713511212206135,1.0102292445489016,0.4376417233560091,0.778091408859642,1.0,2/10,11.89%,TRPC5;TRPC1
prerank,cholesterol binding (GO:0015485),-0.30006856667894594,-1.008497143643396,0.42424242424242425,0.7404007026908129,1.0,12/47,12.62%,ABCA1;ANXA6;OSBPL8;SOAT1;GRAMD1C;OSBPL5;SIDT1;VDAC1;NR1H3;NPC2;ERLIN1;APOD
prerank,hormone activity (GO:0005179),0.2928954892865852,1.0074256115765823,0.4188376753507014,0.7809331259491471,1.0,13/54,20.07%,AMH;TRH;ADCYAP1;NMB;SST;POMC;GRP;PNOC;VGF;EDN1;CCL25;METRN;AGT
prerank,growth factor receptor binding (GO:0070851),-0.26288431095883136,-1.0065140487779503,0.4296875,0.7423859502377902,1.0,18/95,15.35%,EFEMP1;PDGFRA;FGF1;PDGFRB;IL6ST;PIBF1;PLSCR1;SHC1;FRS2;NCSTN;FER;PDGFC;KL;IL6R;VEGFA;ERN1;VEGFD;ITGA5
prerank,sequence-specific mRNA binding (GO:1990825),0.4257924271200991,1.0064409764226048,0.430406852248394,0.7788346480865147,1.0,2/10,6.85%,LARP6;ETF1
prerank,zinc ion binding (GO:0008270),0.23063314535389265,1.0061274164279812,0.4080808080808081,0.7749211875134956,1.0,46/293,11.74%,MT2A;MMP12;MME;GLRA1;S100A9;S100A8;GRIN2A;SHANK3;PDE2A;TRIM2;GRIN2B;QPCT;PPARG;PHEX;RPS27;SNCA;ENPP2;MT1X;MT1F;MT1M;MT1H;MT1E;MT1A;MT1G;MT1B;SNRPC;CA2;NUDT12;KLF4;MYT1;TIMP1;MMP16;PITRM1;MSRB2;ZDHHC15;TMEM163;RNF112;ARHGEF2;DPF3;TRIM24;SMPDL3A;SMPD1;ZNF22;IKZF5;THAP1;SLC30A5
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2901436303862215,1.0053138273120725,0.39789473684210525,0.7723682682858011,1.0,13/55,14.16%,SLC24A4;SLC24A2;GRIN1;TRPC5;RYR2;ATP2B3;TRPM2;CACNB2;TRPC1;TMCO1;PSEN1;ATP2B4;ATP2B2
prerank,cytokine receptor binding (GO:0005126),-0.2706623305489561,-1.0046850367035796,0.4256120527306968,0.7441267179825561,1.0,8/83,5.30%,TGFBR3;SMAD3;IL34;IL6ST;JAK1;PIBF1;IL13RA1;SMAD2
prerank,syntaxin-1 binding (GO:0017075),0.3569203937129697,1.0026090778388685,0.4578313253012048,0.7751757809644929,1.0,6/22,10.56%,SYT1;SNAP25;UNC13A;SNPH;SYNPR;CPLX1
prerank,MHC class II protein complex binding (GO:0023026),0.4216657591395958,1.0005526398645839,0.4673684210526316,0.7763347302872303,1.0,4/11,17.04%,HSPA8;HSP90AB1;ATP1B1;HSP90AA1
prerank,hyaluronic acid binding (GO:0005540),-0.43496364107026525,-0.997673616017428,0.48295454545454547,0.7593663972596545,1.0,6/10,34.43%,CEMIP;IMPG2;C1QBP;LYVE1;CHODL;CD44
prerank,myosin II binding (GO:0045159),-0.4365430963058675,-0.997136621571792,0.4791288566243194,0.7579125727036682,1.0,2/10,2.45%,GSN;STXBP5
prerank,tRNA binding (GO:0000049),-0.3031685834220786,-0.9970702317227575,0.4570383912248629,0.7549950766699186,1.0,21/43,33.69%,FARS2;TRMT9B;NSUN6;ALKBH1;EIF2AK4;TYW5;NSUN2;ELP5;KARS1;TERT;DALRD3;RPUSD4;TRNT1;PSTK;NAT10;IGHMBP2;TRMT10C;MRPS27;PUS1;ALKBH8;CARS1
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.3186526208889058,-0.9967165912997134,0.47534516765285995,0.7528918158348391,1.0,18/35,30.56%,FOXP1;BAZ2A;NR3C1;TAF4;TBP;STAT1;HDAC1;SNAPC3;GTF2B;PARK7;PIH1D1;DRAP1;AGO1;TBPL1;TAF1C;RRN3;RUVBL2;GTF2A1
prerank,nucleotide diphosphatase activity (GO:0004551),-0.4015245086884359,-0.995642968300055,0.45956607495069035,0.752801529601434,1.0,3/14,3.50%,FHIT;ENPP1;NUDT4
prerank,nucleotidyltransferase activity (GO:0016779),-0.36676159198045916,-0.9954362345758216,0.4742857142857143,0.7503224406055949,1.0,5/19,13.96%,TENT2;NUDT5;CRPPA;TUT4;REV1
prerank,beta-tubulin binding (GO:0048487),0.3211429816103323,0.9951173603876159,0.4722792607802875,0.7865717381554506,1.0,5/31,5.97%,PACRG;TTLL7;FGF13;GABARAPL1;GABARAP
prerank,RNA stem-loop binding (GO:0035613),-0.41617998031886644,-0.9937335757627731,0.4877126654064272,0.7517660938440124,1.0,4/12,14.84%,RC3H1;DHX9;CSDE1;DDX3X
prerank,filamin binding (GO:0031005),-0.4206028984041058,-0.992023088496177,0.4708097928436911,0.7532912618019107,1.0,2/11,9.99%,DPYSL3;SYNPO2
prerank,acylglycerol lipase activity (GO:0047372),0.4251961296967166,0.9916037889053683,0.4578059071729958,0.7917510745480874,1.0,2/11,5.48%,ABHD2;LIPE
prerank,iron ion binding (GO:0005506),-0.2912368943635067,-0.99103992224775,0.44204322200392926,0.7527690755211195,1.0,15/48,20.96%,AGMO;AOX1;FTO;KDM7A;PHF8;ACO2;PHF2;EGLN3;ALKBH1;KDM3A;TYW5;NFU1;ETHE1;FDX1;FXN
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.40057299215779985,-0.9900059077288047,0.49808429118773945,0.7525625453107836,1.0,2/14,11.71%,DHRS3;AKR1A1
prerank,cardiolipin binding (GO:1901612),-0.42699540682850456,-0.9897755840347251,0.4915572232645403,0.7502899852463448,1.0,5/10,21.37%,OPA1;GSDME;GSDMD;STOML2;PLEKHN1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.32725984214001236,-0.9874988265553539,0.48330058939096265,0.7530948345717476,1.0,4/29,7.01%,SLC13A3;SLC1A5;SLC26A7;SLC26A2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.27448416025804484,0.9864499306803142,0.4661016949152542,0.8018882735065714,1.0,16/73,17.97%,HCRTR1;LGR5;SORCS3;SORCS1;APLNR;HCRTR2;F2R;GRPR;OPRK1;CCKBR;NPR1;NPSR1;CALCRL;ADCYAP1R1;CYSLTR1;EDNRB
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.28379503898378755,-0.9849777286902753,0.4800796812749004,0.7564809471099853,1.0,12/54,14.80%,NGLY1;HDAC8;HDAC4;ASPA;ASAH2;ACER3;MIER1;NTAN1;SIRT5;UPB1;HDAC1;ASPG
prerank,acetylcholine receptor activity (GO:0015464),0.34734700580447125,0.9833210836435936,0.4711111111111111,0.8057874270588556,1.0,1/22,1.73%,CHRM3
prerank,outward rectifier potassium channel activity (GO:0015271),-0.41915496963593135,-0.9751891103811038,0.524074074074074,0.7789782229403363,1.0,2/11,1.32%,KCNK2;KCNT2
prerank,neuropeptide hormone activity (GO:0005184),0.34603366145450687,0.9738315066776307,0.47890295358649787,0.8276927775603471,1.0,4/22,11.62%,ADCYAP1;NMB;GRP;PNOC
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3713958591178087,0.9721965093857912,0.48936170212765956,0.8274955142138619,1.0,3/16,7.53%,SLC18A3;SLC25A42;SLC7A8
prerank,endopeptidase activator activity (GO:0061133),0.42579164946106507,0.9696940951623333,0.5128205128205128,0.8298195586262295,1.0,3/10,21.76%,PSENEN;PSME3;APH1B
prerank,phosphatidylcholine transporter activity (GO:0008525),0.3657330439755907,0.9689625769639313,0.5064377682403434,0.8270879123235896,1.0,4/17,5.48%,PLTP;ATP10A;ATP10B;PITPNM1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.3645121604966764,0.9679364796729001,0.5110663983903421,0.8251286272092869,1.0,7/16,25.46%,MACROD2;RPS3;CD38;ADPRS;SARM1;ADPRH;TDG
prerank,exoribonuclease activity (GO:0004532),0.3983501495747801,0.966888332186376,0.5040485829959515,0.8232210839520454,1.0,1/12,0.97%,EXOSC5
prerank,sterol transfer activity (GO:0120015),0.35805184106011706,0.9661185552692969,0.4793028322440087,0.8207195698338848,1.0,2/17,5.56%,PLTP;GRAMD1B
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.2993918481354445,0.9653586946822601,0.5351239669421488,0.8183481737853077,1.0,5/37,6.27%,AARS2;VARS1;VARS2;GARS1;RARS1
prerank,dynactin binding (GO:0034452),0.3958754074100207,0.9650389398944249,0.5132924335378323,0.8147763174132566,1.0,3/12,8.93%,BICD1;BICDL1;SPTBN5
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.4220512080715789,-0.9637334327887905,0.5194805194805194,0.8060809146829074,1.0,2/10,2.20%,B4GALT1;B3GALT1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.2983499721365778,0.9607598710855784,0.5175983436853002,0.8217306266756066,1.0,8/35,10.84%,GPCPD1;PLCXD3;ENPP2;PDE11A;PLCB4;SMPDL3A;APEX1;SMPD1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.31913142467699507,0.9605547100614545,0.5128755364806867,0.8177400519523779,1.0,5/26,11.70%,B4GALNT1;CSGALNACT1;CHSY3;B3GALT5;B3GNT2
prerank,receptor tyrosine kinase binding (GO:0030971),0.27435225911509387,0.9603299238993814,0.5210084033613446,0.8138408388251384,1.0,6/56,5.48%,NRG3;GRB14;NRG1;DOCK4;GAS6;PITPNM1
prerank,leucine zipper domain binding (GO:0043522),-0.42588440302980096,-0.9580866474155794,0.5431192660550459,0.8179519016778228,1.0,2/10,2.80%,PAWR;ERC1
prerank,protein kinase regulator activity (GO:0019887),-0.2512413352499965,-0.9573756978506938,0.5523255813953488,0.8167127790765766,1.0,19/95,15.86%,PRKAG2;PARVA;CCNL2;CCNT2;CCNL1;CCNH;RPTOR;CCNT1;TAOK3;CCNK;GPRC5C;WNK1;CCNYL1;DNAJC3;GMFB;CCND3;NCK1;CNPPD1;SH3BP5L
prerank,phosphatase activity (GO:0016791),-0.2611082484491585,-0.9573142113885121,0.5278350515463918,0.8137978976802641,1.0,20/73,19.53%,ATP1A2;PLPP3;DUSP16;NT5M;PRUNE1;PTPN22;DUSP11;APTX;PXYLP1;PPP1CB;ENOPH1;SACM1L;EPHX2;ACP2;DUSP10;LPIN2;LPIN3;INPP5K;PSPH;HDDC2
prerank,lysine N-methyltransferase activity (GO:0016278),-0.35054523435689194,-0.9572508079213284,0.5192697768762677,0.8109304515561876,1.0,7/20,19.34%,SETD7;SETD3;SETD2;EHMT1;METTL21A;EEF2KMT;KMT5A
prerank,SUMO binding (GO:0032183),-0.3955120419942917,-0.9549979069025825,0.5420743639921722,0.8136594845646239,1.0,4/13,20.26%,HERC2;SERBP1;SIMC1;PML
prerank,cholesterol transfer activity (GO:0120020),0.35917412866650944,0.953738836902634,0.5138004246284501,0.8267483675417325,1.0,2/16,5.56%,PLTP;GRAMD1B
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.4009243886191769,-0.9530846642287157,0.5378927911275416,0.8159515224127911,1.0,8/11,59.79%,CHRNA4;CHRNA7;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,phosphatidylglycerol binding (GO:1901611),0.3827726008103574,0.9527235408438596,0.5235042735042735,0.8248021754761699,1.0,2/13,1.59%,PLTP;MME
prerank,chloride transmembrane transporter activity (GO:0015108),0.3641474108847323,0.9522140079934669,0.527542372881356,0.8217552943271753,1.0,2/16,4.33%,SLC4A1;SLC1A1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.40936628446303536,-0.9520943714816421,0.5458089668615984,0.8154849491794418,1.0,4/11,18.34%,SASH1;ROR2;TCF3;TRAF6
prerank,protein kinase C binding (GO:0005080),-0.2941399671128441,-0.9509543085663784,0.5555555555555556,0.8154937693230132,1.0,9/43,10.53%,GRK5;PDLIM5;ITGAV;PARD6G;ABL1;IRS1;ADCY6;DACT1;ADAM9
prerank,galactosyltransferase activity (GO:0008378),-0.4110491701079945,-0.9479638278078335,0.5426356589147286,0.820599570940059,1.0,8/11,35.75%,B4GALT1;A4GALT;B4GALT5;B4GALT7;B4GALT3;A3GALT2;B3GALT6;B4GALT2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.29361409608712036,-0.9466722751532253,0.5653846153846154,0.8211656774626979,1.0,13/40,20.11%,PCMTD2;DNMT3A;COMT;SETD3;N6AMT1;METTL2B;METTL2A;PCMT1;TPMT;THUMPD3;PRMT8;RRP8;CARNMT1
prerank,retinoid X receptor binding (GO:0046965),-0.3996500973058414,-0.9464570428116231,0.5284090909090909,0.8187579644841586,1.0,5/11,21.77%,RARG;NSD1;NCOA6;NR4A2;ARID5A
prerank,tau protein binding (GO:0048156),-0.29369734826970645,-0.945655551335335,0.5555555555555556,0.8178946039778983,1.0,15/40,21.02%,ROCK2;EP300;ROCK1;GSK3B;MARK3;SMAD2;MARK4;PPP2CB;BRSK1;APOE;MARK1;PICALM;PRKAA1;TAOK1;PPP2CA
prerank,snRNA binding (GO:0017069),-0.28877014521817274,-0.9441990823808923,0.5705765407554672,0.8186365891058083,1.0,16/42,31.98%,CCNT2;CCNT1;RNPC3;GEMIN5;SNRNP70;COIL;EFTUD2;SNU13;HNRNPU;NCBP2;PRPF8;LSM11;RBM22;CDK9;SNRPA1;RBM41
prerank,phospholipase C activity (GO:0004629),-0.32641887299839895,-0.9440647675918715,0.5411089866156787,0.8159742893847871,1.0,8/25,16.69%,PLCE1;PLCD3;EDNRA;PLCG1;PLCB3;PLCD1;BDKRB2;PLCL1
prerank,omega peptidase activity (GO:0008242),0.2518720195794134,0.9437226234402267,0.5534979423868313,0.8401765269430838,1.0,27/89,19.11%,USP44;OTUD7A;USP29;USP53;USP14;USP49;ASRGL1;UCHL1;GGT7;YOD1;UCHL3;GGH;GGT1;USP32;USP22;OTUB2;USP48;USP31;USP30;OTUB1;USP42;OTULIN;USP8;UCHL5;ATXN3;OTUD7B;JOSD1
prerank,steroid hydroxylase activity (GO:0008395),-0.36285062782353716,-0.9435265513732266,0.5543478260869565,0.8143977267992447,1.0,3/16,9.27%,CYP7B1;CYP27A1;CYP1B1
prerank,deubiquitinase activity (GO:0101005),0.25087394721948036,0.9402307599346578,0.6032719836400818,0.8448296447159264,1.0,26/88,19.11%,USP44;OTUD7A;EIF3F;USP29;USP53;USP14;USP49;UCHL1;YOD1;UCHL3;USP32;USP22;OTUB2;MINDY1;MINDY2;USP48;USP31;USP30;OTUB1;USP42;OTULIN;USP8;UCHL5;ATXN3;OTUD7B;JOSD1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3134976545578371,0.9394453735923096,0.55,0.8423917516469807,1.0,7/27,17.14%,POLR1H;POLR2J;POLR2B;POLR2I;MED20;POLR3A;POLR2G
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.39969432104509567,-0.9372856938535995,0.5706214689265536,0.8269139606121564,1.0,3/11,24.06%,PPP1R1A;PPP1R2;PPP1R14A
prerank,serine-type peptidase activity (GO:0008236),0.24766643350213496,0.9372585555996782,0.5777777777777777,0.8437768673139889,1.0,10/96,11.24%,MASP2;PCSK1;PCSK2;RHBDF2;PCSK6;ENDOU;PREP;PCSK7;TMPRSS4;PROC
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.27831652739451634,-0.9371301600527707,0.5508982035928144,0.8243435617340551,1.0,5/53,3.12%,SLC7A11;SLC7A2;SLC1A3;SLC47A1;SLC1A5
prerank,neurexin family protein binding (GO:0042043),0.41087260303914913,0.9344879371931463,0.5356371490280778,0.8469632016310333,1.0,2/10,6.42%,NLGN1;SYTL2
prerank,ion channel inhibitor activity (GO:0008200),-0.29194352714119287,-0.9334620537621829,0.5508317929759704,0.8309562063249742,1.0,5/35,9.41%,ITPR1;VTI1B;CAMK2D;WNK4;WNK1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.33094109586805304,-0.9327493702442848,0.5576923076923077,0.829553284097921,1.0,6/23,10.26%,PLCE1;PLCD3;EDNRA;PLCG1;PLCB3;PLCD1
prerank,cytokine receptor activity (GO:0004896),-0.24574250632603117,-0.9299058001138667,0.605009633911368,0.8337415189404566,1.0,14/83,16.17%,LEPR;IL6ST;IL31RA;GHR;CCR9;IL15RA;IL13RA1;F3;IL17RA;CNTFR;IL17RD;IL6R;IFNGR1;CMKLR1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3549705752401207,-0.9252016338311021,0.5653021442495126,0.8426487358912018,1.0,6/15,17.33%,EEA1;SNX9;ZFYVE1;SNX10;ZFYVE16;PICALM
prerank,cysteine-type peptidase activity (GO:0008234),-0.25275595739822215,-0.9245657077654414,0.6378269617706237,0.841151884034431,1.0,22/73,25.31%,USP24;USP7;CTSC;CTSH;USP33;USP47;CASP2;USP12;USP11;USP46;USP35;USP50;USP2;USP13;ATG4D;USP34;CTSF;CTSL;USP18;USP9X;USP28;CASP6
prerank,microtubule plus-end binding (GO:0051010),0.33475459408007835,0.9242705388857754,0.5601750547045952,0.8692610557294339,1.0,10/20,19.69%,KNSTRN;DST;MAPRE3;CLIP2;APC;DCTN1;CLASP2;KIF18A;TTBK2;CLASP1
prerank,ferrous iron binding (GO:0008198),0.3331836306070876,0.9238018262540422,0.5749440715883669,0.8659946257967822,1.0,7/21,18.31%,FTH1;SNCA;FTL;ISCU;ALKBH3;FECH;EGLN1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.3609350199854517,0.9195008604550551,0.5734989648033126,0.872927471750743,1.0,1/13,1.05%,DNASE1
prerank,proton transmembrane transporter activity (GO:0015078),0.2799892628846582,0.9175167292104628,0.6096491228070176,0.8735311584283176,1.0,14/39,21.28%,COX7A1;NDUFA4;COX4I1;COX6A1;ATP6V1F;COX6B1;DMAC2L;UQCRH;NNT;COX10;COX8A;CLCN3;CLCN4;COX5B
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.25049454847994435,-0.9166956717060765,0.6220472440944882,0.8576523322138907,1.0,12/70,18.36%,GXYLT2;LARGE1;B4GALT1;B3GALT1;EXT1;B3GLCT;POGLUT2;OGT;HEXA;CHPF2;CHSY1;GCNT2
prerank,methyltransferase activity (GO:0008168),-0.2739837982626357,-0.9147979399652465,0.6135084427767354,0.8594796906958605,1.0,15/46,20.48%,COQ3;COMT;NSUN3;TRMT11;N6AMT1;EHMT1;PRMT5;BUD23;NSUN2;PRMT8;RRP8;NTMT1;FTSJ1;CARNMT1;COQ5
prerank,aminopeptidase activity (GO:0004177),-0.310425508941903,-0.9102294551291853,0.5965909090909091,0.8680427109561043,1.0,7/26,15.61%,XPNPEP1;CTSH;ANPEP;MMP14;LAP3;NPEPPS;LNPEP
prerank,phospholipase activity (GO:0004620),-0.25198777568367775,-0.9094260646924339,0.6374501992031872,0.8669166523870069,1.0,15/67,19.18%,PLCE1;SEC23IP;DDHD1;PLA2G4A;PLCB3;ABHD3;NAPEPLD;PNPLA8;PNPLA7;ASPG;PLCL1;ABHD12;SMPD4;ABHD6;MGLL
prerank,ATP hydrolysis activity (GO:0140603),-0.27670028296995963,-0.9082363306494659,0.6123711340206186,0.8667619115478163,1.0,11/41,18.41%,RNF213;ABCA4;VPS4B;VWA8;DHX9;ABCD2;CHD3;ATP2B1;DDX3X;SMCHD1;VCP
prerank,chemoattractant activity (GO:0042056),0.3133442941161959,0.9074247296782256,0.6328293736501079,0.895133388457256,1.0,5/26,10.55%,MIF;FGF10;GPNMB;PDGFB;SCG2
prerank,antiporter activity (GO:0015297),0.32487869083065174,0.9070907984399207,0.6079207920792079,0.8914001665434216,1.0,5/20,12.51%,SLC35A1;ATP1A3;SLC25A14;SLC35C1;SLC35E4
prerank,telomerase RNA binding (GO:0070034),-0.3245592513624288,-0.9055081684645903,0.602996254681648,0.8701884481460085,1.0,10/22,30.54%,SMG6;DHX36;SMG7;XRN1;EXOSC10;HNRNPU;TERT;GAR1;PARN;PINX1
prerank,protein phosphatase regulator activity (GO:0019888),-0.26055149743177236,-0.9049593697978988,0.6530214424951267,0.8686366365701604,1.0,20/53,27.66%,PTN;SHOC2;PPP1R7;PPP4R2;CABIN1;ANKLE2;DMPK;PPP2R5E;EIF2AK2;PPP2R5D;BOD1L1;PTPA;PPP2R5C;PPP2R1B;PPP4R1;PPP1R2;PPP2R2C;BOD1;SAG;PPP1R15B
prerank,MAP kinase activity (GO:0004707),-0.3579579703256187,-0.9027150536260229,0.5936329588014981,0.8708827259028241,1.0,5/14,25.74%,MAPK4;MAPK6;MAPK7;MAPK9;MAPK14
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.3892059952387749,0.9020628372160718,0.5895691609977324,0.8998935649853057,1.0,3/11,6.46%,RYR2;RYR3;TRPM2
prerank,heme binding (GO:0020037),-0.2529733943179133,-0.901000811257501,0.6522593320235757,0.8720784897433974,1.0,9/65,9.27%,PTGIS;CYP26B1;CYP27A1;CYB5B;CYB5R4;EIF2AK1;NOX4;PGRMC2;CYP1B1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.392392016076832,0.9004238198329443,0.5892116182572614,0.8994754634789586,1.0,1/10,0.28%,MECOM
prerank,potassium ion leak channel activity (GO:0022841),0.34618321467926105,0.8967258348476635,0.6033402922755741,0.9040149275992502,1.0,4/15,8.42%,KCNK13;KCNK10;KCNK9;KCNK1
prerank,DNA polymerase binding (GO:0070182),-0.3384486429106386,-0.8962007983689577,0.6164122137404581,0.8801332054638146,1.0,10/18,35.31%,SMG6;HMGB1;NABP2;FANCI;PCNA;NAT10;LONP1;FANCD2;RAD51;SMARCA4
prerank,chloride channel inhibitor activity (GO:0019869),-0.3962754022934728,-0.8953637919846885,0.6194029850746269,0.8790539727691249,1.0,6/10,27.26%,VTI1B;WNK4;WNK1;STX8;STX1A;STX7
prerank,chemokine activity (GO:0008009),0.29226325255205104,0.8947051070806372,0.6116700201207244,0.9045401796685143,1.0,6/31,20.51%,CXCL12;CCL2;CCL25;CKLF;CCL13;CCL19
prerank,serine-type endopeptidase activity (GO:0004252),0.2451990946986302,0.8935408809353249,0.7062374245472837,0.902870578254003,1.0,8/80,11.24%,MASP2;PCSK1;PCSK2;RHBDF2;PCSK6;PCSK7;TMPRSS4;PROC
prerank,phosphatidic acid binding (GO:0070300),-0.32261501246718494,-0.8931012525850057,0.6191369606003753,0.88165320002118,1.0,7/19,15.66%,OPA1;PACSIN2;MAPKAP1;PITPNC1;GSDMD;RAPGEF2;MARK1
prerank,O-acyltransferase activity (GO:0008374),0.2938591486409526,0.8864804867938911,0.6293103448275862,0.9155915113669574,1.0,8/30,16.72%,MBOAT1;LPCAT2;DGAT2;PLAAT1;GPAM;MOGAT1;SOAT2;PIGW
prerank,cation:chloride symporter activity (GO:0015377),-0.3850113955516943,-0.8841432058258007,0.6113138686131386,0.8993138861108081,1.0,5/10,20.31%,SLC12A7;SLC12A2;SLC6A1;SLC12A8;SLC12A9
prerank,epidermal growth factor receptor binding (GO:0005154),0.3030821672975345,0.883847783176164,0.6313559322033898,0.9175001828196023,1.0,5/25,12.15%,ERBB4;HIP1;LINGO1;CCDC88A;ARF4
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3165555653888601,-0.8836237261333035,0.6312849162011173,0.8973412372426741,1.0,2/21,0.52%,PDE1A;PDE5A
prerank,U6 snRNA binding (GO:0017070),0.3510988161847674,0.88297459912239,0.6352941176470588,0.9150540956172583,1.0,8/14,27.26%,LSM4;LSM2;LSM7;LSM3;PRPF4;DDX39B;EIF5A;LSM8
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.39010779870124507,-0.8819365144384969,0.6,0.898284651985233,1.0,1/10,0.21%,PRKAG2
prerank,ribonuclease activity (GO:0004540),-0.2555725955158512,-0.8799815301698832,0.688,0.9000859337420558,1.0,12/56,15.97%,SMG6;DIS3L2;DICER1;ZC3H12C;NYNRIN;CPSF3;RNASE12;KHNYN;ZC3H12B;EXOSC9;ERN1;EXOSC10
prerank,snoRNA binding (GO:0030515),-0.2889948484159418,-0.8796276495657667,0.6547619047619048,0.897857069727416,1.0,16/30,32.29%,NUDT4;NUDT5;BMS1;PRKDC;NOP58;SNU13;UTP6;IMP3;GAR1;TSR1;DHX37;NUDT1;TBL3;NUDT7;NUDT16;NUDT16L1
prerank,metalloaminopeptidase activity (GO:0070006),-0.3378817698573506,-0.8788147202371985,0.6416184971098265,0.8966806026216773,1.0,5/16,15.61%,XPNPEP1;ANPEP;MMP14;NPEPPS;LNPEP
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2412262678687589,-0.87797803567631,0.7145631067961165,0.8955528463509933,1.0,35/74,33.75%,PI4KA;NADK2;FAM20A;GK5;DGKA;NADK;ADK;PANK2;FAM20C;DCAKD;PIK3C3;RFK;PDXK;PIK3CD;FCSK;SHPK;PKM;DGKD;GALK2;SPHK1;DGKK;GALK1;MVK;ETNK1;DOLK;POMK;SPHK2;PI4KB;PIK3C2A;HK2;TKFC;PAPSS1;HYKK;COASY;TRPT1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.35342342291748347,0.8755076345269326,0.6199575371549894,0.9281115048542289,1.0,3/13,17.31%,MIF;IDI1;EBP
prerank,gamma-tubulin binding (GO:0043015),-0.3161850873947836,-0.8732503887672031,0.6370510396975425,0.9032902105904308,1.0,8/22,14.84%,CENPJ;TUBGCP6;TUBGCP2;MARK4;BRSK1;RAD51D;BRCA2;DDX3X
prerank,lipase activity (GO:0016298),-0.2645996017793377,-0.872213459109531,0.6981891348088531,0.9024474667976996,1.0,13/43,26.15%,SEC23IP;DDHD1;ABHD5;ABHD3;PNPLA8;PLA1A;ABHD12;ABHD6;MGLL;SMPD2;DAGLB;PNPLA2;LPL
prerank,adenylate cyclase binding (GO:0008179),0.37490046886436057,0.8714841699134822,0.5957894736842105,0.9330880544676904,1.0,5/10,14.32%,AKAP6;CAP2;CALM1;CALM2;CALM3
prerank,fatty acid synthase activity (GO:0004312),0.36827153276022023,0.8711214384344615,0.588865096359743,0.9294241631546889,1.0,2/10,7.45%,ELOVL7;ELOVL4
prerank,endodeoxyribonuclease activity (GO:0004520),-0.30877473652236875,-0.8709081395791772,0.6442307692307693,0.9023727087350027,1.0,6/20,26.36%,RBBP8;MRE11;ZRANB3;EXOG;ERCC1;ENDOV
prerank,palmitoyltransferase activity (GO:0016409),0.29119918804318023,0.8703811139025284,0.6844349680170576,0.9265146709682929,1.0,6/28,15.44%,ZDHHC22;ZDHHC17;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3035059017233643,-0.8686811383515987,0.647834274952919,0.9044021183897912,1.0,2/23,0.52%,PDE1A;PDE5A
prerank,nucleotidase activity (GO:0008252),0.3351569288920587,0.8686125600612153,0.6286919831223629,0.9259994754083168,1.0,3/15,12.72%,NT5DC2;NT5C;BPNT2
prerank,GTPase activity (GO:0003924),-0.2059314610962452,-0.8675946998541256,0.8297029702970297,0.9038713762403136,1.0,58/192,26.41%,RHOQ;OPA1;LRRK2;RHOJ;ATL3;RND3;DNM1L;RAP1B;ABCA4;MRAS;RAB22A;GFM1;MMUT;TBC1D24;CDC42;ATL2;RHOA;RHOT1;RAB11A;GNA14;RALA;GNAS;RHOBTB2;GTPBP10;RASL12;GNG5;GFM2;ARHGDIB;RAB21;GBP3;BMS1;DNAJC27;DDX3X;EFTUD2;GNB1;GBP7;GBP2;RHOBTB1;RHOH;RHOC;GBP6;MTG2;RAB24;RIT1;RABL3;NKIRAS1;GNAZ;GPN3;RHOT2;RAB8A;RAB9A;SAR1B;RAB7A;IRGM;RAB5A;RRAGA;TSR1;MFN2
prerank,protein kinase C activity (GO:0004697),0.3457037063546511,0.8673771597460458,0.6244635193133047,0.9244021776583282,1.0,3/14,6.51%,PRKCH;PKN1;PRKCQ
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3842263942861681,-0.8671311620406043,0.625250501002004,0.9019470870668874,1.0,7/11,32.29%,NUDT4;NUDT5;NUDT1;NUDT11;NUDT7;NUDT16;NUDT16L1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3449068496614826,0.8641344141321724,0.6845493562231759,0.92720481983736,1.0,3/15,5.82%,SLC17A6;SLC1A1;SLC1A2
prerank,exonuclease activity (GO:0004527),-0.2560905469667375,-0.8640899635940279,0.7063492063492064,0.9056378636720119,1.0,11/46,16.38%,ENPP1;APEX2;CPSF3;WRN;REXO5;ENPP3;XRN2;REXO1;EXOSC9;EXOSC10;MRE11
prerank,mRNA 5'-UTR binding (GO:0048027),0.2905028213763068,0.8612188919397429,0.6597510373443983,0.9295935536952498,1.0,7/24,15.56%,LARP6;RPL41;RPL5;RPS7;RPS14;UTP23;MYH10
prerank,ATPase activator activity (GO:0001671),0.31058183083587676,0.8595153674691268,0.6521739130434783,0.9289558538279711,1.0,8/20,22.33%,DNAJC15;ATP1B1;DNAJA2;DNAJB2;AHSA1;DNAJC19;DNAJA1;ATP1B2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3273557417938931,-0.8594641655680185,0.6752767527675276,0.9094045287766149,1.0,3/16,7.13%,ATP6V1B2;ATP6V0D1;ATP6V0A4
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3273557417938931,-0.8594641655680185,0.6752767527675276,0.9094045287766149,1.0,3/16,7.13%,ATP6V1B2;ATP6V0D1;ATP6V0A4
prerank,neuropeptide receptor binding (GO:0071855),-0.342519280180261,-0.8563182353792791,0.6863905325443787,0.9130971276599444,1.0,5/14,43.43%,AGRP;NMU;PPY;NPY;APLN
prerank,protein phosphatase 2A binding (GO:0051721),0.29964770751855496,0.8562837419882897,0.6778947368421052,0.9318070211568016,1.0,6/23,14.55%,ADCY8;DAB2IP;GRIN3A;FOXO1;CTTNBP2NL;MFHAS1
prerank,ADP binding (GO:0043531),-0.2927973809307223,-0.8542861633965975,0.7067395264116576,0.9143362191995299,1.0,9/25,27.55%,PRKAG2;GLUD1;ME1;PGK1;ERN1;MSH6;TAP1;GCLC;LONP1
prerank,ephrin receptor binding (GO:0046875),-0.3027682825710385,-0.8520663559449962,0.66728280961183,0.9160253774579716,1.0,4/21,6.93%,EFNB2;ABL1;SHC1;LYN
prerank,clathrin adaptor activity (GO:0035615),0.3310861183498174,0.8512088384168472,0.6554621848739496,0.938564891338882,1.0,3/15,8.95%,AP2M1;HIP1;AP2B1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.2930579277559039,-0.8504459823389029,0.6896551724137931,0.9164769532214392,1.0,10/23,23.62%,SH3PXD2B;GBF1;MAPKAP1;KIF16B;WIPI1;WDR45B;WIPI2;PLEKHA4;HIP1R;JPH2
prerank,disordered domain specific binding (GO:0097718),-0.2995150811250633,-0.8491331128480439,0.6924528301886792,0.916431503597875,1.0,6/23,13.15%,NUMA1;SMAD2;TEAD2;RB1;FN1;FKBP8
prerank,NAD+ binding (GO:0070403),0.3484975498407892,0.8458505845215555,0.6681222707423581,0.9458326296333378,1.0,4/12,10.20%,HADH;SIRT1;HPGD;UXS1
prerank,3'-5' exonuclease activity (GO:0008408),-0.2500718074489846,-0.8456608572993412,0.7529880478087649,0.9206178116553752,1.0,17/45,28.14%,ERI3;DIS3L2;WRN;CNOT8;XRN2;ERI2;EXOSC9;PAN2;EXOSC10;MRE11;USB1;ANGEL2;EXOSC3;PNLDC1;PDE12;DIS3;PARN
prerank,peptidase activator activity (GO:0016504),0.2986072782685535,0.8456258883869996,0.6869747899159664,0.9420118798369553,1.0,2/22,4.98%,MAL;PSENEN
prerank,hexosyltransferase activity (GO:0016758),0.21927412959757794,0.8434547254329967,0.8145833333333333,0.9423591281059404,1.0,12/101,10.06%,TMTC2;MFNG;B4GALNT1;CSGALNACT1;FUT9;CHSY3;PIGM;B3GALT5;B4GALT6;ALG1;MGAT4C;DPY19L1
prerank,protein kinase activator activity (GO:0030295),-0.24130647356391552,-0.8404209297646267,0.7884231536926147,0.9281622141104702,1.0,17/60,20.62%,PRKAG2;STK3;FAM20A;CAB39L;RPTOR;PAK2;IGF2;MAP2K1;GPRC5C;WNK1;ABI1;RICTOR;DDX3X;AFAP1L2;MTCP1;TAOK1;CAB39
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3000352840046266,0.8388286332460396,0.6718403547671841,0.9475200665499899,1.0,1/20,0.24%,DLG2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.37349913732950735,-0.8386817869472241,0.6912878787878788,0.9285700809720367,1.0,2/10,9.18%,CXADR;JUP
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.3159398006961345,0.834427864167165,0.6708074534161491,0.9519502150908645,1.0,1/16,2.35%,BCO1
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.36441983264938704,-0.8331230947728454,0.7073643410852714,0.9366638776899386,1.0,5/10,24.24%,EHHADH;ECHDC2;ECHDC3;ECI1;AUH
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3511648868475354,0.8294579172598504,0.7116564417177914,0.9577057399785323,1.0,4/11,17.60%,HMGA2;APEX1;RPS3;APLF
prerank,kinase activator activity (GO:0019209),-0.2737493239440766,-0.827785485643566,0.7424242424242424,0.9440037891456572,1.0,5/30,13.38%,PRKAG2;RPTOR;GPRC5C;WNK1;MOB1B
prerank,thiol-dependent deubiquitinase (GO:0004843),0.22268606898957147,0.8244949596665077,0.8485477178423236,0.9629381313159268,1.0,23/83,19.11%,USP44;OTUD7A;USP29;USP53;USP14;USP49;UCHL1;YOD1;UCHL3;USP32;USP22;OTUB2;USP48;USP31;USP30;OTUB1;USP42;OTULIN;USP8;UCHL5;ATXN3;OTUD7B;JOSD1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.31743428815064306,-0.8238603395624421,0.7087378640776699,0.948482556446138,1.0,7/16,29.93%,SLC13A3;SLC1A5;SLC25A11;SLC38A7;SLC25A22;SLC13A5;SLC1A6
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.2846454288526642,0.8184284081806691,0.7331838565022422,0.9704229092722613,1.0,2/22,3.84%,DUSP6;PPM1F
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.35317926480243533,-0.8182472666715171,0.708256880733945,0.9558656412901921,1.0,1/10,2.52%,KAT2B
prerank,G protein-coupled receptor binding (GO:0001664),-0.20374219999641932,-0.8176212444347464,0.8864970645792564,0.9541879667061948,1.0,24/132,18.94%,LRP6;WNT4;RNF43;PRKN;WNT5B;WNT6;FLNA;RYK;WNT9A;GRK3;USP33;TULP3;ARHGEF12;GNA14;AGTR1;GNAS;FZD7;USP4;PTCH1;ARRB1;ARHGEF11;WNT5A;FZD1;MYOC
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.27149461592069374,0.8165492299484715,0.7546391752577319,0.9696574118138094,1.0,6/28,13.22%,RPP40;APEX1;RPP30;POP5;DROSHA;RNASEH2A
prerank,GTP binding (GO:0005525),-0.19581322183819638,-0.8158963195858887,0.9418604651162791,0.9542973651739455,1.0,57/172,30.40%,RHOQ;ANXA6;LRRK2;RHOJ;ATL3;ARL3;RND3;RAP1B;RAB10;MRAS;RAB22A;GLUD1;CDC42;ATL2;RHOA;RHOT1;ARFIP2;DYNC1LI1;ARF1;RALA;RHOBTB2;GTPBP10;RASL12;RAB21;GBP3;BMS1;GBP7;GBP2;RHOBTB1;TUBB2A;RHOH;RHOC;GBP6;MTG2;NME1;RIT1;RABL3;TUBB6;ARL5A;RHOT2;RAB8A;RAB9A;NOA1;RAB7A;RAB5A;RRAGA;TSR1;GNL3;DIRAS2;ARL4C;TUBA1C;RAB39A;RANBP17;TUBB2B;GNL1;ADSS1;ARF6
prerank,protein phosphatase activator activity (GO:0072542),-0.32567829410370264,-0.8152734755022935,0.7137330754352031,0.9524590423025532,1.0,5/13,18.00%,IGFBP3;PPP2R5E;PPP2R5D;PTPA;PPP2R5C
prerank,kinase inhibitor activity (GO:0019210),-0.25971005998806973,-0.8149308439634517,0.75,0.9501578546167658,1.0,10/33,22.53%,PARVA;LRP6;TAOK3;DNAJC3;GMFB;NCK1;SH3BP5L;RHOH;CDKN1C;PRKRIP1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2867552727059296,-0.8148948188005707,0.7339622641509433,0.9473535094184676,1.0,6/22,20.59%,ATP6V1B2;ATP6V0D1;ATP6V0A4;ATP2A2;TCIRG1;ATP2A3
prerank,voltage-gated anion channel activity (GO:0008308),-0.3219592981083652,-0.8133035993994034,0.7073643410852714,0.9473799107484273,1.0,6/15,23.99%,CLCN2;VDAC1;ANO1;GPR89B;GPR89A;CLCN6
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.18542069586957374,-0.8124948580807456,0.969758064516129,0.9458742010816898,1.0,66/248,24.93%,RHOQ;OPA1;LRRK2;RHOJ;ATL3;RND3;DNM1L;RAP1B;RNF213;ABCA4;VPS4B;MRAS;VWA8;RAB22A;GFM1;MMUT;DHX9;TBC1D24;CDC42;ABCD2;ATL2;CHD3;RHOA;RHOT1;ATP2B1;RAB11A;GNA14;RALA;GNAS;RHOBTB2;GTPBP10;KIF1C;RASL12;GNG5;GFM2;ARHGDIB;RAB21;GBP3;BMS1;DNAJC27;DDX3X;EFTUD2;GNB1;SMCHD1;GBP7;GBP2;RHOBTB1;VCP;RHOH;RHOC;GBP6;MTG2;RAB24;RIT1;TOR1A;RABL3;NKIRAS1;GNAZ;GPN3;RHOT2;CLPX;RAB8A;RAB9A;SAR1B;RAB7A;IRGM
prerank,O-methyltransferase activity (GO:0008171),0.34501131130397183,0.8117247170233398,0.6991150442477876,0.9745747713691356,1.0,5/10,20.34%,CMTR2;CMTR1;BCDIN3D;MEPCE;ASMT
prerank,MAP kinase phosphatase activity (GO:0033549),-0.33344438771624596,-0.8084995048141908,0.7262773722627737,0.9501610514594656,1.0,4/12,22.43%,DUSP16;DUSP1;DUSP10;DUSP7
prerank,Hsp90 protein binding (GO:0051879),0.2584155841760548,0.8083912891447296,0.7768052516411379,0.9763725456792993,1.0,10/33,18.99%,PACRG;KDR;NPAS2;CYP2E1;UNC45B;RPS3;PTGES3;CHORDC1;AHSA1;NOD2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.3168681171055169,0.8056853064299105,0.7274590163934426,0.9767108309964494,1.0,2/14,10.01%,MAL;NOD1
prerank,motor activity (GO:0003774),0.22936824294962221,0.8046665233829662,0.8438735177865613,0.9743042471792164,1.0,15/60,20.01%,MYO1E;KIF1A;KIF21B;KIFC2;MYL6;MYO6;KIF26B;KIF19;KIFC3;STARD9;DNAH3;KIF21A;KIF18A;KIF1B;KIF26A
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.30566565441351146,-0.8039226840209437,0.7527881040892194,0.955278185791065,1.0,5/17,23.24%,ACAA2;ACOT11;ACOT9;ACOT8;ACOT6
prerank,microtubule minus-end binding (GO:0051011),-0.32715934776611466,-0.8033291089367025,0.7406716417910447,0.9534654399386145,1.0,7/13,30.46%,NUMA1;TUBGCP6;TUBGCP2;TUBGCP4;HAUS7;CAMSAP2;HAUS4
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.262728458354856,-0.7951760902940817,0.7954971857410882,0.9643475526361063,1.0,3/29,4.08%,PRKAG2;KAT2B;RPTOR
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.2657180506377014,-0.7934234507909604,0.7965779467680608,0.9642556821281631,1.0,7/28,19.94%,LRRK2;PRKAA2;MAP2K4;MAP2K1;MAP2K7;PRKACA;MAP2K6
prerank,double-stranded RNA binding (GO:0003725),0.22177861200818402,0.7931124341279928,0.869757174392936,0.990235254760125,1.0,10/70,13.36%,TFRC;ADARB2;ZFR2;HSP90AB1;DUS2;STRBP;LRRFIP1;HSPD1;DROSHA;RFTN1
prerank,NADP binding (GO:0050661),0.2572512033278674,0.7928678533075476,0.7945492662473794,0.9863659765562705,1.0,8/32,17.56%,NDOR1;NOS3;DUS2;KCNAB1;HSD11B1;DHCR7;TM7SF2;NNT
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.30879753060879334,0.7909613111392393,0.7674418604651163,0.9852402343459876,1.0,3/14,12.31%,RPP40;RPP30;POP5
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.27804170276342144,0.788972062633046,0.7714884696016772,0.9844447195892538,1.0,2/21,11.50%,GRIK2;P2RX7
prerank,anion:anion antiporter activity (GO:0015301),0.29372382876198116,0.7886097937890615,0.7731958762886598,0.9808542182326616,1.0,1/17,0.53%,SLC4A1
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.26559141017232896,-0.7884805228944453,0.7861163227016885,0.9693535384839589,1.0,4/27,6.17%,SLC41A1;SLC9A1;SLC9A8;SLC9A2
prerank,hydro-lyase activity (GO:0016836),-0.24233977102634968,-0.7882283897911473,0.8180112570356473,0.966870485923324,1.0,21/41,32.89%,GMDS;ACO2;EHHADH;ACO1;ECHDC2;HACD4;ECHDC3;ECI1;PARK7;APIP;UROS;AUH;IREB2;CBS;ENO3;TBXAS1;ENO1;CDYL;FAHD2A;CYP2S1;ALAD
prerank,5'-nucleotidase activity (GO:0008253),0.31284735051818346,0.7869600642519111,0.73125,0.9793008736978374,1.0,2/13,9.52%,NT5DC2;NT5C
prerank,titin binding (GO:0031432),0.31383279937432185,0.7854143354702916,0.7526427061310782,0.9777497108258326,1.0,4/13,14.32%,TCAP;CALM1;CALM2;CALM3
prerank,nucleoside-diphosphatase activity (GO:0017110),0.31573171233905134,0.7848002547535655,0.7415966386554622,0.9745043442336798,1.0,5/12,23.37%,SLC25A42;ENTPD3;ENTPD1;ENTPD5;ENTPD7
prerank,GDP binding (GO:0019003),0.22184642204708305,0.7829714455830393,0.9002123142250531,0.973227302956459,1.0,15/63,17.97%,RIT2;DIRAS1;NME2;RAB4A;RAB35;MIEF1;RASEF;HRAS;RAP1A;GNAI1;RAB29;RAP2B;RAB31;RALB;RERG
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.33048851642180654,-0.780705156329179,0.7519230769230769,0.9761981485938934,1.0,5/11,25.93%,PRMT2;PRMT5;PRMT8;PRMT9;FBXO11
prerank,exopeptidase activity (GO:0008238),0.22705690361245057,0.7780132480541796,0.8632478632478633,0.9770654295631367,1.0,4/50,6.05%,DPP10;MME;METAP2;DPP6
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.26093447387142565,-0.7773199210106777,0.8126195028680688,0.9784783358807118,1.0,7/27,17.79%,SLC26A7;SLC39A14;SLC26A2;SLC22A6;SLC5A5;SLC25A11;ANO1
prerank,kinase activity (GO:0016301),-0.20304190995523366,-0.7766161862840424,0.9476534296028881,0.9766346755308423,1.0,29/109,21.05%,PI4KA;NADK2;ABL1;LRRK2;GK5;GSK3B;DGKA;MAP4K4;NADK;TRRAP;LYN;MTOR;EPHA4;PANK2;PGK1;DCAKD;PIK3C3;RFK;CSNK2A1;PDXK;PIK3CD;PRKD1;FCSK;ITPKC;IRAK1;TAOK1;SHPK;BCKDK;DGKD
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.27250268389851695,-0.7749229239862025,0.7953216374269005,0.976304128762497,1.0,6/24,14.22%,OSBPL8;OSBPL5;PLA2G4A;ARFIP2;GSDMD;PLEKHA8
prerank,guanyl ribonucleotide binding (GO:0032561),-0.1817875564450686,-0.7745621472638241,0.9868667917448405,0.9740045839196975,1.0,38/196,19.50%,PDE5A;RHOQ;MPPED2;ANXA6;LRRK2;RHOJ;ATL3;ARL3;RND3;RAP1B;RAB10;MRAS;RAB22A;GLUD1;RAB12;CDC42;ATL2;RHOA;RHOT1;ARFIP2;DYNC1LI1;ARF1;RALA;RHOBTB2;GTPBP10;RASL12;RAB21;GBP3;BMS1;RAPGEF2;GBP7;GBP2;RHOBTB1;TUBB2A;RHOH;RHOC;GBP6;MTG2
prerank,transaminase activity (GO:0008483),-0.33250582832433395,-0.7742212275138546,0.7710622710622711,0.9716758684945672,1.0,5/11,34.72%,ABAT;OAT;PSAT1;GOT1;GOT2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.30860802615348554,-0.7734733841023221,0.7786259541984732,0.9699322048360803,1.0,2/14,7.01%,SLC26A7;SLC26A2
prerank,symporter activity (GO:0015293),0.33087991540542727,0.7712236664989733,0.7610993657505285,0.9832375117251655,1.0,1/10,3.76%,MFSD2A
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.30447998004222226,-0.7697592702052943,0.791907514450867,0.9725328125465564,1.0,6/15,31.99%,PI4KA;PIK3C3;PIK3CD;PI4K2B;PI4KB;PIK3C2A
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3337963235176027,-0.7694639713490597,0.7967914438502673,0.9672997546453516,1.0,4/10,22.43%,DUSP16;DUSP1;DUSP10;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3337963235176027,-0.7694639713490597,0.7967914438502673,0.9672997546453516,1.0,4/10,22.43%,DUSP16;DUSP1;DUSP10;DUSP7
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.31583903572101196,0.7648714692900093,0.7652173913043478,0.9885367270719373,1.0,12/12,68.44%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;RHO;OPN1MW;OPN1MW3;RRH;GPR52;GPR88;OPN3
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.32084202877700624,-0.7646109720969985,0.7911877394636015,0.9713188504850214,1.0,6/12,36.18%,CTSH;BCL2L13;ATP2A3;APAF1;PYCARD;CASP1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.29252562045740116,0.7622361959249704,0.7805383022774327,0.9882021323848178,1.0,1/15,0.53%,SLC4A1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.3118406476818542,0.7621427616281189,0.7782515991471215,0.9842472805141571,1.0,1/13,1.91%,PIP5K1B
prerank,mechanosensitive ion channel activity (GO:0008381),-0.32086686479047155,-0.761005358198724,0.7996323529411765,0.9735991876768274,1.0,3/12,19.25%,PIEZO2;TMC4;TMC6
prerank,histone deacetylase activity (GO:0004407),-0.27486603775458707,-0.7581278891979408,0.822550831792976,0.974649979385323,1.0,13/19,38.07%,HDAC8;HDAC4;MIER1;HDAC1;HDAC2;SIRT3;HDAC3;MIER2;HDAC10;MIER3;HDAC5;SIRT6;SUDS3
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3120740326313833,-0.7572233131458771,0.8030592734225621,0.9730958499196954,1.0,5/13,20.38%,AGPAT4;ABHD5;GPAT4;LPCAT1;GPAT3
prerank,5'-3' RNA polymerase activity (GO:0034062),0.25296592421581704,0.7550642853181602,0.8535031847133758,0.9902206020360873,1.0,7/27,17.14%,POLR1H;POLR2J;POLR2B;POLR2I;MED20;POLR3A;POLR2G
prerank,N-acyltransferase activity (GO:0016410),-0.2488254243560214,-0.7530556416188079,0.8452830188679246,0.9757634159538734,1.0,3/32,3.30%,CERS5;EP300;NMT2
prerank,alpha-tubulin binding (GO:0043014),0.2416980119190065,0.7518086624565921,0.839835728952772,0.9906663807822401,1.0,11/31,21.31%,PACRG;TTLL7;SNCA;TRIM36;DIP2B;EFHC2;ARL8A;FYN;TRPV4;CDK5R1;HDAC6
prerank,ATPase regulator activity (GO:0060590),0.2341744713607642,0.7492875803322494,0.8629550321199143,0.9898238737375735,1.0,14/38,22.55%,HSPBP1;DNAJC15;BRSK2;ATP1B1;PFN1;DNAJA2;DNAJB2;AHSA1;BAG2;DNAJC19;DNAJA1;BAG1;ATP1B2;FNIP2
prerank,BMP binding (GO:0036122),-0.31388491060684404,-0.7357064614152016,0.8290766208251473,0.9955378436549998,1.0,2/11,11.08%,NBL1;GREM2
prerank,chemokine receptor binding (GO:0042379),0.23650457879309605,0.7350889939526762,0.8752556237218814,1.0,1.0,7/35,22.93%,CXCL12;CCL2;CCL25;CKLF;CCL13;CCL19;ITCH
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.25926974597436614,-0.7334538625646758,0.8458574181117534,0.9954421342113421,1.0,7/22,21.14%,RNF169;PARP10;ZBTB1;SPRTN;ZRANB3;IKBKE;WDR81
prerank,metallocarboxypeptidase activity (GO:0004181),-0.249674622636252,-0.7326645185210838,0.8963531669865643,0.9936254250620146,1.0,5/26,17.09%,AEBP1;AGBL3;CPM;CPXM2;CPXM1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.2977463013964625,0.7324596980964797,0.8103448275862069,1.0,1.0,3/12,8.48%,TENT5C;TENT4A;PAPOLB
prerank,phosphatase activator activity (GO:0019211),-0.2861072734401751,-0.7291621436080709,0.8582677165354331,0.9951008545989197,1.0,6/14,22.78%,FRS2;PPP2R5E;PPP2R5D;PPP2R5C;BMP2;GTF2F1
prerank,GTPase inhibitor activity (GO:0005095),0.28642096930888006,0.7250603828784183,0.7931726907630522,1.0,1.0,2/13,8.56%,IPO5;GPS2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.2969927735617331,-0.7250467428336296,0.8262548262548263,0.997197391379316,1.0,1/13,0.48%,SLC7A2
prerank,mRNA methyltransferase activity (GO:0008174),0.2944090596950913,0.7221944736534768,0.8258064516129032,1.0,1.0,4/12,21.55%,CMTR2;CMTR1;METTL8;METTL3
prerank,NF-kappaB binding (GO:0051059),-0.2501060336127266,-0.7210888102240818,0.8775894538606404,0.9989244751535366,1.0,3/24,4.84%,EP300;GSK3B;ANXA4
prerank,mitogen-activated protein kinase binding (GO:0051019),0.23509443582273298,0.7201126215529755,0.8719101123595505,1.0,1.0,8/29,17.11%,DUSP6;SIRT1;DIRAS1;PTPRJ;ATF7;GCH1;MAPKAPK2;TNIP1
prerank,DNA replication origin binding (GO:0003688),-0.250765863798879,-0.7191412707190592,0.8725490196078431,0.9982949371692652,1.0,15/23,44.85%,DHX9;MCM9;MCM6;ORC1;MCM4;MCMDC2;CDC45;POLA1;MCM2;MCM7;MCM5;MCM10;GRWD1;ORC3;CDC6
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.19411147478341417,0.7170113287646547,0.967280163599182,1.0,1.0,20/75,21.42%,HADHA;HADH;KCNAB1;HSD17B7;PHGDH;HPGD;PRXL2B;ABCC4;BDH1;KDSR;RDH11;HSD17B10;LDHB;IMPDH1;LDHA;NSDHL;RDH10;UGDH;HSD17B4;HSD3B7
prerank,receptor antagonist activity (GO:0048019),0.26775786677133684,0.7169989235204802,0.8389121338912134,1.0,1.0,1/17,2.62%,FST
prerank,CARD domain binding (GO:0050700),0.28484312077268237,0.7099598953889066,0.864476386036961,1.0,1.0,3/14,11.59%,CARD19;NOD1;BCL10
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.2370553936564298,-0.7091082533794066,0.888015717092338,1.0,1.0,7/29,17.25%,GANC;ACER3;HEXD;GUSB;PGGHG;GANAB;ABHD10
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.29866528052667946,-0.7085264224607984,0.8444444444444444,1.0,1.0,4/12,19.35%,VEGFA;VEGFD;ITGA5;ITGB3
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.2826236508758846,0.7066212779299408,0.8582834331337326,1.0,1.0,4/14,15.33%,ISCU;ISCA2;ETFDH;RSAD2
prerank,carbohydrate kinase activity (GO:0019200),0.28979456533061404,0.7065003306596919,0.8308977035490606,1.0,1.0,1/11,3.26%,KHK
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.2961912673223238,0.7051472930889211,0.8574660633484162,0.9977334868684524,1.0,2/11,5.53%,SLC25A42;SLC25A23
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.20640185866154087,-0.7009996207845073,0.943579766536965,1.0,1.0,7/46,14.23%,LARGE1;B3GALT1;EXT1;B3GLCT;MGAT3;OGT;HEXA
prerank,gated channel activity (GO:0022836),-0.27980588349759855,-0.6973909698057261,0.8706099815157117,1.0,1.0,1/14,1.06%,PIEZO2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.2873784819339199,0.6970395856316801,0.8705357142857143,1.0,1.0,2/12,5.53%,SLC25A42;SLC25A23
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.2879001037354885,0.689485536307787,0.8372591006423983,1.0,1.0,6/12,21.69%,ISCU;ISCA2;ISCA1;CISD2;CIAPIN1;CISD1
prerank,pyrophosphatase activity (GO:0016462),-0.2060121963931703,-0.6892103461787652,0.9500998003992016,1.0,1.0,22/50,32.29%,ENPP1;NUDT4;NUDT5;DHX9;PRUNE1;ENPP3;PPA1;DDX3X;ENTPD6;RNGTT;ALPL;PPA2;DOLPP1;NUDT1;NUDT11;PLPP1;PLPP5;NUDT7;CILP;FITM2;NUDT16;NUDT16L1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.2810654038766929,0.68880276607337,0.8496732026143791,1.0,1.0,1/12,1.49%,SPPL2B
prerank,lysophospholipase activity (GO:0004622),0.24880743867082622,0.6870303117066979,0.9164882226980728,0.9995872707147043,1.0,2/20,4.89%,ENPP2;LYPLA1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.2629652904988313,0.6865683820111449,0.8931623931623932,0.9962046755158678,1.0,2/15,8.27%,ACKR4;GPR17
prerank,chloride channel regulator activity (GO:0017081),-0.2712011006948028,-0.6857929092470434,0.88268156424581,1.0,1.0,7/14,31.13%,VTI1B;WNK4;WNK1;STX8;STX1A;STX7;SGK1
prerank,translation initiation factor activity (GO:0003743),-0.21912389286043513,-0.6848444969066952,0.9350393700787402,1.0,1.0,14/36,31.40%,EIF4G3;EIF4A2;EIF4E;EIF3A;EIF4G1;EIF3L;EIF2B4;EIF2B5;EIF4E3;EIF3H;EIF3C;EIF3M;COPS5;EIF2B1
prerank,histone methyltransferase binding (GO:1990226),-0.29312488009667725,-0.6833822783430089,0.8607594936708861,1.0,1.0,3/11,14.12%,LCOR;CBX1;PHF1
prerank,WW domain binding (GO:0050699),-0.22641924879938416,-0.6830995498889403,0.920303605313093,1.0,1.0,9/26,34.36%,PMEPA1;RAPGEF2;TCEAL9;WBP11;WBP1;TCEAL8;DAZAP2;TCEAL1;TRAF4
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3054578697654029,-0.6829584104285459,0.8745247148288974,1.0,1.0,3/10,23.99%,CLCN2;ANO1;CLCN6
prerank,MHC protein binding (GO:0042287),-0.25118843291125625,-0.6814098010165635,0.9066147859922179,1.0,1.0,7/20,35.67%,TAP2;DERL1;TAP1;CD81;ATP5F1A;LAG3;TAPBP
prerank,tumor necrosis factor receptor binding (GO:0005164),0.2807913040475203,0.6812326774591201,0.8824742268041237,0.997161331409321,1.0,2/12,7.04%,TRAF1;TRIM37
prerank,deoxyribonuclease activity (GO:0004536),0.2718675677832599,0.678330475885162,0.8758169934640523,0.9958389090194417,1.0,4/14,17.60%,APEX1;RPS3;DFFB;APLF
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.29193737855478064,-0.6770055576226399,0.8846880907372401,1.0,1.0,1/11,2.66%,SLC5A3
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.2368625414256522,-0.6720278850775391,0.9277777777777778,1.0,1.0,12/22,38.67%,RBMS3;DHX36;EXOSC9;CPEB1;NUDT21;CPSF1;ZFP36L2;EXOSC8;RBM24;ELAVL1;MEX3D;ILF3
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.23864283479322507,-0.6628779405534339,0.939922480620155,1.0,1.0,6/20,20.38%,AGPAT4;ABHD5;GPAT4;MOGAT3;LPCAT1;GPAT3
prerank,DNA polymerase activity (GO:0034061),-0.2317794685403532,-0.6595196724411406,0.9123809523809524,1.0,1.0,13/22,38.88%,POLM;REV1;POLE4;TERT;POLN;PRIMPOL;POLE2;POLH;POLA1;POLE;POLD4;REV3L;POLE3
prerank,P-type ion transporter activity (GO:0015662),0.2661555296716333,0.6584510006697666,0.89375,1.0,1.0,4/12,19.25%,ATP2B3;ATP2B4;ATP2B2;ATP2C1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.2723508721614208,0.6580632016966614,0.9135021097046413,1.0,1.0,4/12,18.98%,PIK3R3;ATM;IPMK;PIK3R6
prerank,ubiquitin-dependent protein binding (GO:0140036),0.2862751907677974,0.6569345277443025,0.9023354564755839,1.0,1.0,6/10,25.82%,DNAJB2;ANKRD13A;DNAJC2;USP15;ANKRD13D;LAPTM5
prerank,death receptor binding (GO:0005123),-0.26204082473368095,-0.6565307143571254,0.900562851782364,1.0,1.0,2/15,9.78%,EDA;NGF
prerank,peptide hormone receptor binding (GO:0051428),0.2752684098400584,0.6524191149784195,0.8986784140969163,1.0,1.0,1/11,7.52%,ADCYAP1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.20706921747682172,-0.6499637000007858,0.9653179190751445,1.0,1.0,17/35,33.75%,FTO;TRMT9B;PUS10;TARS2;ALKBH1;QTRT2;FTSJ1;LCMT2;DTWD1;DUS3L;ELAC2;DTWD2;MRPL58;TYW3;QRSL1;TRMT12;TRPT1
prerank,C-C chemokine receptor activity (GO:0016493),0.2240573621545224,0.6477374953757867,0.9397849462365592,0.9998476136370275,1.0,2/21,9.26%,ACKR4;GPR75
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.2022640374918312,0.6474787153518156,0.9744680851063829,0.9962432110345943,1.0,3/38,10.04%,SPOCK1;SERPINB8;SLPI
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.2509000730097195,-0.6469854105476556,0.9190140845070423,1.0,1.0,3/16,15.38%,MTMR12;MTMR3;SACM1L
prerank,C-C chemokine binding (GO:0019957),-0.2287650580796493,-0.6420374634469483,0.9247104247104247,1.0,1.0,15/22,54.92%,CCR9;CX3CR1;CCR5;ACKR1;CCR2;CXCR4;CCRL2;CXCR6;CCR1;ZFP36;CCR10;CXCR5;ACKR3;CCR6;CXCR2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.25670857931776286,-0.6418937143398964,0.9267326732673268,1.0,1.0,6/14,35.61%,MTHFR;ALDH1L1;ALDH4A1;PYCR2;AASS;PYCR3
prerank,glutathione transferase activity (GO:0004364),0.22417439945303114,0.6409705448998791,0.9411764705882353,0.9967710704633769,1.0,2/23,8.05%,GSTA4;GSTM5
prerank,carboxypeptidase activity (GO:0004180),-0.20477941359643748,-0.6400804498734313,0.969811320754717,1.0,1.0,6/35,17.09%,AEBP1;AGBL3;CPM;CTSA;CPXM2;CPXM1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.25197645087221876,-0.6392954525540542,0.9281553398058252,1.0,1.0,5/15,20.38%,AGPAT4;ABHD5;GPAT4;LPCAT1;GPAT3
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.2641976895339485,-0.6389871947456249,0.9064220183486239,1.0,1.0,1/12,2.20%,B3GALT1
prerank,adenyl nucleotide binding (GO:0030554),0.25697105178969787,0.6278736745683613,0.9112050739957717,0.9970076998114867,1.0,1/11,1.66%,HSPBP1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.25697105178969787,0.6278736745683613,0.9112050739957717,0.9970076998114867,1.0,1/11,1.66%,HSPBP1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.2666002273360616,0.6228865148682383,0.9362637362637363,0.9962315427460282,1.0,2/10,13.11%,APEX1;POLD1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.2383154460841309,-0.616981512218836,0.941712204007286,1.0,1.0,5/15,27.75%,SH3PXD2B;PLA2G4A;PLEKHF1;JPH2;SAP30L
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.2632517957800733,0.6166285455194347,0.9377682403433476,0.9959407198473192,1.0,3/11,15.46%,SGMS1;AASDHPPT;SAMD8
prerank,MHC class I protein binding (GO:0042288),-0.25083745855586204,-0.6151673328631062,0.9386617100371747,1.0,1.0,5/13,35.67%,TAP2;DERL1;TAP1;ATP5F1A;TAPBP
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.2639523440826626,-0.6132504540648063,0.9226190476190477,1.0,1.0,6/11,32.86%,NABP2;CTC1;TERF2;STN1;RPA2;HNRNPA2B1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.23187792437213012,0.6053407096455615,0.9488888888888889,0.9978687014866465,1.0,4/17,16.64%,PECR;TECR;DHCR7;TM7SF2
prerank,transferrin receptor binding (GO:1990459),-0.26356655508693494,-0.6017992305760144,0.9393939393939394,1.0,1.0,1/10,8.17%,RGMA
prerank,purinergic nucleotide receptor activity (GO:0001614),0.22973511820074793,0.6001319364574798,0.9508196721311475,0.9964556274593683,1.0,2/15,11.50%,P2RY1;P2RX7
prerank,ribosome binding (GO:0043022),-0.18019275751562625,-0.5974762430341628,0.990530303030303,1.0,1.0,16/46,31.67%,YTHDF3;GEMIN5;SERBP1;NAA15;CPEB1;SHFL;PYM1;BAG6;NAA16;SRP72;EIF3C;IGHMBP2;CCDC47;C1QBP;SRP19;MRPS27
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.25517980075067065,-0.5964003372479749,0.9398907103825137,1.0,1.0,6/11,36.39%,NAA15;NAA16;NAA80;NAA25;NAA40;NAA10
prerank,ribosomal large subunit binding (GO:0043023),-0.2590091964724459,-0.5894223390085106,0.9524714828897338,1.0,1.0,4/11,35.56%,MRRF;LTN1;DHX33;NPM1
prerank,ribosomal small subunit binding (GO:0043024),-0.22116493935496412,-0.5863636095198439,0.9441233140655106,1.0,1.0,5/17,27.54%,LARP1;DDX3X;NME1;ERAL1;PIM1
prerank,pseudouridine synthase activity (GO:0009982),-0.2402109400933861,-0.5851217064137822,0.9532374100719424,1.0,1.0,8/13,42.04%,PUS10;PUS3;RPUSD4;PUS1;PUS7L;PUSL1;RPUSD2;RPUSD3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.24588479659034587,-0.5833852992680391,0.9557692307692308,1.0,1.0,2/11,11.71%,AKR1B1;AKR1A1
prerank,microtubule motor activity (GO:0003777),0.16945990763548743,0.5828862980414083,1.0,0.9996913620102812,1.0,12/51,20.01%,KIF1A;KIF21B;KIFC2;KIF26B;KIF19;KIFC3;STARD9;DNAH3;KIF21A;KIF18A;KIF1B;KIF26A
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.20878588454892277,-0.582489525382503,0.9597701149425287,1.0,1.0,12/21,38.88%,POLM;REV1;POLE4;POLN;PRIMPOL;POLE2;POLH;POLA1;POLE;POLD4;REV3L;POLE3
prerank,phospholipase A2 activity (GO:0004623),0.19512800890961665,0.5807682326935241,0.973630831643002,0.9968978098246629,1.0,5/26,19.73%,PLAAT1;PLA2G12A;PNPLA3;PLA2G4E;PRDX6
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.19335252878238537,0.5752362912198373,0.9877800407331976,0.9952275846527036,1.0,6/28,18.95%,TRAF1;TRIM37;DAB2IP;MADD;TMBIM1;RIPK1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.2282636882430306,0.5723544375947885,0.9644351464435147,0.9925996283886136,1.0,5/14,18.81%,YOD1;MINDY1;MINDY2;ATXN3;OTUD7B
prerank,aspartic-type peptidase activity (GO:0070001),-0.25162805098698815,-0.5689138345983643,0.9705882352941176,1.0,1.0,1/10,7.42%,DDI2
prerank,protein phosphatase 1 binding (GO:0008157),-0.19789713570545908,-0.5544311030731842,0.9833024118738405,1.0,1.0,5/21,22.76%,SHOC2;PPP1R3B;SH3RF2;PPP1R3C;PPP1R3F
prerank,methyl-CpG binding (GO:0008327),-0.1983827284296601,-0.5533729798915838,0.9810246679316889,1.0,1.0,10/22,33.85%,MBD2;PRMT5;CXXC5;MBD3;CXXC4;ZBTB4;TET3;ZBTB38;ERH;ZBTB21
prerank,copper ion binding (GO:0005507),0.16793810855808947,0.5462752984066311,0.9938900203665988,0.9966646140766346,1.0,6/42,16.48%,AOC2;SNCA;ATOX1;SNCB;COX17;COA6
prerank,CCR chemokine receptor binding (GO:0048020),0.17509286713811975,0.5331229826027247,0.9937629937629938,0.996242527125631,1.0,26/28,62.24%,CCL2;CCL25;CCL13;CCL19;NARS1;CCL14;CCL22;CCL17;CCL24;CCL26;CXCL13;DEFB1;XCL1;CCL3;CCL1;DEFB130A;MSMP;CCL8;CCL7;CCL4;CCL11;CCL5;CCRL2;CNIH4;CX3CL1;CCR2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.21418712227310843,-0.5271866959564124,0.9875,1.0,1.0,2/14,13.05%,MTMR12;MTMR3
prerank,triglyceride lipase activity (GO:0004806),-0.18815205489867393,-0.5179363881418453,0.9923076923076923,1.0,1.0,4/20,26.15%,ABHD5;DAGLB;PNPLA2;LPL
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.22122513016755807,-0.5029405245980192,0.988929889298893,1.0,1.0,5/10,36.39%,NAA15;NAA16;NAA80;NAA25;NAA10
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.1969505935857827,-0.49074459282390304,0.9854545454545455,1.0,1.0,5/14,27.07%,DTYMK;NME6;NME1;CMPK2;AK1
prerank,single-stranded DNA helicase activity (GO:0017116),-0.18001630314316117,-0.48634375758196424,0.9962825278810409,1.0,1.0,10/19,43.69%,DHX9;MCM6;HELB;HELQ;RAD51;MCM2;MCM7;MCM5;DSCC1;CHTF18
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.21578320549404525,-0.48584763080879234,0.9813432835820896,1.0,1.0,4/10,34.03%,PML;ANKRD13B;FAAP20;IDE
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.16905580894997346,-0.48262018154588665,0.9962756052141527,1.0,1.0,9/24,34.30%,DTYMK;NME6;ITPKC;NME1;IP6K2;CMPK2;AK1;AK7;PPIP5K2
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.18340121302125598,-0.4798548066257455,0.9981884057971014,0.9992916298876845,1.0,5/17,27.07%,DTYMK;NME6;NME1;CMPK2;AK1
prerank,RNA methyltransferase activity (GO:0008173),-0.1747303418447218,-0.46903531678274546,0.9980988593155894,0.9979254826480239,1.0,7/19,33.27%,TRMT9B;TGS1;FTSJ1;LCMT2;TYW3;MRM2;TRMT12
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.20146525941371013,0.4614799556691615,0.9913793103448276,1.0,1.0,2/10,14.18%,PIK3R3;ATM
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.17623176408092528,0.4527654214011725,0.9958419958419958,1.0,1.0,2/15,17.41%,PLA2G12A;PLA2G4E
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.19267290662333852,0.44418951170801296,0.9933184855233853,0.9973119502923178,1.0,4/10,24.18%,YOD1;ATXN3;STAMBP;CYLD
prerank,solute:proton symporter activity (GO:0015295),-0.166645069855902,-0.4308570939941093,1.0,0.9982124722947041,1.0,6/16,33.61%,SLC33A1;SLC25A3;CTNS;SLC2A10;SLC17A5;SLC11A2
